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Abstract 
 
Introduction 
Surgical resection of the primary tumour remains the mainstay of treatment for colorectal cancer 
(CRC), which is the most common cancer in Australia and most other affluent countries. 
Traditionally, CRCs were resected through a large surgical incision (open resection). In the early 
1990’s laparoscopic resection (minimal-access) was introduced. Large randomised clinical trials 
(RCT) have since shown post-operative benefits to patients, including less pain and blood loss, 
faster return of gastrointestinal function, lower risk of pneumonia and shorter hospital stay. RCTs 
with longer term follow-up have shown equivalent oncological outcomes. Additionally, economic 
modelling suggests that laparoscopic resection is cost-effective: it uses more resources than open 
resection, but these additional health system costs are offset by costs associated with shorter 
hospital length of stays (LOS), fewer post-operative complications and improved patient quality-of-
life. Despite this, widespread adoption of laparoscopic resection for CRC has been slower than 
other laparoscopic procedures. Reasons for this slower uptake include early concerns about port-site 
metastases, a long learning curve for surgeons and the need for costly and specialised equipment.  
Aim 
The overarching aim of the thesis is to utilise existing government databases to provide a better 
understanding of current uptake of laparoscopic surgery, especially for CRC. The results will 
provide evidence to assist future planning to ensure optimal uptake.    
The specific research questions are: 
1. What is the utility of secondary diagnosis codes in hospital morbidity data for determining 
summary stage of CRC?  
2. What has been the uptake of laparoscopic segmental resection of the colon and laparoscopic 
resection of the rectum across Australia, and how does it compare between public and private 
hospitals?  
3. What has been the uptake of laparoscopic resection for CRC by procedure type and patient 
characteristics in Queensland for the period from 1999/2000 to 2010/2011? 
4. What is the hospitalisation costs of laparoscopic resection compared with open resection for CRC 
in Queensland? 
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5. What has been the uptake of the laparoscopic technique for colorectal resection, hysterectomy, 
cholecystectomy, fundoplasty and nephrectomy, across Australia from 1993/94 to 2010/11, and 
how has the uptake differed between cancer and non-cancer indications? 
Methods  
The government databases used in this thesis provide complete coverage of two entire geographic 
populations, either of Queensland (the north-eastern state of Australia) or all of Australia. The main 
outcome measure was the laparoscopic percentage, that is the number of resections done 
laparoscopically divided by the total of all resections (i.e., laparoscopic + open). Analyses were 
stratified by complexity of procedure, cancer stage, cancer site, public versus private hospital, and 
comorbidities, as well as patients’ age and sex. Statistical methods used to perform analyses 
include: Poisson regression to estimate the annual percentage change in uptake of laparoscopic 
resection; and multivariable regression to analyse costs, LOS, duration of surgery, and admission to 
intensive care (with adjustment for prognostic factors).  
Results 
Questions 2 and 5: Uptake of laparoscopic techniques in Australia 
In Australia, uptake of laparoscopic resection for CRC has been slow relative to other procedures. 
Within four years of introduction, almost all cholecystectomies were laparoscopic (9% in 1990/91; 
79% in 1993/94). Similarly, more than 80% of fundoplasties were laparoscopic by 2000/01. In 
contrast, for laparoscopic resection for CRC, segmental resections of the colon increased from 2% 
in 2000/01 to 28% in 2007/08, and rectal resections increased from 1% to 22%. Uptake was faster 
in private than in public hospitals.  
Question 3: Uptake of laparoscopic CRC by procedure type and patients 
In contrast, Queensland experienced a rapid uptake of laparoscopic resection for CRC across all 
procedure types, including the complex procedures usually excluded from the RCTs. For example, 
the laparoscopic percentage of transverse colectomies increased from 4% to 48% between the early 
time period (1999/00-2002/03) and late time period (2009/10-2010/11), which was similar to 
laparoscopic left hemicolectomy (4% to 54%). Furthermore, other patient groups normally excluded 
from the RCTs (e.g., those with cardiac or pulmonary conditions, or distant spread of cancer) did 
not experience slower uptake in laparoscopic resection.  
Question 4: In-hospital cost of laparoscopic compared with open resection for CRC 
Queensland hospital costing data showed that, after adjusting for potential confounders, 
laparoscopic resection was associated with reduced LOS, fewer and shorter admissions to intensive 
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care, and equivalent surgical duration to open resection. In 2012, laparoscopic resection was $2,524 
less expensive than open resection ($25,036 versus $27,561).  
Conclusion 
In Queensland, a jurisdiction where uptake is mature, laparoscopic resection for CRC has diffused 
across all patient types, including those normally excluded from the RCTs. Whether a patient with 
CRC receives laparoscopic resection is determined by access to hospitals with the necessary 
equipment, and surgical teams with the necessary training and experience. The findings from this 
thesis can be used by clinicians, service planners, policy-makers and budget-holders to plan and 
manage uptake of laparoscopic resection for CRC, and potentially other new surgical technologies. 
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Chapter 1 Introduction 
Queensland is the north-eastern state of Australia with a population of 4.5 million children and 
adults. Queensland is geographically large with almost half of the population living outside of 
cities.  
The Federal Government provides the majority of funding for Australia’s healthcare system across 
the public and private healthcare sectors. It is the responsibility of state and territory governments to 
deliver and coordinate public health care within their respective state or territory. Patients who 
receive care as a public patient experience no or little out-of-pocket expenses for their medical care 
and do not choose their treating clinicians. Patients who elect to be treated as a private patient incur 
expenses, but can choose their treating clinicians. As an admitted patient, treatment in the private 
healthcare sector receives federal government reimbursement for a portion of their care; the 
remainder (gap) is subsidised by private healthcare insurance and/or directly from the patient.(1) 
The majority of clinical training occurs in the public healthcare sector and in public hospitals, which 
means that clinicians complete their training in public hospitals before commencing in the private 
sector. Public hospitals are only likely to invest in expensive specialised equipment in major 
teaching hospitals and facilities that receive a high volume of patients, at least until the equipment 
becomes less expensive and the procedure requiring the specialised equipment becomes the 
standard of care.  
Each of the states and territories is responsible for the management of hospital morbidity and 
clinical costing data. The State Government’s Department of Health in Queensland (Queensland 
Health) maintains the Queensland Hospital Admitted Patients Data Collection (QHAPDC), which is 
a comprehensive dataset for all separations of admitted patients from all public and private hospitals 
in Queensland. QHAPDC, along with similar datasets from each of the other Australian states and 
territories are collated by the Australian Institute of Health and Welfare (AIHW) to produce the 
National Hospital Morbidity Database (NHMD). Through this thesis, I had the support of 
Queensland Health and was therefore able to acquire detailed, patient level data from QHAPDC. I 
was able to request aggregated NHMD data from AIHW. Similarly, I was able to acquire from 
Queensland Health patient level data that included costs associated with the provision of services as 
an admitted patient. 
This thesis provides analyses of the uptake, patient selection and cost associated with laparoscopic 
resection for colorectal cancer (CRC). Colorectal surgeons in Queensland were early adopters of the 
technique and uptake was rapid. Queensland is therefore further along the adoption curve for 
laparoscopic resection for colorectal cancer than most other jurisdictions around the world. 
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Queensland’s population-based, government data sources were utilised throughout this thesis to 
describe “real-world” clinical practices in this region where surgical teams now have high levels of 
experience in laparoscopic resection for CRC. Additionally, NHMD data were obtained from the 
AIHW to study the uptake of laparoscopic resection for CRC across Australia and to compare 
uptake between public and private hospitals, and high and low volume hospitals. The NHMD was 
also used to compare the uptake of laparoscopic techniques for a range of therapeutic procedures, 
for malignant and non-malignant related conditions.  
The overarching aim of the thesis is to utilise existing government databases to provide a better 
understanding of current uptake of laparoscopic surgery, especially for CRC. The results will 
provide evidence for policy-makers, budget-holders and service-planners in health departments 
throughout Australia, to assist in future planning and ensure optimal uptake of this surgery.    
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Chapter 2 Background 
This section provides epidemiological information about CRC in Australia, describes stages of CRC 
and prognosis, and identifies current clinical practice for the management of CRC. A sub-section is 
specifically dedicated to the description of laparoscopic resection for CRC including a summary of 
available evidence, surgical training and patient selection for this procedure, and data relating to 
laparoscopic resection for CRC in Queensland. I then describe theories around the diffusion of 
surgical innovation. Finally, I describe the aims and objectives, and the organisation of the thesis. 
2.1 Colorectal cancer in Australia  
CRC is the most common cancer affecting both men and women in Australia.(2) In 2012 the AIHW 
estimated that 15 840 newly diagnosed cases of CRC would occur in that same year.(2) CRC is 
more common in men than women. In 2009, the risk of diagnosis before the age of 75 years was 1 
in 19 for men and 1 in 28 for women.(2) Risk increases progressively with age and the average age 
at diagnosis is 69.3 years.(3) Among the aging population, the number of new cases in 2025 is 
estimated between 22 708 and 23 548.(4)   
The relative 5-year survival for CRC has increased from 48% in 1982-1987 to 66% in 2006-
2010,(3) mainly due to improvements in detection and treatment. However, it remains the second 
most common cause of cancer deaths, accounting for 3982 deaths in 2010.(3)   
CRC is the 10th leading cause of hospital admission and was the reason for 29 263 admissions in 
2010/11.(3) As a disease affecting the older population, it is expected to impose greater burden on 
the healthcare system as the population ages. In an effort to alleviate this burden, one of the main 
objectives of the National Bowel Cancer Screening Program is to reduce the incidence of CRC 
through the detection and subsequent removal of polyps and adenomas.(5)  
According to the National Colorectal Cancer Care Survey report, 55% of patients with CRC in 
Australia have their major surgery in a public facility and 75% of the treating hospitals are in 
metropolitan or inner regional areas.(6) Most tumours occur in the left (descending) colon (37%), 
with 28% in the right (ascending) colon, 8% in the transverse colon and 27% in the rectum (Figure 
2-1). In 2000, elective screening for CRC was uncommon, with only 5.9% of patients presenting 
with screen detected CRC.(6) The majority of patients with CRC presented with symptoms 
(83.4%); the remainder of admissions for CRC (10.7%) were emergency admissions. Most patients 
diagnosed with CRC (95%) undergo surgery.(6)     
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Of the 1911 patients reported to have had their CRC resected, 18% had metastatic spread of disease 
(Dukes’ stage D); 27% had regional spread of disease (Dukes’ stage C); and 51% had localised 
disease (Dukes’ A or B).(6) 
Figure 2-1 Anatomic sites of the colon. 
 
Source: AJCC cancer staging atlas.(7) 
2.2 Colorectal cancer stage and prognosis 
Identifying the stage of CRC is vital for determining treatment and prognosis; the earlier the stage at 
diagnosis, the higher the chance of survival.(8) Presently in Australia, there is no routine collection 
of cancer stage at a statewide or national population level. Smaller clinical cancer registries 
managed locally by Australian health service regions or privately by clinicians include cancer stage 
information. The largest collections of clinical cancer data are individually maintained for public 
facilities by six Area Health Services in New South Wales.(9) For CRC, the clinical cancer 
registries capture data for 94% of people admitted to hospitals within the Area Health Services for a 
procedure.(9) Stage information is available in the clinical cancer registries for 77% to 84% of these 
patients.(9) 
The American Joint Committee on Cancer (AJCC) has assigned a staging system for CRC based on 
the level of infiltration of the primary tumour (Tumour), metastasis to regional lymph nodes (Node) 
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and metastasis to other organs or sites (Metastasis), known as the TNM classification system (Table 
2-1).(10)    
Table 2-1 Definitions of TNM classifications for colorectal cancers 
Primary Tumour (T) 
TX Primary tumour cannot be assessed       
T0 No evidence of primary tumour       
Tis Carcinoma in situ: intraepithelial or invasion of lamina propria   
T1 Tumour invades submucosa         
T2 Tumour invades muscularis propria        
T3 Tumour invades through the muscularis propria into pericolorectal tissues   
T4a Tumour penetrates to the surface of the visceral peritoneum   
T4b Tumour directly invades or is adherent to other organs or structures 
Regional lymph nodes (N) 
NX Regional lymph nodes cannot be assessed      
N0 No regional lymph node metastasis       
N1 Metastasis in 1–3 regional lymph nodes      
N1a Metastasis in one regional lymph node      
N1b Metastasis in 2–3 regional lymph nodes      
N1c Tumour deposit(s) in the subserosa, mesentery, or nonperitonealized pericolic or 
perirectal tissues without regional nodal metastasis 
N2 Metastasis in four or more regional lymph nodes    
N2a Metastasis in 4–6 regional lymph nodes      
N2b Metastasis in seven or more regional lymph nodes    
Distant metastasis (M) 
M0 No distant metastasis         
M1 Distant metastasis          
M1a Metastasis confined to one organ or site (e.g., liver, lung, ovary, non-regional 
node) 
M1b Metastases in more than one organ/site or the peritoneum   
Source: modified from the AJCC cancer staging manual 7th edition.(10)  
In its most recent edition (7th edition), the AJCC Cancer Staging Manual restructured the mapping 
of TNM and ‘anatomic stages/prognostic groups’ to include better alignment with survival 
outcomes (Table 2-2).(10) Dukes’ stage was the original and standard system of staging CRC prior 
to the AJCC staging(8) and was commonly reported in the published literature (Table 2-2). In 
Australia, CRC stage is often referred to as the Australian clinicopathological stage (ACPS).(11) 
6 
 
Table 2-2 Pathologic TNM staging mapped to AJCC and Dukes’ and 
ACPS stage for colorectal cancer 
Anatomic stage/prognostic groups 
AJCC 
Group 
T N M Dukes’/ACPS 
0 Tis N0 M0 – 
I T1 N0 M0 A 
 T2 N0 M0 A 
IIA T3 N0 M0 B 
IIB T4a N0 M0 B 
IIC T4b N0 M0 B 
IIIA T1–T2 
T1 
N1/N1c 
N2a 
M0 
M0 
C 
C 
IIIB T3–T4a N1/N1c M0 C 
 T2–T3 N2a M0 C 
 T1–T2 N2b M0 C 
IIIC T4a N2a M0 C 
 T3–T4a N2b M0 C 
 T4b N1–N2 M0 C 
IVA Any T Any N Any D* 
IVB Any T Any N Any D* 
Source: modified from the AJCC cancer staging manual 7th edition.(10) 
* Modified to include clinicopathological staging identification of 
Dukes’ stage for metastatic colorectal cancer (Dukes’ D).  
Survival directly correlates with the incremental increases in AJCC stage group, with the exception 
of AJCC stage III cancers, which spread to lymph nodes. While survival rates are incremental for 
IIIA to IIIC, they have survival rates better than those seen among cancers of some earlier stages 
(stage I and II). This is particularly apparent for Stage IIIA cancers for which the survival rates 
throughout the five years are akin to that of AJCC stage I cancers (Figure 2-2 and Figure 2-3). For 
cancers of the colon, this is probably due to the success of post-surgical adjuvant chemotherapy, 
which is highly recommended for stage III colon cancers.(11) For rectal cancers, although 
chemotherapy is recommended for stage II and stage III cancer, (11) a survival advantage remains 
for stage III over stage II.  
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The 7th edition of the AJCC Cancer Staging Manual emphasises the importance of complete 
documentation of all staging classifications, clinical and pathologic, for CRC.(10) Appropriate 
recording of clinical stage permits comparison between cases,(12) and facilitates research  
investigating healthcare delivery and cancer outcomes. The AJCC has developed templates for the 
purpose of aiding in the standardised pathologic reporting of CRC. (10)   
2.3 Clinical management of colorectal cancer 
Treatment for CRC usually consists of surgical resection with or without adjuvant treatment.(13) 
The objective of surgical treatment is to remove the primary tumour along with adequate surgical 
margins and assess any regional spread.(11) It is recommended that a minimum of 12 lymph nodes 
from the abdomen are resected to clearly establish stage of disease.(14) Formation of a successful 
anastomosis with preservation of anorectal sphincter function is standard where possible.(15) To 
achieve this, the conventional method for surgical resection of CRC has required a large open 
wound to the abdomen which could extend from the costal margin to the pubic bone (Figure 
2-4).(16) Although transverse muscle-cutting incisions may be used for excision of regions such as 
the right colon,(16) a midline incision is often preferred(17). Open access to the abdomen via these 
incisions leads to considerable post-operative pain for the patient, a long recovery and hospital-stay 
and exposure to complications which can lead to high-dependency care.(18) 
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Figure 2-2 5-Year survival rates of colon cancer by stage 
 
Observed survival rates for 28 491 cases with adenocarcinoma of the 
colon. Data from the SEER 1973–2005 Public Use File diagnosed in 
years 1998–2000. Stage I includes 7 417; Stage IIA, 9 956; Stage IIB, 
997; Stage IIC, 725; Stage IIIA, 868; Stage IIIB, 1 492; Stage IIIC, 2 
000; and Stage IV, 5 036. Source: AJCC Cancer Staging Manual.(10) 
 
 
 
 
Figure 2-3 5-Year survival rates of rectal cancer by stage 
 
Observed survival rates for 9 860 cases with adenocarcinoma of the 
rectum. Data from the SEER 1973-2005 Public Use File diagnosed in 
years 1998-2000. Stage 1 includes 3 470; Stage IIA, 2 752; Stage IIB, 
165; Stage IIC, 268, Stage IIIA, 595; Stage IIIB, 615; Stage IIIC, 761; 
and Stage IV, 1 234. Source: AJCC Cancer Staging Manual.(10) 
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2.3.1 Laparoscopic resection 
The term “laparoscopy” refers to the visual examination of the abdominal cavity by means of 
a laparoscope (endoscope). “Laparoscopic surgery” includes diagnostic and therapeutic 
procedures after gaining access to the abdominal cavity.(19) Pneumoperitoneum is the 
gaseous insufflation of the abdomen that is routinely used during laparoscopic surgery to 
allow the surgical team to visualise the viscera and to perform the procedure.(20) This thesis 
focuses on the resection of tissue from organs, and laparoscopic surgery will be referred to as 
laparoscopic resection.  
Beginning in the late 1980’s to early 1990’s, laparoscopic surgery revolutionised abdominal 
surgery and procedures such as laparoscopic cholecystectomy became the standard of 
care.(19) Beneficial short-term outcomes of laparoscopic over open colorectal resection 
include: less intraoperative blood loss, reduced pain, reduced postoperative ileus and hospital 
stay, and improved pulmonary function and quality of life.(21) Laparoscopic resection also 
results in fewer incisional hernias and adhesions, resulting in reduced rates of adhesional 
obstruction.(22) These benefits provide impetus for uptake of this technique.  
Figure 2-4 Representations of incisions for: a) open colorectal resection; b) 
laparoscopic colorectal resection  
   a)                                              b)
 
Source: Cancer News “Laparoscopic colorectal surgery for cancer: Is it ready 
for prime time?”(23) 
a) One large excision  
b) Multiple small incisions are used for instruments and the camera. The 
specimen is removed by enlarging one of the incisions. 
Acceptance of laparoscopic surgery for the treatment of CRC by healthcare providers was 
slower than for some other conditions. Reasons for delay in its uptake include less than 
optimal equipment, limited opportunities for training and a long learning curve. In addition, 
there were concerns about whether medium- to long-term outcomes were as good as those 
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achieved with open surgery.(19) For example, in one small but commonly cited case series, 
port-site metastases (tumour spread at wound site/s for laparoscopic instruments or tumour 
removal during surgery) were reported for 3 of 14 patients (21%).(24) 
Several multi-centre RCTs were established in response to concerns about the oncological 
safety of laparoscopic resection for CRC (Table 2).(25-33) For example, a meta-analysis 
reported that across seven studies, only 3 of 826 (0.4%) colon cancer patients who were 
randomised to laparoscopic surgery had port-site metastases, which is similar to the 1 patient 
of 801 (0.12%) in the open resection group.(34)  
These RCTs report short- and long-term outcomes for laparoscopic resection that are non-
inferior to open resection. With regards to resection for CRC, short-term outcomes generally 
refer to post-operative findings for the duration of the hospital admission, but may include a 
short period following discharge (within 30 days). Short-term outcomes include findings 
relating to the procedure (e.g., duration, blood loss); the well-being of the patient (e.g., post-
operative ileus, adverse events such as wound infection, pain, mortality); and matters relating 
hospital administration (e.g., length of hospital stay, demands on nursing staff). Long-term 
outcomes have been described by the RCTs at 3-years and 5-years following the hospital 
admission for resection for CRC and include the overall survival, disease free survival and 
recurrence of CRC. Table 2-3 lists the key characteristics of the major RCTs for laparoscopic 
resection for CRC.  
The most recent meta-analyses (which include RCT findings listed in Table 2-3) have 
confirmed reports from the RCTs. Laparoscopic resection is favoured over open resection for 
short-term outcomes (Table 2-4). Reports from the meta-analyses suggest that laparoscopic 
resection could result in improved intermediate-term outcomes, specifically, incisional 
hernia and bowel obstruction; however, the data are inconclusive.(35, 36) A current 
Cochrane review concluded that resection with laparoscopic access of colon cancer is 
associated with long-term outcomes no different to that of open colectomy, however, more 
randomised trials are needed to make the same assessment for rectal surgery.(37) Findings 
from the literature reviews and meta-analyses on laparoscopic resection for colorectal cancer 
are detailed in Table 2-4.  
Despite reduced length of hospital stay and fewer complications, laparoscopic resection for 
CRC is commonly associated with increased or equivalent delivery costs; this is due to 
longer operating time and requirements for specialised equipment.(38-42) However, studies 
reporting greater costs associated with laparoscopic resection are based on data from early in 
11 
 
the adoption period when surgical teams were less experienced in the technique. As surgeons 
gain experience in laparoscopic resection, the operating time can be similar to that of open 
resection,(43) potentially reducing the cost of laparoscopic resection and resulting in cost 
savings when compared with open resection.  
Laparoscopic resection for cancer of colon or rectum is endorsed by the National Institute for 
Health and Clinical Excellence (NICE) in the United Kingdom,(18) the American Society of 
Colon and Rectal Surgeons,(44, 45) and the European Association for Endoscopic Surgery 
(EAES).(46) In Australia, laparoscopic resection for CRC is only recommended for colon 
cancer; however, the relevant guidelines have not been updated since 2005.(8)  
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Table 2-3 The seven largest randomised clinical trials evaluating laparoscopic resection 
compared with open resection for cancer of the colon and/or rectum 
RCT/Setting Scope Key Exclusions Most recently published findings 
CLASICC 
(United 
Kingdom) 
 
27 Centres 
794 Participants 
Transverse colon 
Chronic cardiac 
or pulmonary 
disease 
2007(47) – 3-year outcomes 
Equivalent OS, DFS and 
recurrence rates 
COST  
(United 
States) 
 
48 Centres 
863 Participants 
Stage IV 
Rectal cancers 
Transverse 
cancers 
2007(48) – 5-year outcomes 
Equivalent OS, DFS and 
recurrence rates 
COLOR  
(Europe) 
29 Centres 
1076 
Participants 
Metastasis to liver 
or lung 
Transverse colon 
Rectal cancers 
2009(49) – 3-year outcomes 
Unable to determine equivalence – 
upCI reached pre-determined non-
inferiority boundary for DFS. 
Clinically acceptable. 
COLORII 
(Europe) 
30 Centres 
1103 
Participants 
Colon cancers 
T4 and some T3 
Other than 
adenocarcinoma 
ASA IV or V 
Active Crohn’s 
disease or 
ulcerative colitis  
2013(50) – short-term outcomes 
Improved GI function following 
laparoscopic resection and reduced 
blood loss and LOS.  
Longer operating time. 
Equivalent oncological outcomes, 
morbidity and mortality. 
ALCASS 
(Australasia) 
31 Centres 
587 Participants 
Stage IV 
Rectal cancers 
Transverse colon 
ASA IV or V 
2012(51) – 5-year outcomes 
Equivalent OS, DFS and 
recurrence rates 
Barcelona 
(Spain) 
1 Centre 
219 Participants 
Stage IV  
Rectal cancers 
Transverse colon 
2008(52) – long-term outcomes 
Higher OS, DFS and reduced 
recurrence laparoscopic group. 
Benefit among stage III mainly. 
Leung 
(Hong Kong) 
1 Centre 
403 Participants 
Stage IV 
Colon cancers 
2004(30) – long-term outcomes 
Probability of 5-year survival 
higher for laparoscopic group (not 
significant). Longer operating time 
and greater direct costs greater for 
laparoscopic group. Laparoscopic 
group had better recovery. 
* OS = Overall Survival; DFS = Disease Free Survival; GI = Gastrointestinal; LOS = Length 
of stay; ASA = American Society of Anaesthesiologists’ (physical status classification 
system) 
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Table 2-4 Literature reviews and meta-analyses relating to laparoscopic resection for colorectal cancer  
Review/meta-
analyses 
Objective Studies 
included 
Main outcome/s Pooled effect  Conclusions 
Theophilus 
2013(53)  
Meta-analysis 
Colon cancer 
To compare long-term 
outcomes by stage 
after laparoscopic and 
open colectomy (rectal 
cancer excluded from 
analysis) 
5 RCTs OS stage I 
OS stage II 
OS stage III 
OS all stages 
HR 1.04 (0.69, 1.57) 
HR 1.21 (0.96, 1.51) 
HR 0.99 (0.81, 1.21) 
HR 0.93 (0.80, 1.07) 
Equivalent long-term survival for 
stage I, stage III and all stages. 
Insignificant trend towards a 
survival disadvantage for stage II 
cancers. 
Kuhry 2008(37) 
Cochrane review 
Colorectal cancer
To determine long-
term outcome after 
laparoscopically-
assisted versus open 
surgery for non-
metastatic colorectal 
cancer 
33 RCTs Incisional hernia 
 
Local recurrence colon 
Local recurrence 
rectum 
Port-site/wound 
recurrence             
CRM Colon                     
CRM Rectum 
Lap: 7.9%, Open: 10.9%, 
P=0.32 
OR 0.84 (0.47, 1.52) 
OR 0.81 (0.61, 1.06) 
Port site/wound recurrence          
OR 0.98 (0.14, 7.0)    
                             
OR 0.15 (0.01, 2.94) 
OR 0.80 (0.61, 1.06) 
Equivalent long-term outcomes 
for colon. More data needed for 
long-term outcomes following 
laparoscopic resection of rectal 
cancer. Further research needed 
for determine any difference in 
incidence of incisional hernia or 
adhesions. 
Transatlantic 
Laparoscopic 
Assisted versus 
Open Colectomy 
Trials Study 
Group 2007(54) 
Multinational 
Colon cancer 
Combine outcomes 
from large RCTs to 
enhance power for 
determining 
oncological safety of 
laparoscopic resection 
for cancer compared 
with open resection 
4 RCTs Number lymph nodes  
 
Postoperative mortality 
3-year disease-free 
survival 
3-year overall survival  
3-year local recurrence 
3-year distant 
recurrence 
Lap: 11.8±7.4, Open: 
12.2±7.8, P=0.4 
OR 1.3 (0.5, 3.4) 
HR 0.99 (0.80, 1.22)  
 
HR 1.07 (0.83, 1.37) 
Diff.: -1.8% (-3.8, 0.3)  
Diff.: -0.5% (-3.5, 2.4) 
No difference in oncological 
outcomes between open and 
laparoscopic resection.  
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Review/meta-
analyses 
Objective Studies 
included 
Main outcome/s Pooled effect  Conclusions 
Breukink 
2007(55) 
Cochrane review 
Rectal cancer 
To evaluate 
differences in safety 
and efficacy after 
laparoscopic resection 
compared with open 
resection 
3 RCTs 
3 R 
5 CC 
28 CS 
No meta-analyses. 
Review discusses: 
Surgical outcomes 
Complications 
Morbidity 
Recurrence 
Mortality 
Cost evaluation 
 No difference in DFS, local 
recurrence, mortality or 
morbidity, anastomotic leakage, 
resection margins or number of 
lymph nodes. Laparoscopic 
resection has reduced blood loss, 
pain, immune response, faster 
return of GI function. 
Laparoscopic resection has 
longer operating time and higher 
costs. 
Abrahams 
2007(56) 
Australia 
Colorectal cancer
To perform a review 
of non-randomised 
comparative studies of 
laparoscopic resection 
with open resection for 
colorectal cancer 
49 
NRCTs 
Conversion 
Operating time (mins) 
Postoperative ileus 
(flatus) 
Postoperative pain (day 
one) 
Postoperative hospital 
stay 
No. lymph nodes 
Early mortality 
Total morbidity 
CWR = 13.3% 
CWD = 41, CWR = 1.28  
CWD = 1.2, CWR = 0.67 
 
CWR = 0.85 (visual analogue 
scale) 
CWD = 3.4, CWR = 0.71 days 
 
CWR = 0.98 
OR 1.07 (0.67, 1.69) 
OR 0.77 (0.63, 0.95) 
Operating time longer for 
laparoscopic resection. Improved 
short-term outcomes. No 
difference in mortality. 
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Review/meta-
analyses 
Objective Studies 
included 
Main outcome/s Pooled effect  Conclusions 
Liang 2007(57) 
China 
Colorectal cancer
To compare recurrence 
rates between 
laparoscopic resection 
and open resection 
10 RCTs Overall recurrence 
Local recurrence 
Distant metastasis 
Port-site/wound 
recurrence 
OR 0.93 (0.71, 1.21) 
OR 0.80 (0.50, 1.29) 
OR 0.90 (0.62, 1.29) 
OR 0.92 (0.77, 1.10) 
Recurrence rates do not differ 
between laparoscopic and open 
resection. 
Lourenco 
2007(58) 
United Kingdom 
Colorectal cancer
To determine the 
clinical effectiveness 
of laparoscopic 
resection in 
comparison with open 
resection 
19 RCTs Length of stay (days)       
 
Anastomotic leakage 
Wound breakdown 
Wound infection 
Urinary tract infection 
Operative mortality 
30-day mortality 
Recurrence 
Incisional hernia 
Overall survival 
Disease-free survival 
WMD -2.58 (-3.12, -2.03, 
p<0.001) 
RR 1.13 (0.74, 1.73) 
RR 0.63 (0.26, 1.52) 
RR 0.86 (0.64, 1.14) 
RR 1.15 (0.66, 1.98) 
RR 0.84 (0.29, 2.47) 
RR 0.57 (0.25, 1.29) 
RR 0.92 (0.74, 1.14) 
RR 1.49 (0.76, 2.92) 
RR 1.03 (0.98, 1.09) 
RR 1.01 (0.95, 1.07) 
Laparoscopic resection 
associated with quicker recovery 
and LOS. No difference in 
complications or long-term 
outcomes. 
Sample for incisional hernia and 
operative mortality small. 
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Review/meta-
analyses 
Objective Studies 
included 
Main outcome/s Pooled effect  Conclusions 
NICE 2006(18) 
United Kingdom 
Colorectal cancer
To provide a 
recommendation 
regarding use of 
laparoscopic resection 
for colorectal cancer 
when compared with 
open resection 
Clinical effectiveness 
Economic 
effectiveness 
19 RCTs 
 
30-day mortality 
Operative mortality 
Overall survival 
Disease-free survival 
Tumour recurrence 
Wound recurrence 
RR 0.57 (0.25, 1.29) 
RR 0.84 (0.29, 2.47) 
RR 1.03 (0.98, 1.09) 
RR 1.01 (0.95, 1.07) 
RR 0.92 (0.74, 1.14) 
RR 1.97 (0.18, 21.62) 
Laparoscopic resection estimated 
to cost                           
₤265(95%CI -₤3829,₤4405) 
more than open resection. 
Laparoscopic resection 
recommended. 
Aziz 2006(35) 
United Kingdom 
Rectal cancer 
Conduct meta-
analyses to compare 
short- and long-term 
outcomes of 
laparoscopic with open 
resection for rectal 
cancer 
 20 
studies: 
14 PNR 
3 R 
3 PR 
Operating time (mins) 
No. lymph nodes 
Postoperative ileus 
(BM) days 
Postoperative hospital 
stay days 
Early mortality 
Wound infection 
Chest infection 
Postoperative hernia 
Bowel obstruction 
WMD 40.18 (26.46, 56.13)  
WMD -0.87 (-2.24, 0.49) 
WMD -0.72 (-1.21, -0.22)  
 
WMD -2.67 (-3.81, -1.54)  
 
OR 0.6 (0.28, 1.27) 
OR 0.84 (0.52, 1.37) 
OR 1.47 (0.74, 2.92) 
OR 1.28 (0.39, 4.22) 
OR 0.40 (0.12, 1.36) 
Laparoscopic longer operating 
time. Improved postoperative 
recovery for GI function, LOS. 
Reduced odds of early mortality, 
wound infection and bowel 
obstruction, however these did 
not reach statistical significance. 
Increased odds of chest infection 
and postoperative hernia; also 
did not reach statistical 
significance. 
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Review/meta-
analyses 
Objective Studies 
included 
Main outcome/s Pooled effect  Conclusions 
Noel 2006(59) 
United States 
Colorectal cancer
To compare short-term 
outcomes of 
laparoscopic colorectal 
resection with open 
resection (only 
outcomes for cancer 
presented here) 
49 
studies 
13 RCTs 
36 C/CC 
Sepsis 
Wound infection 
Urinary tract infection 
Anastomotic leak 
Respiratory/pneumonia 
Cardiac complications 
Venous-
thromboembolism 
Bleeding 
Operating time 
Incision size (mm) 
Blood loss (mL) 
OR 0.60 (0.13, 2.80) 
OR 0.70 (0.50, 0.96) 
OR 1.09 (0.67, 1.77) 
OR 0.97 (0.62, 1.50) 
OR 0.96 (0.60, 1.54) 
OR 0.84 (0.52, 1.36) 
OR 0.62 (0.30, 1.29) 
 
OR 0.97 (0.54, 1.74) 
MR 1.27 (1.20, 1.34) 
MR 0.37 (0.29, 0.48) 
MR 0.55 (0.44, 0.69) 
Although not always statistically 
significant, many effect 
measures favour laparoscopic 
surgery. Laparoscopic resection 
has a longer operating time. 
* All outcome measures compare laparoscopic to open, i.e. WMD = laparoscopic – open (negative values favour laparoscopic), ratios = 
laparoscopic/open (values <1 favour laparoscopic) 
** RCT = Randomised Clinical Trial, DFS = Disease Free Survival, OR = Odds Ratio, HR = Hazard Ratio, NRCT = Non randomised clinical trial, RR 
= Relative Risk, PNR = Prospective Non-Randomised, R = Retrospective patient identification, PR = Prospective Randomised study, CC = Case-
Control, CS = Case Series, C = Cohort, BM = Bowel Movement, MR = Meta-analytic ratio, CRM = Cancer related mortality 
*** CWR = Cumulative Weighted Ratio, CWD = Cumulative Weighted Difference and WMD = Weighted Mean Difference. These measures are for 
continuous variables adjusted for sampling variance – little explanation on statistical methods for these provided in the relevant manuscripts. 
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2.3.2 Surgeon training and patient selection 
Laparoscopic colorectal resection is one of the most complex of laparoscopic procedures and 
requires the mobilisation of a bulky physiological structure, access to more than one quadrant of the 
abdomen, control of multiple large blood vessels, extraction of a large specimen and successful 
creation of an anastomosis.(60) Resection of malignant tumours has more demanding requirements 
to achieve oncologic principles: attainment of adequate surgical margins, removal of lymph nodes, 
proximal ligation of the vascular pedicles and minimal handling and avoidance of perforating the 
tumour.(60) It is paramount that surgeons have adequate training and experience to undertake 
laparoscopic resection of cancers of the colon or rectum.(61, 62) 
There is substantial discussion in the literature regarding the learning curve associated with 
laparoscopic CRC resection. Studies have shown that some outcomes from surgery improve with 
the learning curve; that is, surgeon performance improves with the greater number of laparoscopic 
resections performed. These include reduced operating time,(61) shorter length of hospital stay,(62) 
and fewer conversions from laparoscopic to open resection.(43, 63) Other studies, however, have 
found operating time did not decrease with surgeon experience. This was attributed to the selection 
of more difficult procedures with increasing confidence rather than reflecting a lack of change in 
technical proficiency.(63) Buchanan and colleagues report a dramatic increase in attempted 
laparoscopic resection for cancers of the colon and rectum as experience in the procedure 
increased.(43) Reduction in conversions could also be attributed to better patient selection and 
confidence to complete difficult procedures with laparoscopic access. 
Little has been published about which patients are suitable for laparoscopic resection. The clinical 
trials commonly exclude cancers of the transverse colon and rectum, and patients with metastasis or 
chronic comorbidities (Table 2-3). These characteristics require more complex clinical management 
and the outcomes may not be as favourable as for patients with less complex clinical presentation, 
which is likely to influence the surgical outcomes in the clinical trials. However, it is possible that 
these patients are having laparoscopic resection outside the clinical trial environment. For example, 
according to one study, about 90% of patients undergoing elective resection of CRC are suitable for 
laparoscopic resection, only excluding those with threatened margins as predicted with magnetic 
resonance imaging (MRI) and a history of complicated previous surgery (both of which are the 
main indicators for open resection).(43) Patients requiring emergency surgery (generally due to 
obstruction of the bowel) are not suitable for laparoscopic resection. 
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2.3.3 Laparoscopic resection for colorectal cancer in Queensland 
In Queensland, several surgeons were early adopters of laparoscopic surgery for CRC and the first 
laparoscopic resection for cancer of the colon was conducted at the Royal Brisbane Hospital in July 
1991.(64) Consequently, Queensland has seen a rapid increase in the percentage of resections 
performed with laparoscopic access. Data in Table 2-5 from the Queensland Hospital Admissions 
Patient Data Collection (QHAPDC) shows the annual percentages of all segmental resections of the 
colon and resections of the rectum for patients with CRC for the financial years 1999/2000 to 
2010/2011.  
Table 2-5 Percentage of all resection for cancer of the colon or rectum with 
laparoscopic access in Queensland; 1999/2000 to 2010/2011 
 Segmental resections of the 
colon 
Resections of the rectum 
Total  Laparoscopic (%) Total  Laparoscopic (%)
1999/2000 1055 70 (6.6%) 403 28 (7.0%) 
2000/2001 1088 74 (6.8%) 459 19 (4.1%) 
2001/2002 1104 118 (10.7%) 477 23 (4.1%) 
2002/2003 1115 145 (13.0%) 513 34 (6.6%) 
2003/2004 1068 141 (13.2%) 477 75 (15.7%) 
2004/2005 1120 235 (21.0%) 520 113 (21.7%) 
2005/2006 1247 379 (30.4%) 542 148 (27.3%) 
2006/2007 1267 448 (35.4%) 593 197 (33.2%) 
2007/2008 1286 537 (41.8%) 602 265 (44.0%) 
2008/2009 1358 666 (49.0%) 611 283 (46.3%) 
2009/2010 1326 684 (51.6%) 580 324 (55.9%) 
2010/2011 1309 769 (58.8%) 625 405 (64.8%) 
Total 14343 4266 (29.7%) 6402 1914 (29.9%) 
 
The percentages presented above are much higher than those reported for other geographically 
defined populations. The NICE reported 9% of colorectal resections with laparoscopic access in the 
United Kingdom during 2006/07;(65) this increased to 22% in 2008/09 (Figure 2-5).(66) 
Laparoscopic resection for rectal cancer in Ontario, Canada, increased from 5.2% in 2002 to 19.3% 
in 2008.(67) There are several published studies reporting laparoscopic percentages for cancer of 
the colon or rectum in the United States (US) based on data from the National Inpatient Sample 
(NIS). One study reported that 3.3% of resections for colon cancer in 2003 and 2004 were with 
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laparoscopic access,(68) and another found an increase from 1.4% in 2000 to 4.3% in 2004.(69) 
Also based on NIS data, for the years 2008 and 2009, the laparoscopic percentage for colectomy for 
colon cancer was reported as 50%.(70) A publication whose data were from the Perspective Rx 
Comparative Database in the US, reported a laparoscopic percentage for colon cancer of 35.6% in 
2004 to 2006; which is similar to the percentages found in Queensland.(38)   
Queensland therefore has a large sample of patients with CRC who have received laparoscopic 
resection.  
Figure 2-5 Annual percentages in laparoscopic resection for colorectal cancer in 
Queensland and the United Kingdom; 1999/00 to 2010/11 
 
NOTE: United Kingdom data sourced from the NICE implementation uptake 
reports, 2008(65) and 2010(66). 
2.4 Diffusion of surgical innovation 
Rogers proposed that the diffusion of new technology can be modelled as an S curve (Figure 
2-6).(71) Based on such a curve, laparoscopic resection for both colon and rectal cancer in 
Queensland has probably passed the phases of the innovators, early adopters and early majority and, 
assuming that Queensland has almost reached saturation in the number of CRC resections based on 
resource capacity, has entered the phase of the late majority (Figure 2-6).  
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Figure 2-6 Rogers’s theory of diffusion 
 
Source: Reproduced from Rogers (2003)(71) 
Diffusion in innovation is influenced across three areas. First, innovation is affected by Rogers’ 
characteristics of the innovation itself.(71) These characteristics and how they relate to laparoscopic 
resection for CRC, are listed in Table 2-6. Second, medical behaviour is contagious and local 
leaders and champions are important.(72) Third, innovations need to be adaptable to meet the 
characteristics of the local environment.(73)   
With reference to the characteristics outlined in Table 2-6, by the early 2000’s, laparoscopic 
resection was associated with advantages without added risk, and the procedure was proven to be 
compatible within the realm of surgical beliefs. At a time when more surgeons were gaining skills 
in minimal-access surgery and laparoscopic cholecystectomy had become the standard of care, 
laparoscopic resection for CRC was acquiring RCT evidence demonstrating short-term benefits to 
patients and subsequently, long-term oncological safety of the technique.  
Laparoscopic colorectal resection lends itself to be tested (trialled) because surgeons can perform 
the technique for non-cancer related illness with relative safety prior to performing the procedure 
for cancer. The ability to observe laparoscopic resection for CRC in Queensland was better than in 
other jurisdictions because a core group of surgeons were early adopters and offered formal training 
in the technique. In addition, there are large numbers of colorectal resections for cancer and non-
cancer related conditions. 
At an organisational level, diffusion may be hindered by the resources and costs associated with 
innovative techniques.(71) While most of the available literature shows equivalent or increased 
costs for laparoscopic resection compared with open resection for CRC,(38-41, 74, 75) Chapter 7 of 
this thesis presents the first study to evaluate cost in a jurisdiction where the technology is widely 
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adopted; this consequently led to the first study to demonstrate cost benefit for laparoscopic 
resection.  
The rapid uptake of laparoscopic resection for CRC, in combination with the large numbers of 
patients having this procedure in Queensland, presents a valuable opportunity to evaluate the 
diffusion of this technology throughout Queensland hospitals and patients with CRC.  
Table 2-6 Characteristics of a new technology which influence diffusion as proposed by Rogers(71) 
Characteristic of a new 
technology 
Description In relation to laparoscopic 
resection colorectal cancer 
1. Reduction in uncertainty 
and  relative advantage 
The more knowledge individuals 
can gain about the expected 
consequences of an innovation 
the more likely they are to adopt 
it 
RCT evidence short-term 
benefits and equivalent long-
term outcomes 
2. Compatibility Change must align with values, 
beliefs, past history and needs of 
an individual 
Minimal-access surgery popular 
for other techniques 
Improvement to patient 
outcomes 
3. Complexity More complex innovations take 
longer to spread. Also, 
innovations are modified as they 
spread 
More complex procedures 
introduced later (not included in 
RCTs – rectal resection / 
transverse colon) 
4. Trialability Whether the innovation can be 
adopted/tested on a smaller scale 
and proceed to larger scale 
Able to be performed for non-
cancer related conditions prior 
to cancer related conditions 
5. Observability The ability for potential adopters 
to observe others conducting the 
procedure 
Strong community of specialist 
surgeons in Queensland who 
presented other surgeons with 
the opportunity to attend 
formalised training in the 
technique 
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2.5 Aims and objectives 
This thesis was funded by Queensland Department of Health (Queensland Health) and the 
Australian Centre for Health Services Innovation (AusHSI). Queensland Health’s main role is to be 
the policy-makers, budget-holders and planners for Queensland’s tertiary and regional hospitals, 
and community health centres. AusHSI receives funding from Queensland Health to support 
projects that are designed to show policy-makers how to improve services, ideally by making them 
lower cost and higher quality. Consequently, the overarching aim of this thesis was to use existing 
government population-based databases to develop the information necessary to assist clinicians, 
policy-makers, budget-holders and service-planners within Australia to manage and plan the uptake 
of laparoscopic surgery for CRC.  
The existing literature has identified barriers to the uptake of laparoscopic resection for CRC, 
including a long learning curve, highly specialised and high-cost equipment and uncertainty relating 
to the oncological safety and long-term outcomes. Despite shorter length of hospital stay and fewer 
post-operative adverse events (e.g., wound infection), early studies have found that laparoscopic 
resection is associated with equivalent or higher cost compared with open resection, mainly due to 
longer operating times for laparoscopic resection.  
The majority of the available evidence on laparoscopic resection for CRC comes from large, well-
designed multi-centre RCTs. However, patients with CRC were recruited into these studies when 
laparoscopic resection for CRC was in the early phase of adoption and surgeons were not highly 
experienced in the technique. Furthermore, large groups of patients were excluded from the studies. 
The existing literature does not inform healthcare administrators about which patients with CRC are 
selected for laparoscopic resection and the extent to which laparoscopic resection is performed on 
the patients usually excluded from RCTs. It is also unknown whether the utilisation of hospital 
resources in the real world is the same as those which have been reported from the RCTs. 
Furthermore, surgeons are now more experienced in performing laparoscopic surgery than when 
these RCTs were performed and the techniques have evolved, probably improving outcomes.  
In Queensland, laparoscopic resection for CRC is now in its post-adoption phase; that is, surgical 
teams are experienced in the technique and the necessary equipment is available in almost all 
hospitals. Cost savings are achievable as the surgical duration for laparoscopic resection is 
equivalent to open resection among experienced surgeons. Additionally, long-term outcomes from 
the RCTs have been published and demonstrate the oncological safety of laparoscopic resection for 
CRC. With the barriers to laparoscopic resection for CRC now overcome, Queensland presents a 
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good opportunity to evaluate current practices including patient selection, and to evaluate resource 
utilisation and costs.  
The broad aim of this thesis is to characterise the uptake of laparoscopic resection for CRC by 
hospital and patient characteristics. A secondary aim is to present a “post-adoption” phase 
comparison on the hospital resource utilisation, including cost between laparoscopic and open 
resection for CRC. The findings from this thesis will provide details about past and current practices 
of laparoscopic resection for CRC. It will also provide evidence of the impact that this procedure 
has on the healthcare system by comparing laparoscopic versus open resection for CRC in terms of 
resource utilisation and costs.  
Routinely collected population-based data sources have been used to examine the uptake, diffusion 
and costs associated with laparoscopic resection for CRC. These government databases are 
primarily used for budget-allocation. An additional aim of this thesis was to make use of these well-
managed routinely collected data sources and to help government departments to utilise their own 
data to better understand the current diffusion of new health technology, and consequently, to 
enhance their ability to plan for its uptake.  
2.5.1 Hypotheses 
1. It is hypothesised that whether a patient diagnosed with CRC is selected for laparoscopic 
resection is determined by access to adequately trained and experienced surgeons rather than 
characteristics relating to the patient or cancer.  
2. It is hypothesised that compared with their counterparts who receive open resection, patients 
who receive laparoscopic resection will have shorter length of hospital stay and fewer ICU 
admissions, and that hospital costs associated with the hospital admission will not be more. 
2.5.2 Research questions 
Chapter 4: What is the utility of other diagnosis codes in routinely collected hospital morbidity data 
for determining summary stage of CRC? 
Objective: This was a methodological research question designed to evaluate the utility of hospital 
morbidity data for determining stage of CRC and thus identifying the value and limitations of these 
data sources to conduct CRC research. 
Chapter 5: What is the uptake of laparoscopic segmental resection of the colon and laparoscopic 
resection of the rectum across Australia for the financial years 2000/01 to 2007/08, and how does it 
compare between hospital types (private/public, high/low-volume)? 
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Objective: This research question was designed to inform healthcare administrators of the national 
uptake of laparoscopic resection and any disparity in access to this procedure by hospital type. 
Chapter 6: What is the uptake of laparoscopic resection for CRC by procedure type and patient 
characteristics in Queensland for the financial years 1999/2000 to 2010/2011? 
Objective: This research question was designed to identify which patients receive laparoscopic 
resection for CRC and whether uptake has been slower for those with more complicated clinical 
presentation such as patients normally excluded from the RCTs. Healthcare administrators can use 
this information to develop policies to ensure that patients with complex clinical presentation are 
appropriately referred for laparoscopic resection for CRC. 
Chapter 7: What is the cost of laparoscopic resection compared with open resection for CRC in 
Queensland between June 2009 and June 2011?  
Objective: This research question was designed to measure costs, surgical duration, length of 
hospital stay and duration admitted to intensive care units (ICU) in Queensland where surgical 
teams are now experienced in laparoscopic resection for CRC.  
Chapter 8: What is the uptake of the laparoscopic technique for colorectal resection, hysterectomy, 
cholecystectomy, fundplasty and nephrectomy across Australia between 1993/94 and 2009/10, and 
how does uptake differ between cancer and non-cancer indications? 
Objective: This research question allows for comparison between different laparoscopic therapeutic 
procedures, for cancer and non-cancer indications. These findings can be used to identify 
differences between the procedures which are likely to influence the uptake of new technology. 
2.5.3 Organisation of the thesis 
Chapter 4 is the first of five analysis chapters presented in this thesis. Chapters 4, 5 and 7 include 
published manuscripts and Chapter 6 includes a manuscript which is submitted to a peer-reviewed 
journal for publication.  
Each chapter includes an introductory section which comprises a summary of the introduction 
included in the published manuscript and any additional information not included in the published 
manuscript. The contribution of each of the authors is also outlined here. Additional methodological 
information and/or data analyses which were not included in the publication are then integrated into 
the chapter. Finally, the discussion comprises a summary of the published discussion and 
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commentary on any additional information presented in the chapter which was not included in the 
publication.  
Chapter 8 is presented in the traditional thesis format, rather than as a manuscript for publication. 
This is a requirement of the university. Chapter 9 provides a discussion for the entire thesis. 
Throughout this thesis, laparoscopic surgery relating to colorectal resection will be referred to as 
“laparoscopic resection”. The broad term, “laparoscopic surgery”, is used in Chapter 8 and Chapter 
9 to describe a range of procedures commonly performed using laparoscopic techniques, including 
cholecystectomy, fundoplasty, hysterectomy and nephrectomy. 
Throughout this thesis, laparoscopic resection is identified by a concurrent code for laparoscopy 
with the relevant code for segmental resection of the colon, or, rectal resection. “Laparoscopic 
resection” therefore refers to all resections for CRC which involved laparoscopy and may be 
laparoscopic-assisted or entirely laparoscopic. Laparoscopic-assisted resections for CRC were 
included in the laparoscopic arm of the three large RCTs.(33, 76, 77) Further information about 
which codes were used to identify colorectal resections, and laparoscopic colorectal resections, is 
included in Table 1 of the published manuscript in Chapter 5. 
The terminology “healthcare administrators” is used to refer to individuals whose roles are to 
determine healthcare policy, education programs, resource and budget allocation, and health 
services planning within the Australian public healthcare system.   
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Chapter 3 Data sources 
Data for the research chapters of this thesis were obtained from routinely collected population-
based data sources. The research questions are based on the delivery of services to patients who 
have been diagnosed with CRC. The most suitable data sources for these questions were those 
which capture diagnosis and procedure information for all hospital admissions. Each state and 
territory health authority maintains a database of records for each episode of care in public and 
private hospital in Australia.(78) In Queensland this database is called Queensland Hospital 
Admitted Patients Data Collection (QHAPDC). The National Hospital Morbidity Database 
(NHMD) is a compilation of confidentialised summary records for QHAPDC and all other hospital 
morbidity databases from each of the states and territories.(78)     
3.1 Validity of data sources 
Upon receipt of hospital morbidity data from the states and territories, the Australian Institute of 
Health and Welfare performs extensive validations on the data including: checks for valid values, 
logical consistency, historical consistency, and cross-checks with other data sources.(79) However, 
data quality of the hospital morbidity datasets is primarily the responsibility of the states and 
territories.(80) In Queensland, internal and external bodies conduct audits with a focus on financial, 
statistical and clinical data and these checks occur at many levels: at the point of coding, data entry, 
processing, in the production of reports and overall monitoring of the health system activity. (80) 
Further checks are conducted by the Statistical Output Unit who perform comprehensive validity 
checks which are sent to hospitals for errors to be rectified.(81)  
The NHMD contains records from each of the states and territories since the financial year 
1993/94.(79) The data are based on the National Minimum Data Set for admitted patient care which 
is revised and implemented nationally on the 1st of July each year.(82) This includes common 
coding practices for procedures and diagnoses, as well as common standards for the collection of 
information relating to the episode of care and demographics, across the states and territories.(82) 
A hospital clinical coder is a specialised professional who is trained in the translation of written 
clinical documents about patient care into code format. In Australia, this is the International 
Statistical Classification of Diseases and Related Health Problems, 10th Revision, Australian 
Modification (ICD-10-AM) which is based on the World Health Organisation ICD-10 system, 
updated with the Australian Classification of Health Interventions (ACHI), Australian Coding 
Standards (ACS) and ICD-O-3 (International Classification of Diseases for Oncology, 3rd 
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edition).(83) For major procedures like colorectal resection, clinical coding in the hospital 
morbidity datasets is likely to very accurate and complete because clinicians in the private sector 
and public hospitals rely on the documentation of these codes for funding. A study which validated 
the New South Wales Admitted Patients Data Collection for treatment of prostate cancer, reported 
sensitivity of 91%, and specificity of 100% for radical prostatectomy.(84) 
3.2 Derived variables 
3.2.1 Socio-Economic Indexes for Areas (SEIFA) 
In the absence of measures of individual income or employment status, Socio-Economic Indexes for 
Areas (SEIFA) was used as a measure of socio-economic status. SEIFA provides a measure of 
Relative Socioeconomic Advantage/Disadvantage for a geographical area based on information 
from census. In QHAPDC, SEIFA is categorized into 10 categories based on a division of 
Statistical Local Areas.(85)  For the purpose of this study, SEIFA was further collapsed into 3 
categories; 1-3 (least advantaged), 4-6 and 7-10 (most advantaged), which resulted in an even 
distribution of the study sample.  
3.2.2 Accessibility/Remoteness Index of Australia (ARIA+) 
Accessibility/Remoteness Index of Australia Plus (ARIA+) measures were used to indicate 
remoteness of residence. ARIA+ is measured in five categories based on access to Service Centre 
(defined by the population of the urban centre) from a population locality (as defined by the 
population centres recognised around Australia).(86)  ARIA+ was assigned to individuals based on 
the population locality of their residential address.(85) For the purpose of this study, these 
categories were further collapsed into; major city/inner regional, outer regional and remote/very 
remote.     
3.2.3 High and low volume hospitals 
The threshold of 40+ elective procedures for CRC was pre-specified (before analysing the data) 
after consultation with the Royal Australian College of Surgeons. This number was used to reflect a 
case load of around one resection per week (allowing for holidays). To affirm this cut-off, the total 
number of resections for CRC performed at each hospital per year was determined from the 
QHAPDC. Review of these frequencies in combination with knowledge of Queensland’s tertiary 
hospitals and which hospitals had permanent or visiting specialist colorectal surgeons, it was 
determined that, in general, hospitals performing fewer than 40 resections for colorectal cancer 
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should be considered as low volume hospitals. This threshold was examined over the time period 
1999/2000, to 2009/2010, and found to be appropriate for all years. We could not access the same 
data on hospital frequency of resections for CRC in the other Australian states and territories. We 
therefore decided that it was appropriate to apply the same threshold to the analysis of the national 
data (Chapter 5). 
3.3 Data obtained for this thesis 
As outlined in Appendix 1, data obtained for each of the research chapters was extracted for 
different date ranges. There have only been minor changes to ICD-10-AM and ACHI coding of 
diagnosis and procedures relating to CRC. Mapping to account for any changes was conducted in 
consultation with clinical coders within Queensland Health. The date range of the data extraction 
and analysis in Chapter 8 pre-dates ICD-10-AM and extensive mapping of diagnosis and procedure 
codes (with ICD-9) was conducted to ensure completeness of the extraction and accuracy of the 
analysis. 
Detailed information about the data extracted for each of the research chapters is included in 
(Appendix 1).  
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Chapter 4 The utility of population-based data sources for colorectal cancer 
research 
4.1 Introduction 
Presently in Australia, information pertaining to cancer stage is not recorded in routinely collected 
population-based data sources. In the US, summary stage is routinely recorded in the Surveillance 
Epidemiology and End Results (SEER) database for all cancer types. SEER staging uses all 
information available in the medical records, including clinical and pathological documentation of 
extent of disease, to determine a summary stage.(87) SEER stage is almost always recorded with 
only 5% of colorectal cancers between 2003 and 2009 coded as “9” (unknown); for breast cancer, 
this figure was 2%.(88) For reporting of survival, SEER stage is further collapsed into four groups: 
localised (confined to the primary site), regional (spread to regional lymph nodes), distant (cancer 
has metastasised) and unknown (unstaged).(88) 
Each of the authors contributed to this study and the resulting manuscript as follows. I was 
responsible for the conception and design of the study in conjunction with Michael Coory. Data 
from the clinical cancer registry is owned and maintained by John Lumley. I was responsible for the 
data acquisition, linkage, analysis and interpretation of the results. Michael Coory provided 
guidance on the data analysis and interpretation of the results. I was responsible for the first and 
subsequent drafts of the manuscript under the guidance of, and with feedback from, Michael Coory 
and John Lumley. 
This study was published in the peer-reviewed journal Asia Pacific Journal of Clinical Oncology in 
2012. 
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Abstract
Aims: There is currently no routine collection of cancer stages in population-based data in Australia. This
study evaluates the accuracy of International classification of diseases (ICD) codes for secondary neoplasms
recorded in hospital morbidity data to assign spread of disease at diagnosis for colorectal cancer.
Methods: The reference (gold) standard was the Australian clinicopathological stage (ACPS) documented
by a treating colorectal surgeon and derived from histopathology and clinical findings. To allow comparison
with stages derived from the hospital morbidity data (HMD), ACPS was mapped to the spread of disease
(local, regional and distant). Sensitivity, specificity and positive-predictive values were calculated to compare
the accuracy of stage derived from HMD.
Results: Data from both the reference standard and HMD were available for 499 patients. HMD slightly
overestimated patients with local disease (62.3 vs 56.9%). There was a corresponding underestimation of
regional and distant spread of disease. While sensitivity for regional and distant disease was moderate (66.4
and 71.4%, respectively), specificity was high (92.7 and 96.6%, respectively).
Conclusion: ICD codes for secondary neoplasms in HMD are limited in their utility for determining the
spread of disease for colorectal cancer. Clinicians need to ensure that clinical coders are provided with
enough information to accurately code for spread of disease. We recommend reporting histopathology in a
synoptic format which includes background information on the presence or absence of distant metastasis
and the tumor node metastasis stage.
Key words: colorectal, epidemiology, ICD coding, pathology, stage.
INTRODUCTION
Colorectal cancer (CRC) is the most common cancer
among men and women in Australia.1 Surgery is the
mainstay of treatment for CRC, of which there are a
variety of established and emerging techniques.2
Population-based monitoring of the delivery and out-
comes of these techniques is important to ensure
consistency in the quality of care. Routinely collected,
population-based databases are being increasingly used
to examine outcomes of surgery for CRC, particularly in
the USA3,4 and the UK.5–7 While Australia has similar
population-based databases, they lack information on
the stage of cancer. Stage at diagnosis is a prognostic
variable that critically affects management and out-
comes. The absence of stage information drastically
limits the utility of the existing population-based data-
bases in Australia for monitoring oncological outcomes.
Each state and territory of Australia maintains hos-
pital morbidity databases (HMD) which include unit
record information for every admission to all public
and private hospitals.8 As well as detailed information
Correspondence: Ms Bridie Thompson PhD scholar, School
of Population Health, University of Queensland, Level 2,
Public Health Building, Herston Road, Herston, QLD 4006,
Australia. Email: bridie.thompson@uqconnect.edu.au
Accepted for publication 29 January 2012.
bs_bs_banner
Asia-Pacific Journal of Clinical Oncology 2012; 8: e17–e22 doi:10.1111/j.1743-7563.2012.01537.x
© 2012 Wiley Publishing Asia Pty Ltd
relating to the admission (such as dates of admission
and separation), HMD include diagnosis, procedure and
socio-demographic data.8 The HMD uses the Interna-
tional classification of diseases (ICD) to code all diag-
noses for every hospital admission.8 This includes codes
for metastases to lymph nodes in specific locations
(e.g., secondary malignant neoplasm of intra-abdominal
lymph nodes [C77.2]) and codes for metastases to spe-
cific organs (e.g., secondary malignant neoplasm of the
liver [C78.7]),9 which can be mapped to a summary
staging system of the degree of spread, similar to sur-
veillance epidemiology and end results (SEER) staging in
the USA.10 However, this is dependant on the accuracy
of coding for the secondary neoplasm. The ability to
derive the degree of spread from HMD would fill the
gap in the availability of stage information at a popula-
tion level.
There have been two published studies that examined
the utility of secondary diagnosis codes in hospital
administration data, similar to HMD, for determining
the summary stage of cancer.11,12 Neither of these was
based in Australia and only one included CRC.12
Clinicians at three private and one tertiary public
hospital in Brisbane, Australia, have been recording the
stage at diagnosis for their patients with CRC. This
offered a unique opportunity to determine whether ICD
codes for cancer spread in HMD can be reliably used to
derive the degree of spread of CRC.
METHODS
The clinical cancer registry maintains information for
patients treated for CRC by clinicians in three private
and one public hospital, which includes the Australian
clinicopathological stage (ACPS),13 which is transcribed
from histopathology reports or derived from clinical and
histopathology reports. To enable the pathologist to
report the complete ACPS in the histopathology, the
clinician must include information about the presence or
absence of distant metastasis when asking for the patho-
logical review of a specimen.14 ACPS recorded in the
registry was used as the reference or gold standard of
stage at diagnosis for all patients who had a resection for
cancer of the colon or rectum between 30h June 2001
and 31 April 2009.
Record linkage was used to ascertain the accuracy of
coding of the spread of CRC in the HMD. In Australia,
clinical coders use the hard-copy and electronic clinical
notes to assign International classification of diseases
and health related problems, 10th revision, Australian
modification (ICD-10-AM) codes to primary and sec-
ondary diagnosis fields in HMD.15 Particularly in private
hospitals where clinical coders may not have access to
complete clinical notes, the histopathology report can be
the primary or the only source of information for the
spread of cancer. While there are no specific data fields
for cancer stage, there are ICD-10-AM codes for the
metastatic spread of malignant diseases.9 In Queensland,
clinical coders are instructed to code for metastatic
spread to the lymph nodes or distant organs if there is
confirmation of such spread from histopathology
reports, imaging reports or other documentation by a
clinician.15
Deterministic linkage requires that predefined vari-
ables agree exactly between two data sources to form a
linked pair.16 Records from the clinical cancer registry
were deterministically matched to the HMD by hospital,
date of birth and date of procedure. Probabilistic linkage
applies weights for agreement and disagreement for each
variable based on the difference in probability that a
variable agrees among matches and non-matches.16
Probabilistic linkage was used to identify an additional
9% of patients based on the date of procedure, sex and
type of procedure. Excluded from analysis were 64/857
(7.5%) of patients in the clinical cancer registry, who
were unstaged.
The ACPS system for staging CRC requires clinical
information that is more specific than ICD-10-AM
coding allows (e.g., the level of local invasion in submu-
cosa and muscularis propria). Therefore, ACPS from the
clinical cancer registry and ICD diagnostic codes in the
HMD were mapped into localized, regional and distant
spread of disease (Table 1).
The spread of disease, as derived from ACPS in the
clinical cancer registry, was taken to be the reference
standard and was used to obtain estimates of sensitivity,
specificity and positive predictive value (PPV) for the
spread of disease as derived from the ICD codes in the
HMD. Sensitivity, specificity and PPV were calculated
separately for local, regional and distant spread of dis-
ease.17 Exact 95% confidence intervals (CI) for these
proportions were obtained using Stata statistical soft-
ware (Stata Corporation, College Station, TX, USA).18
Ethics approval for this study was granted by the
Queensland Health Human Research Ethics Committee
and the School of Population Health Research Ethics
Committee of the University of Queensland.
RESULTS
The clinical and socio-demographic characteristics of
patients included in the study are shown in Table 2.
e18 B Thompson et al.
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There were very few patients falsely identified with
metastases by HMD, as shown by specificity of 96.6%
for the category of distant spread of disease (Table 3).
Specificity for regional spread of disease was also high
(92.7%), while specificity for local disease was only
moderate (81.9%).
In contrast to high specificity for distant spread of
disease, sensitivity for this category was only moderate
at 71.3% (Table 3). Sensitivity for regional spread was
poor at 66.4%, while sensitivity for local disease was
high at 95.8%. Taken together, the results for specificity
and sensitivity indicate that HMD tend to allocate too
many patients to local disease and not enough to
regional or distant spread; as compared to the gold
standard of the clinical cancer registry.
Table 4 shows the distribution of HMD stage by clini-
cal registry stage. The percentages on the diagonals are
the sensitivities shown in Table 3. The other percentages
show the distribution of false negatives across the other
two categories. Of note, most misclassified regional
cases were misclassified to local in HMD, not to distant
spread.
Sensitivity for regional disease among public patients
was significantly poorer than among private patients
(difference: difference: -25.1%; 95% CI -49.7%,
-0.7%). Conversely, sensitivity for metastatic disease
was slightly poorer among the private patients than the
public patients. However, this finding was not statisti-
cally significant. There was no material difference in
specificity among private and public patients.
Table 1 Mapping of Australian clinicopathological stage (ACPS) from the clinical cancer registry and International Classification
of Diseases and Health Related Problems, 10th Rev., Australian Modification codes in inpatient hospital morbidity data to local,
regional and distant spread of disease
Local† Regional‡ Distant§
Clinical Cancer Registry ACPS A or
ACPS B
ACPS C ACPS D
Hospital morbidity data Lymph nodes Lymph nodes
C77.2 Intra-abdominal C77.0 Head, face & neck
C77.5 Intra-pelvic C77.1 Intrathoracic
C77.3 Axillary & upper limb
C77.4 Inguinal & lower limb
C77.8 Multiple regions
C77.9 Unspecified
Respiratory & digestive organs
C78.0 Lung
C78.1 Mediastinum
C78.2 Pleura
C78.3 Other & unspecified respiratory organs
C78.4 Small intestine
C78.5 Large intestine & rectum
C78.6 Retroperitoneum & peritoneum
C78.7 Liver
C78.8 Other & unspecified digestive organs
Other sites
C79.0 Kidney & renal pelvis
C79.1 Bladder & other unspecified urinary organs
C79.2 Skin
C79.3 Brain & cerebral meninges
C79.4 Other & unspecified nervous system
C79.5 Bone & bone marrow
C79.6 Ovary
C79.7 Adrenal gland
C79.8 Secondary malignant neoplasm of other
specified sites
C80 Malignant neoplasm without specification of site
†Primary tumor only. ‡Local lymph nodes and apical lymph nodes involved. §Secondary tumor to distant organ/s or tumor transected.
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DISCUSSION
Spread of CRC to regional lymph nodes or distant
organs is underreported in the HMD, leading to under-
staging. While only 66% of patients with regional and
71% of patients with distant CRC at diagnosis are iden-
tified in the HMD, those who are identified are accurate
because regional or distant spread of CRC is rarely
coded for in HMD when the patient does not actually
have regional or distant spread.
Table 2 Clinical description and characteristics of patients
Colorectal cancer patients N = 499
Age median (range) 67 (19–92)
Sex n (%)
Male 253 (50.7)
Female 246 (49.3)
Hospital type n (%)
Public 77 (15.4)
Private 422 (84.6)
ACPS n (%)
A 121 (24.3)
B 164 (32.9)
C 130 (26.1)
D 84 (16.8)
Procedure n (%)
Right hemi-colectomy/extended hemi-colectomy 146 (29.3)
Left hemi-colectomy, sigmoid colectomy 34 (6.8)
High anterior resection 94 (18.8)
Total colectomy, proctocolectomy 8 (1.6)
Transcolectomy 6 (1.2)
Anterior resection, low anterior resection, ultra-low
anterior resection
189 (37.9)
Abdoperineal resection 28 (5.6)
ACPS, Australian clinicopathological stage.
Table 3 Accuracy of spread of disease from International classification of diseases codes in inpatient hospital morbidity data with
spread of disease from clinical cancer registry as reference standard
Local Regional Distant
Sensitivity (95% CI) 95.8 (92.7, 97.8) 66.4 (57.6, 74.4) 71.4 (60.5, 80.8)
Specificity (95% CI) 81.9 (76.0, 86.8) 92.7 (89.5, 95.1) 96.6 (94.4, 98.1)
Positive predictive value (95% CI) 87.5 (83.3, 90.9) 76.3 (67.4, 83.8) 81.1 (70.3, 89.3)
Table 4 Spread of disease at diagnosis as mapped from International classification of diseases codes in inpatient hospital morbidity
data and Australian clinicopathological stage from clinical cancer registry
Colorectal cancer patients
Clinical cancer registry (gold standard)
Local (N = 284) Regional (N = 131) Distant (N = 84)
n (%) n (%) n (%)
Hospital morbidity data
Local 272 (95.8) 34 (26.0) 5 (6.0)
Regional 8 (2.8) 87 (66.4) 19 (22.6)
Distant 4 (1.4) 10 (7.6) 60 (71.4)
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There is only one other published study that has
assessed the utility of a large population-based data
source for determining the stage of CRC.12 In 1999
Cooper et al. published results from a study in the USA
that determined the relative accuracy of ICD codes (9th
rev.) in Medicare claims for measuring the stage of
disease for six cancers, using summary stage reported
in SEER registry.12 They report a sensitivity of 34.3% for
regional CRC, which is almost half that found in the
present study. This difference may be due to changes
in practices in the harvesting and reporting of lymph
nodes with the release of surgical guidelines for CRC
in 2000.19 ICD coding for secondary malignancies in
regional lymph nodes in the HMD is more accurate
when there is an adequate documentation of lymph
node involvement in histopathology reports.
CRC staging is required for determining patient
management.13 For the occasional case where the stage
of cancer is not established prior to surgery, surgeons
and clinical coders alike will not have access to infor-
mation about secondary malignant neoplasm. These
cases will not affect the results of this study but may
account for some of the cases in the clinical cancer
registry that were unstaged.
Patients who had neoadjuvant therapy were included
in the analysis. Any change to the extent of the primary
tumor as a result of neoadjuvant therapy will not change
the broad categories of stage used in this study because
local spread of disease included tumor status 1–4, pro-
vided that the nodal status was 0. That is, neoadjuvant
therapy would not cause patients to move between
the three categories of stage used in this study: local,
regional and distant.
We did not conduct an audit of coding in this sample
of patients and cannot verify that coding for a secondary
neoplasm was complete even when the information was
available to the clinical coders. Such an audit may reveal
that clinical coders need to be educated in the impor-
tance of accurate coding of spread of disease as second-
ary neoplasms.
This study has the advantage that many of the histo-
pathology reports were completed by a single patholo-
gist in a synoptic report format which included all the
information required to accurately determine the stage
of CRC: the number of lymph nodes in the specimen,
the number of involved nodes, tumor node metastasis
(TNM) and/or ACPS stage, the presence of vascular,
perineural or serosal invasion and the extent of local
spread.
Synoptic histopathology reporting enables the reader,
usually a clinician, to locate the required prognostic
information more readily than with free text report-
ing.20 This presumably can be extended to clinical
coders. In this study the histopathology reports for
patients treated in private hospitals were often in syn-
optic format, unlike the public patients whose histopa-
thology reports were in free text. This may explain
the difference in sensitivity for the regional spread of
CRC between the public and private patients. Clinical
coders code secondary lymph node involvement when
it is clearly reported in the histopathology report. It is
therefore possible that clinical coders miss information
indicating lymph node involvement when the histo-
pathology report was in free text format. The clear
documentation of information, such as synoptic histo-
pathology reporting, would assist clinical coders in
identifying spread of disease, potentially resulting in
more accurate coding.
In this particular group of surgeons it is usual
practice to include the presence or absence of distant
metastasis on the pathology request form, such as
“liver clear”, “liver metastasis” or “nodal metastasis”.
Among the private patients this information was often
included in the histopathology report as TNM or ACPS
stage and as free text in the history section. However,
these do not always include a specification of site of
metastatic spread, as is required for best coding prac-
tice. A code for a secondary malignant neoplasm with
the site unspecified (C79.9) was introduced in a later
edition of ICD-10-AM to allow clinical coders to allo-
cate a code when they are unable to determine the site
of metastatic spread. However, this code was not avail-
able for the patients in this study and the accuracy of
HMD for identifying the distant spread of disease for
CRC may have increased with the introduction of this
code.
The TNM stage is a globally accepted method for
staging cancers.21 Provided that the information related
to the presence or absence of distant metastasis is
included in the pathology request form, the TNM stage
can be routinely documented in the histopathology
report of the primary tumor specimen; which was the
case for many patients in this sample. There is the poten-
tial for the ICD coding system to incorporate cancer
stage-specific codes to indicate the TNM stage as well as
codes for site-specific spread of cancer.
Clinical coders have access to clinical notes and
results of investigations (e.g., imaging, cytology and his-
tology) to assist with identifying the spread of CRC.
Because of this, HMD might be the most cost effective
way of collecting population-based data on the spread
of disease for cancers like CRC, where nearly all patients
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are admitted to hospital. For other cancers, such as
prostate cancer, where up to 30% of patients may not be
admitted; other sources of data for the spread of disease
might be required.
ICD codes for a secondary neoplasm in HMD are
limited in their utility for determining the spread of
disease for CRC and should be used with caution.
While changes to ICD codes to include TNM stage
would improve the utility of HMD for determining
spread of disease, the onus lies with the clinicians to
ensure that clinical coders are provided with the infor-
mation to accurately code for the spread of disease.
We recommend reporting histopathology in a synoptic
format which includes background information on
the presence or absence of distant metastasis and TNM
stage.
ACKNOWLEDGMENTS
This project was funded by the Patient Safety and
Quality Improvement Service of Queensland Health.
The authors wish to acknowledge the assistance of Julie
Turtle, Clinical Coding Auditor/Educator of the Tasma-
nian Department Health and Human Services, for assist-
ing with clarifying coding practices in Queensland.
REFERENCES
1 Australian Bureau of Statistics. Cancer in Australia:
a snapshot, 2004–05. Canberra [updated 8 December
2006; cited 8 December 2011]. Available from: http://
www.abs.gov.au/ausstats/abs@.nsf/productsbytitle/
8DDD5AED085834DACA256F010077BE4A?
OpenDocument.
2 Hiranyakas A, Ho YH. Surgical treatment for colorectal
cancer. Int Surg 2011; 96: 120–6.
3 Delaney CP, Chang E, Senagore AJ, Broder M. Clinical
outcomes and resource utilization associated with laparo-
scopic and open colectomy using a large national database.
Ann Surg 2008; 247: 819–24.
4 Kemp JA, Finlayson SR. Outcomes of laparoscopic and
open colectomy: a national population-based comparison.
Surg Innov 2008; 15: 277–83.
5 Morris EJ, Jordan C, Thomas JD et al. Comparison of
treatment and outcome information between a clinical trial
and the National Cancer Data Repository. Br J Surg. 2011;
98: 299–307.
6 Morris EJ, Taylor EF, Thomas JD et al. Thirty-day post-
operative mortality after colorectal cancer surgery in
England. Gut 2011; 60: 806–13.
7 Morris EJ, Sandin F, Lambert PC et al. A population-based
comparison of the survival of patients with colorectal
cancer in England, Norway and Sweden between 1996 and
2004. Gut 2011; 60: 1087–93.
8 National hospital morbidity database (NHMD). Austra-
lian Institute of Health and Welfare. [cited 30 Nov 2011].
Available from: http://www.aihw.gov.au/national-hospital-
morbidity-database/.
9 National Centre for Classification in Health. The interna-
tional statistical classification of diseases and related health
problems. 10th Rev. Australian modification (ICD-10-
AM), 3rd edn. University of Sydney, Sydney 2002.
10 Young JL Jr, Roffers SD, Reis LAG, Fritz AG, Hurlbut AA,
eds. SEER Summary Staging Manual – 2000. National
Cancer Institute, Bethesda, MD 2001.
11 Thomas SK, Brooks SE, Mullins CD, Baquet CR, Merchant
S. Use of ICD-9 coding as a proxy for stage of disease in lung
cancer. Pharmacoepidemiol Drug Saf 2002; 11: 709–13.
12 Cooper GS, Yuan Z, Stange KC, Amini SB, Dennis LK,
Rimm AA. The utility of Medicare claims data for measur-
ing cancer stage. Med Care 1999; 37: 706–11.
13 Australian Cancer Network Colorectal Cancer Guidelines
Revision Committee. Guidelines for the prevention, early
detection and management of colorectal cancer. The
Cancer Council Australia and Australian Cancer Network,
Sydney 2005.
14 Australian Cancer Network Colorectal Cancer Guidelines
Revision Committee. Guidelines for the prevention, early
detection and management of colorectal cancer. The
Cancer Council Australia and Australian Cancer Network,
Sydney 2005.
15 National Centre for Classification in Health. Australian
Coding Standards for ICD-10-AM and ACHI. 3rd edn.
University of Sydney, Sydney (NSW) 2002.
16 Tromp M, Ravelli AC, Bonsel GJ, Hasman A, Reitsma
JB. Results from simulated data sets: probabilistic record
linkage outperforms deterministic record linkage. J Clin
Epidemiol 2011; 64: 565–72.
17 Webb P, Bain C. Early detection: what benefits at what
cost? In: Webb, P, Bain C, Pirozzo, S. (eds). Essential Epi-
demiology: An Introduction for Students and Health Pro-
fessionals, 2nd edn. Cambridge University Press, New York
2011; 346–71.
18 Stata Corporation. [Stata Statistical Software]. Vers. 9.2.
Stata Corporation, College Station, TX 2006.
19 Nelson H, Petrelli N, Carlin A et al. Guidelines 2000 for
colon and rectal cancer surgery. J Natl Cancer Inst 2001;
93: 583–96.
20 Markel SF, Hirsch SD. Synoptic surgical pathology report-
ing. Hum Pathol 1991; 22: 807–10.
21 Sobin LH, Gospodarowics MK, Wittekind C (eds).
TNM Classification of Malignant Tumours, 7th edn.
Wiley-Blackwell, Chichester 2009.
e22 B Thompson et al.
© 2012 Wiley Publishing Asia Pty Ltd Asia-Pac J Clin Oncol 2012; 8: e17–e22
  
37 
 
4.2 Additional results 
The tables and figures below provide additional detail about results presented in the published 
manuscript. In the interest of maintaining the requirements of the publishing journal, these tables 
and figures are referred to in the text of the manuscript, but were not included in the manuscript as 
they are appear here. 
Figure 4-1 provides details about the clinical cancer registry used as the “gold standard” for this 
chapter. Of the 857 records available in the clinical cancer registry, 142 (17%) did not have 
adequate information to enable linkage with QHAPDC and were excluded from further analysis. 
Hospital episodes in QHAPDC were restricted to those with procedure codes for resection of the 
colon or rectum and these were successfully matched to 70% of records in the clinical cancer 
registry based on the hospital facility and data of birth. Further review identified that 12 of the 
matched records did not match on dates of admission and sex. This resulted in a total number of 499 
successfully matched records. 
The clinical cancer registry was considered the “gold standard” because all data were 
entered by the treating surgeon who had performed the procedure and, with this, had a 
thorough knowledge of the clinical findings including evidence of spread of disease. As the 
primary clinician, the surgeon had access to all clinical findings and therefore cancer stage 
entered into the clinical cancer registry was considered the “gold standard”. The purpose of 
this study was to determine whether coding of spread of disease in QHAPDC could be used 
to determine a summary stage, and to measure how this compared with the clinical cancer 
registry. The results found that spread of disease was under-staged in QHAPDC, and 
almost never over-staged. This indicates that the clinical findings known by the surgeon 
were not available to the clinical coders coding for spread of disease in QHAPDC.  
The exclusion of records from the clinical cancer registry because of incomplete data for matching 
or because they did not successfully match, should have no material impact on the findings. We 
were unable to access patient identified information in QHAPDC, which limited the success of 
linkage. This was not a limitation of the clinical cancer registry. Data entry into the clinical cancer 
registry was independent of clinical coding for the QHAPDC. Clinical coders entering data into 
QHAPDC have the same information available to them in the clinical notes and medical records 
regardless of completeness of information in the clinical cancer registry.  
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Figure 4-1 Ascertaining the final dataset for analysis 
 
QHAPDC = Queensland Hospital Admitted Patients Data Collection, DOB = date of birth 
 
QHAPDC data 
114 827 
Extract restricted to:  
June 2001 – June 2008 
 
Procedure Block codes: 0907, 0913, 
0914, 0929, 0932, 0933, 0934, 0935, 
0936, 0937. 
 
Facilities: 
Royal Brisbane and Womens’ 
Hospitals, The Wesley Hospital,  
Holy Spirit Northside, North West 
Private Hospital  
Merged on facility and DOB 
511 merged cases 
499 remaining patients 
12 Lost Probabilistic matching 
1 procedure date and sex did not 
match 
11 date of procedure did not occur 
within the period of admission 
142 Lost 
13 without facility identification 
54 missing DOB information 
75 with dummy DOB  
    (1st day, 1st month, known year) 
Clinical Cancer Registry 
857 
Clinical Cancer Registry 
715 
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Table 4-1 Sensitivity for two groupings of summary stage (spread of disease) at diagnosis as 
mapped from International Classification of Disease Codes (Version 10) in inpatients hospital 
morbidity data and Australian clinicopathological stage from clinical cancer registry 
 Local Regional/distant 
Sensitivity (%; 95%CI) 272/284 (95.8%; 92.7, 97.8) 176/215 (81.9%; 76.0, 86.8) 
 Local/regional Distant 
Sensitivity (%; 95%CI) 401/415 (96.6%; 94.4, 98.1) 60/84 (71.4%; 60.5, 80.8) 
 
Table 4-2 Spread of disease with measures of accuracy of summary stage (spread of disease), by 
hospital type.  
Public hospital  Clinical cancer registry (gold standard) 
  Local (n = 45) Regional (n = 18) Distant (n = 14) 
Hospital morbidity data 
Local 43 9 2 
Regional 2 8 1 
Distant 0 1 11 
Total 45 18 14 
Sensitivity 95.6% 44.4% 78.6% 
Specificity 65.6% 94.9% 98.4% 
Positive predictive value 79.6% 72.7% 91.7% 
Private hospital  Clinical cancer registry (gold standard) 
  Local (n = 239) Regional (n = 113) Distant (n = 70) 
Hospital morbidity data Local 229 25 3 
Regional 6 79 18 
Distant 4 9 49 
Total 239 113 70 
Sensitivity 95.8% 69.9% 70.0% 
Specificity 84.7% 92.2% 96.3% 
Positive predictive value 89.1% 76.7% 79.0% 
* Differences in the sensitivity for regional and metastatic disease between public and private 
hospitals are mentioned in the results section of the published manuscript, however data are not 
provided in the manuscript. 
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4.3 Discussion and implications of findings 
Hospital morbidity data may become more accurate for determining stage with improved 
documentation of information in medical records. This may be achieved by ensuring clear 
documentation of spread to lymph nodes in distant organs in the clinical notes. However, at present 
hospital morbidity data are limited in their utility for researching outcomes for CRC.  
Routinely collected population-based data sources such as hospital morbidity data are useful for 
conducting observational studies because they have a large sample size, include all treated patients 
within a jurisdiction (rather than selection based on inclusion/exclusion criteria) and provide 
information on the “real world” of clinical practice.(89) For studies that require stage as a key 
determinant of the outcome, such as survival analysis, hospital morbidity data does not provide 
stage information that is adequately reliable. For the purpose of this thesis, stage of CRC is a 
potential confounding factor for the outcomes measured in Chapter 7. In the absence of reported 
cancer stage information, determining summary stage of CRC from other diagnosis codes 
accurately identifies the majority of patients with spread of disease beyond the primary tumour.   
Conclusion 
This study was performed to evaluate the utility of hospital morbidity data for determining stage of 
CRC and thus identifying limitations of these data sources to conduct CRC research. Hospital 
morbidity data provides adequate summary stage information for the purpose of adjusting for 
spread of CRC as a potential confounder in research, and is used in this capacity in Chapter 6 and 
Chapter 7. As distant and regional spread are under-staged in about one third of the cases, using 
summary stage determined from other diagnosis codes in the hospital morbidity for performing 
analyses on colorectal survival and recurrence, should be avoided or performed with caution. 
Healthcare administrators may find improvement in coding of other diagnosis codes for spread to 
lymph nodes and distant organs if more complete and definitive documentation of clinical findings 
relating to spread of CRC was available to clinical coders in the clinical notes. 
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Chapter 5 Current trends in laparoscopic resection for colorectal cancer in 
Australia 
5.1 Introduction 
This chapter includes a published manuscript that reports the uptake of laparoscopic resection for 
colorectal cancer across Australia. Of particular interest is whether there has been equal uptake in 
laparoscopic resection for CRC between public and private hospitals and high-volume and low-
volume hospitals. The study is based on National Hospital Morbidity Data (NHMD) from 2000 to 
2008. Laparoscopic resection for rectal cancer is supported by considerably less evidence and is a 
technically more difficult procedure than laparoscopic colon resection; trends were therefore 
stratified into segmental resection of the colon and resections of the rectum.  
Each of the authors contributed to this study and the resulting manuscript as follows. I was 
responsible for the conception and design of the study in conjunction with Michael Coory. I was 
responsible for the data acquisition, analysis and interpretation of the results. Michael Coory 
provided guidance on the data analysis and interpretation of the results. John Lumley provided 
clinical expertise and knowledge to determine the procedure groups (segmental resection of the 
colon and rectal resection) and to interpret the results. I was responsible for the first and subsequent 
drafts of the manuscript under the guidance of, and with feedback from, Michael Coory and John 
Lumley. 
This study was published in the peer-reviewed journal Medical Journal of Australia in 2011.  
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Research
ince around 1990, laparoscopic sur-
gery has revolutionised abdominal sur-
gery. Procedures such as laparoscopic
cholecystectomy and Nissen fundoplication
were quickly adopted and their use diffused
rapidly through health systems around the
world.1 However, the widespread adoption
of laparoscopic surgery for colorectal cancer
(CRC) has been much slower despite proven
short-term benefits over open resection.
These benefits incl ded less blood loss,
reduced pain, shorter postoperative ileus,
reduced hospital stay and better postopera-
tive pulmonary function.2 Specifically, time
to first bowel movement is 1 day shorter
with laparoscopic resection compared with
open resection (3.5 v 4.5 days; P = 0.01),
and length of hospital stay is reduced by
about 3 days (8.1 v 11.8 days; P = 0.01).3
Reasons for the delay in uptake of laparo-
scopic surgery for CRC included less than
optimal equipment and the long learning
curve associated with the procedure; but
perhaps most importantly, there were con-
cerns about whether long-term oncological
outcomes (eg, recurrence, overall survival)
were as good as for open surgery.4
These concerns have subsequently been
allayed. For example, a recent meta-analysis
reported that across seven studies, only
three of 826 patients with colon cancer
(0.4%) who were randomly allocated to
laparoscopic surgery had port-site metas-
tases,5 and a Cochrane review concluded
that resection with laparoscopic access
resulted in cancer-related mortality equiva-
lent to that for open surgery.5 Data from
randomised trials in rectal cancer are not as
mature,5 but the evidence that is available
suggests that the oncological outcomes are
equivalent for laparoscopic and open access
surgery.6
In this article, we aim to examine trends
in the uptake of laparoscopic surgery for
CRC in Australia, and to consider the impli-
cations for the organisation of surgical serv-
ices for patients with CRC. We were
particularly interested in whether there were
differences in the uptake of laparoscopic
resection for colon cancer compared with
rectal cancer because resection for rectal
cancer is technically more difficult. We were
also interested in whether there was differ-
ential uptake across the public and private
sectors and whether this varied by the vol-
ume of patients with CRC treated at a
particular hospital.
METHODS
We obtained data for eight financial years,
2000–01 to 2007–08, from the National
Hospital Morbidity Database (NHMD), in
which administrative inpatient data from all
of the Australian states and territories is
collated.7 The data extraction was restricted
to patients with CRC who had had an
elective surgical resection. Patients who had
undergone emergency resections (eg, for
bowel obstruction, bleeding or perforation
secondary to CRC) were excluded because
emergency surgery for complications of
CRC and elective surgery for CRC are two
distinct and different groups of surgical pro-
cures. Currently, laparoscopic surgery is
only routinely considered for elective sur-
gery — randomised controlled trials of
laparoscopic surgery include only elective
cases.
No data that could identify (or re-iden-
tify) an individual patient or hospital were
provided. Information was provided on two
hospital characteristics: public versus pri-
vate and high (40 or more elective resections
for CRC per year) versus low volume. The
state or territory of the hospital was not
provided because, when stratified by public
versus private and high versus low volume,
this might have permitted identification of
individual hospitals in some of the less
populous states and the territories.
The NHMD uses Australian Classification
of Health Interventions (ACHI) codes (Inter-
national statistical classification of diseases and
related health problems. 10th revision, Austral-
ian modification; ICD-10-AM),8 which are
derived from the Medicare Benefits Schedule
to indicate the procedure performed. There
are currently no specific item numbers for
laparoscopic resection of the colon or rec-
tum. Instead, item numbers for laparoscopy
(3039000 and 3039300) are used in
combination with those for open resection
of the colon or rectum to indicate a laparo-
scopic resection (Box 1).8
National trends in the uptake of laparoscopic resection for 
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ABSTRACT
Objective:  To examine the trends in the uptake of laparoscopic resection for colorectal 
cancer.
Design and setting:  Retrospective analysis of Australia-wide data on elective 
resections for colorectal cancer over the 8 financial years 2000–01 to 2007–08, obtained 
from the National Hospital Morbidity Database.
Main outcome measures:  National trends in annual percentage of colorectal 
resections for cancer that were conducted laparoscopically for each year, stratified by 
hospitals conducting a high volume of elective resections (40 or more/year) versus a low 
volume, and by public versus private hospitals.
Results:  For all Australian hospitals combined, the percentage of resections for colon 
cancer conducted laparoscopically increased from 2.4% in 2000–01 to 27.5% in 2007–08. 
For rectal cancer, this increase was from 1.1% to 21.5%. The largest increases were seen 
in high-volume private hospitals (colon cancer, 2.7% to 34.1%; rectal cancer, 1.5% to 
26.2%), but increases also occurred in high-volume public hospitals (colon cancer, 2.7% 
to 32.2%; rectal cancer, 0.5% to 20.3%), low-volume private (colon cancer, 3.8% to 27.1%; 
rectal cancer, 2.4% to 25.5%) and low-volume public (colon cancer, 1.1% to 17.0%; rectal 
cancer, 0.5% to 13.8%) hospitals.
Conclusions:  The use of laparoscopic resection for colorectal cancer has increased 
throughout Australian hospitals. Our findings provide the data necessary to ensure 
adequate resource allocation by the appropriate medical bodies to achieve optimal 
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To simplify and clarify the presentation of
results, we grouped procedures into two
categories: those for elective segmental
resection of the colon and those for elective
resection of the rectum (Box 1). Total colec-
tomy and proctocolectomy were not
included in the data extracted because they
are uncommon. Cases of Hartmann’s pro-
cedure were also excluded from the data
extracted because, in Australia, this is typi-
cally an emergency procedure.
Ethical approval for this analysis was
granted by the University of Queensland’s
School of Population Health Research Ethics
Committee.
RESULTS
There were 5424 elective segmental resec-
tions for colon cancer in Australian hospitals
in 2000–01 and 6523 in 2007–08; elective
resections for rectal cancer increased from
2530 to 3072 in the same period. There was
no change in the percentage of elective
resections for CRC done in public versus
private hospitals between 2000–01 and
2007–08. However, within the private sec-
tor, an increasing percentage of resections
were performed in low-volume compared
with high-volume hospitals. For public hos-
pitals, the percentage of resections per-
formed in low-volume compared with high-
volume hospitals remained about the same
(Box 2).
Over the 8 years of the study, the percent-
age of elective resections for colon cancer
that were performed laparoscopically
increased from 2.4% to 27.5%; the corre-
sponding increase for elective resections for
rectal cancer that were performed laparo-
scopically was from 1.1% to 21.5% (Box 3).
There was an increase in the percentage of
laparoscopic resections across all hospital
types and for cancer of both the colon and
rectum, with the largest increases in high-
volume private hospitals (Box 4). For both
colon and rectal cancer, the rate of uptake of
laparoscopic resection appeared to increase
in 2003–04 (Box 5).
DISCUSSION
Laparoscopic colorectal resection is a very
complex procedure, requiring mobilisation
of a bulky structure, access to more than one
quadrant of the abdomen, control of multi-
ple large blood vessels, extraction of a large
specimen, and successful creation of an
anastomosis.9 Resection for malignant
tumours has even more demanding require-
ments than resection for benign disease,
because the surgeon must adhere to onco-
logical principles — attainment of adequate
surgical margins, removal of lymph nodes,
proximal ligation of the vascular pedicles,
minimal handling, and avoidance of perfo-
ration.9 Surgeons therefore need adequate
training and experience to undertake laparo-
scopic resection for CRC.10
In Australia by 2007–08, about a quarter
of elective resections for CRC were laparo-
scopic. Barring capacity constraints, it is
likely that the percentage of laparoscopic
resections will continue to increase because
such minimally invasive surgery is probably
feasible in about 90% of elective resections
for CRC performed by experienced sur-
geons.11 Also, the number of elective resec-
tions are likely to increase as early detection
of CRC through screening (either with faecal
occult blood tests or colonoscopy) and the
use of colonic stenting for obstruction
reduce the need for emergency resections.
Compared with open resection, there is a
much longer learning curve associated with
1 International statistical classification of diseases and related health problems. 
10th revision, Australian modification (ICD-10-AM)8 codes used to define 
laparoscopic resections for colon and rectal cancer*
Procedure category 
and description ICD-10-AM code
Additional ICD-10-AM codes 
indicating laparoscopic resection
Segmental resections of colon
Right hemicolectomy 3200301, 3200001  
3039000 or 3039300
Left hemicolectomy 3200600, 3200601
High anterior resection 3202400
Extended right hemicolectomy 3200501, 3200401
Sub-total colectomy 3200500, 3200400
Sigmoidectomy 3200300, 3200000
Resections of rectum
Low anterior resection 3202500, 3202600
Ultra-low anterior resection 3202800
Abdominoperineal resection 3203900
Excluded procedures Reason for exclusion
Hartmann’s procedure 3203000 Emergency procedure
Proctocolectomy 3205100, 3205101, 
3201500
Not usually conducted with 
laparoscopic access
Total colectomy 3201200, 3200900 Not usually conducted with 
laparoscopic access
* All cases included a principal diagnosis code of C18.0–C20.0. ◆
2 Absolute numbers and percentage of elective resections for colorectal cancer 
by hospital volume and sector, Australia, 2000–01 and 2007–08
Financial year
2000–01 2007–08
Segmental resections of the colon
Low-volume public hospitals 1601 (29.5%) 1675 (25.7%)
High-volume public hospitals 1065 (19.6%) 1504 (23.1%)
Low-volume private hospitals 709 (13.1%) 1628 (25.0%)
High-volume private hospitals 2050 (37.8%) 1716 (26.3%)
Resections of the rectum
Low-volume public hospitals 649 (25.7%) 768 (25.0%)
High-volume public hospitals 562 (22.2%) 770 (25.1%)
Low-volume private hospitals 286 (11.3%) 703 (22.9%)
High-volume private hospitals 1033 (40.8%) 831 (27.1%)
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laparoscopic resection for CRC; the required
number of cases has been estimated to be up
to 60–100.10,12 In Australia, uptake of lapar-
oscopic resection for CRC across all hospital
types is a reflection of continued postfellow-
ship education and training of surgeons in
this technique.
The training of surgeons and the assess-
ment of their competency in laparoscopic
CRC needs to be hierarchical because lapar-
oscopic surgery for CRC involves a range of
complexities, which are dependent on the
anatomical site. Training typically begins
with segmental resections of the right or left
colon and then progresses to the more diffi-
cult resections of the rectosigmoid colon,
transverse colon, and extraperitoneal rec-
tum. A surgeon’s application for credential-
ling at each level of laparoscopic colorectal
surgery should be accompanied by evidence
of appropriate experience in the relevant
procedures in open surgery. It is important
that emerging specialists are also proficient
in performing open resections for emer-
gency cases and in cases where the laparo-
sc op i c  t ec hn ique  i s  r e l a t i ve l y
contraindicated, such as when there are
bowel adhesions. Progression through the
levels needs to rely on objective evaluations
from teachers and peers.13
The increasing uptake of laparoscopic
resection for CRC in Australia is probably
related to both better equipment and
increasing evidence that long-term oncologi-
cal outcomes are equivalent to those of open
resection. The ultrasonic tissue dissector was
introduced around the late 1990s, and better
endoscopic stapling devices and high-defini-
tion videoendoscopy were introduced in the
early 2000s. These devices improved laparo-
scopic access, particularly for resections
within the pelvis. The increase in laparo-
scopic surgery for CRC in low-volume hospi-
tals indicates that smaller centres outside the
major cities are acquiring the technical facili-
ties to perform laparoscopic resections. For
both colon and rectal cancer, the rate of
uptake increased in 2003–04. Publication of
the Clinical Outcomes of Surgical Therapy
trial14 for colon cancer and of the first ran-
domised data for rectal cancer15 might have
contributed to this.
A strength of our study is that it is based
on data for all of Australia. At the same time,
this is also a limitation because of the lim-
ited data items available nationally. In partic-
ular, we could not obtain data on items that
might be used to assess quality, such as
conversion rates (ie, the rates of planned
laparoscopic resections being converted to
open resections), circumferential resection
margin, local recurrence, distant recurrence,
and overall survival. Further research evalu-
ating such outcomes for patients undergoing
laparoscopic surgery in everyday clinical
practice (as opposed to clinical trials) would
assist in developing service capability frame-
works. For example, should complex lapar-
oscopic surgery (eg, for cancers of the
transverse colon or extraperitoneal rectum)
be restricted to major cancer centres?
We could only find one other study of
population-based trends in the rates of
laparoscopic resection for cancers of the
colon and rectum. That publication, from
the National Institute for Clinical Excellence
in the United Kingdom, reported a percent-
age of laparoscopic procedures for elective
resections for CRC of 9.0% in 2006–07,16
compared with 21.5% from our Australian
study for the same year.
Four publications from the United States
reported the percentage of laparoscopic
resections for cancers of the colon only.17-20
These population-based studies used data
from three different sources and reported a
wide range in the percentage of CRC resec-
tions performed laparoscopically. Three of
these studies reported a percentage of
around 5%, which is very similar to that for
Australia at the same time (2003–04).17,19,20
However, another study reported a percent-
age of 33.7% for the period 1 July 2004 to 30
June 2006,18 which is higher than the 14.3%
for Australia over the same period (Box 3).
The short-term benefits of laparoscopic
resection shown by international studies
3 Laparoscopic resections as a percentage of all elective resections for 
colorectal cancer, Australia, 2000–01 and 2007–08
Segmental resections of colon Resections of rectum
Financial year All Laparoscopic All Laparoscopic
2000–01 5425 130 (2.4%) 2530 28 (1.1%)
2001–02 5629 200 (3.6%) 2544 39 (1.5%)
2002–03 5561 251 (4.5%) 2596 57 (2.2%)
2003–04 5616 302 (5.4%) 2583 119 (4.6%)
2004–05 5709 619 (10.8%) 2717 234 (8.6%)
2005–06 5921 1047 (17.7%) 2745 365 (13.3%)
2006–07 6247 1462 (23.4%) 2979 518 (17.4%)
2007–08 6523 1796 (27.5%) 3072 659 (21.5%)
Total 53300 5952 (11.2%) 24174 2062 (8.5%)
Absolute % increase* (95% CI) 25.10% (24.0%–26.3%) 20.30% (18.8%–21.9%)
* 2007–08 percentage minus 2000–01 percentage. ◆
4 Laparoscopic resections as a percentage of all elective resections for 
colorectal cancer by hospital volume and sector, Australia, 2000–01 and 
2007–08
Financial year
Absolute % 
increase* (95% CI)2000–01 2007–08
Segmental resections of the colon
Low-volume public hospitals 1.1% (18/1601) 17.0% (285/1675) 15.9% (14.0%–17.8%)
High-volume public hospitals 2.7% (29/1065) 32.2% (484/1504) 29.5% (26.0%–32.0%)
Low-volume private hospitals 3.8% (27/709) 27.1% (441/1628) 23.3% (20.7%–25.9%)
High-volume private hospitals 2.7% (56/2050) 34.1% (586/1716) 31.4% (29.1%–33.8%)
Resections of the rectum
Low-volume public hospitals 0.5% (3/649) 13.8% (106/768) 13.3% (10.8%–15.8%)
High-volume public hospitals 0.5% (3/562) 20.3% (156/770) 19.7% (16.8%–22.6%)
Low-volume private hospitals 2.4% (7/286) 25.5% (179/703) 23.0% (19.3%–26.7%)
High-volume private hospitals 1.5% (15/1033) 26.2% (218/831) 24.8% (21.7%–27.9%)
* 2007–08 percentage minus 2000–01 percentage. ◆
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probably provide impetus for the uptake of
this technique in Australia. Short-term out-
comes from the Australian Laparoscopic
Colon Cancer Surgical trial indicate that
laparoscopic resection is associated with
faster return of bowel function and shorter
hospital stay.21 However, whether these and
other short-term benefits such as reduced
blood loss and better postoperative pulmon-
ary function are being experienced outside
the clinical trial environment would be of
interest, and these questions should be the
subject of future research. Also of interest in
the real world of clinical practice is operat-
ing time. In a meta-analysis of randomised
and non-randomised data, the mean operat-
ing time for laparoscopic surgery was 27%
longer than for open surgery (175 minutes
versus 147 minutes).3 Operating time is
related to conversion rates, and it is possible
that, as surgeons become more experienced
with laparoscopic techniques, conversion
rates will decrease and operating time will
reduce to that of open surgery.
Impetus for the increased uptake of laparo-
scopic surgery for CRC comes not just from
good quality evidence from randomised trials
and recommendations by medical bodies,22-24
but also from the positive experiences of
surgeons and their patients in everyday clini-
cal practice. Given equivalent long-term
oncological outcomes, patients with CRC
prefer laparoscopic resections because of
the proven short-term benefits.2
CRC is the most common internal cancer
diagnosed in Australia.25 It is therefore likely
that laparoscopic resection for CRC will be a
procedure in high demand. The results from
our article provide information to help the
appropriate medical bodies achieve optimal
success in the uptake of laparoscopic resec-
tion for CRC in Australia by providing the
data necessary to ensure adequate resource
allocation.
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5.2 Discussion and implication of findings 
The objective of this study was to inform healthcare administrators of the national uptake of 
laparoscopic resection and any disparity in access to this procedure by hospital type. This is the first 
study to report on the uptake of laparoscopic resection for CRC across Australia. While there have 
been increases in laparoscopic resection for colorectal cancer across all hospitals, a disparity in 
access to the procedure between the hospitals exists; specifically, the uptake of laparoscopic 
resection for resection was slower in public hospitals and low-volume public hospitals. This study is 
valuable because it provides the data necessary to aid healthcare administrators responsible for 
resource allocation to ensure further uptake of the technique and equitable access to patients with 
CRC in Australia.(90) 
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Chapter 6 Determinants of uptake of laparoscopic resection for colorectal 
cancer 
6.1 Introduction 
Laparoscopic resection of colorectal cancer includes procedures of varying technical difficulty; it is 
more difficult to perform resections of the rectosigmoid colon and transverse colon compared with 
segmental resections of the right or left colon. Uptake of some procedures may therefore be slower 
than others. 
The large numbers of laparoscopic resections for CRC in Queensland provide a sample size that is 
large enough to accurately determine the characteristics of patients having laparoscopic resection 
for CRC. Hospital morbidity data were utilised to determine whether differences in the uptake of 
laparoscopic resection exist across different procedure types and patient characteristics.  
Each of the authors contributed to this study and the resulting manuscript as follows. Michael 
Coory, John Lumley and I were each responsible for the conception and design of the study. I was 
responsible for the data acquisition, and performed the data analysis. Under the guidance of Michael 
Coory and John Lumley, I interpreted the results. I was responsible for the first and subsequent 
drafts of the manuscript under the guidance of, and with feedback from, Michael Coory, John 
Lumley and Louisa Gordon. 
This manuscript has been submitted for consideration to be published in a peer-reviewed journal. 
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Abstract 
Introduction: Laparoscopic surgery for colorectal cancer (CRC) includes procedure types of 
varying technical difficulty.  The aim of this paper is to assess whether there is differential 
uptake of laparoscopic surgery by procedure type in a geographically-defined area; where 
uptake is relatively mature; and where there are clear referral pathways to colorectal 
surgeons, who specialise in laparoscopic surgery.  
Method: This is a population-based study of trends (1999/2000 – 2010/2011) in laparoscopic 
resection for elective surgery for CRC.  Trends are assessed in subgroups, based on technical 
difficulty, over four time periods.  The main outcome measure is the “laparoscopic 
percentage”; the number of resections performed with laparoscopic access divided by number 
of all relevant resections (laparoscopic + open).  
Results: The laparoscopic percentage for sigmoid colectomy/high anterior resection increased 
from 10.4% in 1999/2000-2002/2003 to 61.4% in 2009/2010-2010/2011. Similarly, the 
laparoscopic percentage for right hemicolectomy increased from 10.7% to 54.5%; and left-
hemicolectomy increased from 4.0% to 54.0%.  There were also large increases in the 
percentages of more difficult procedures: transverse colectomy (4.1% to 47.6%); extended 
right hemicolectomy (5.8% to 40.3%); and restorative proctectomy (5.5% to 63.2%).  Length 
of stay was shorter by 1.7 days in the laparoscopic groups.     
Discussion: The laparoscopic approach has diffused across all procedure types, regardless of 
technical difficulty and regardless of factors such as cancer stage, cancer site and co-
morbidities. In the real-world of everyday clinical practice, surgeons are judging the results 
from RCTs can be validly generalised to nearly all patients with CRC.   
Word count: 238 
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Introduction 
Laparoscopic resection for the management of colorectal cancer (CRC) is one surgical 
intervention for which there are well-designed, large, multi-centre randomised clinical trials 
(RCT).  For colon cancer, high quality randomised evidence has confirmed that, compared to 
open surgery, laparoscopic resection has equivalent long-term oncologic outcomes with 
superior short-term outcomes (i.e., less post-operative pain, lower risk of post-operative 
complications, shorter length of stay).1  For rectal cancer, the randomised data are not as 
mature as for colon cancer; however, the available evidence suggests a similar favourable 
benefit-risk profile.2-4  The National Institute for Health and Clinical Excellence (NICE) 
recommends laparoscopic resection for both colon and rectal cancer5, while other guidelines 
recommend laparoscopic resection of colon cancer only6-8.  Recently the European 
Association for Endoscopic Surgery (EAES) recommended laparoscopic resection of rectal 
cancer.9   
Although RCTs provide the most internally valid measure of the benefits and risks of a new 
surgical technique, they are based on a sample of patients who meet inclusion/exclusion 
criteria and who are treated in specialised centres.10  In the real world of everyday clinical 
practice, surgeons have to judge whether the average results reported from RCTs apply to a 
particular individual patient, who is seeking advice and treatment.  The RCTs for 
laparoscopic resection commonly excluded patients with cancer of the transverse colon11-14 
and rectum,11, 13, 14 those with metastasis,11, 13, 14 poor overall health,13, 15 and chronic cardiac 
or pulmonary disease12.  With the exception of one single-surgeon study, which reported that 
90% of elective CRC patients are suitable for laparoscopic resection,16 little is known about 
the type of patients who are being selected for laparoscopic resection, in the real world of 
everyday clinical practice. 
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Queensland (north-east part of Australia; population 4.2 million) has a group of surgical 
opinion leaders, who were innovators and early-adopters of laparoscopic resection for CRC.17  
Queensland is therefore further along the S-curve18 for uptake of this technology than most 
other jurisdictions.  Specifically, in Queensland in the financial year 2008/09, 48% of 
resections for CRC were performed laparoscopically, whereas in the United Kingdom the 
corresponding figure was 22%.19  In the United States, 20% of resections for rectal cancer 
were laparoscopic in 2009 compared with 46% in Queensland.20  Also, surgeons in 
Queensland who were experienced in laparoscopic surgery were well-known to other 
clinicians and there were well-established referral pathways.17 
This study is the first to report on the uptake of lap surgery for CRC across different 
procedure types in a region where uptake is relatively mature.  Increases in the percentage of 
laparoscopic resections into all patient groups; including, patients requiring technically 
difficult resections (transverse colectomy, resections of the rectum), patients with cardiac or 
pulmonary disease, and patients with metastases, would imply that, in the future, most CRC 
patients will be considered eligible for laparoscopic resection.   
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Methods 
Data for this study were obtained from the Queensland Hospital Admitted Patients Data 
Collection (QHAPDC) for the twelve financial years 1999/2000 – 2010/2011.  QHAPDC 
maintains inpatient data for all admissions to all hospitals in Queensland.  Similar routinely-
maintained, inpatient databases exist in the other Australian states and territories; these 
databases are similar to hospital administrative databases in the United States,21 the United 
Kingdom22 and Canada23.   
In Queensland and Australia, about 60% of major resections are performed in private 
hospitals; the remainder are done in the public sector.24  Patients admitted to public hospitals 
receive treatment supervised by specialists (or advanced trainees) nominated by the 
hospital.25  Specialist surgical training is predominantly conducted at public hospitals.25   
Procedures were grouped into seven categories based on technical difficulty;26 the additional 
codes, 3039000 and 3039300, signified a laparoscopic resection   (International Statistical 
Classification of Diseases and Related Health Problems, Tenth Revision, Australian 
Modification; ICD10-AM).27  Cancer patients (as opposed to those who had a resection for 
benign disease) were identified as those whose principle diagnosis field contained an ICD10-
AM code between C18.0 – C20.9.28  Only elective (booked) resections were considered for 
the study; emergency procedures were excluded.  Total colectomy, proctocolectomy and 
Hartmann’s procedure (4.5%) were not included because they are rarely performed 
laparoscopically.   
Restorative proctectomy includes anterior resections extending from the anal verge to 10cm 
from the anal verge (low and ultra-low anterior resections).  Comorbid cardiac and 
pulmonary diseases were identified from secondary diagnosis codes and included any ICD-
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10AM codes for the broad diagnoses of: congestive heart failure, acute myocardial infarction 
and chronic obstructive pulmonary disease.29 
The main outcome measure is the “laparoscopic percentage”; the number of resections 
performed with laparoscopic access divided by the number of all relevant resections 
(laparoscopic + open).  The analysis was stratified over four time periods; 1999/2000 – 
2002/2003, 2003/2004 – 2005/2006, 2006/2007 – 2008/2009 and 2009/2010 – 2010/2011.  
Confidence intervals for the difference in laparoscopic percentage over time were calculated 
using the Wald method.30 
Ordinary least squares regression analysis was used to estimate differences in the length of 
hospital stay between open and laparoscopic resections for rectal resection, laparoscopic 
segmental resection of the colon, and all resections (rectal and segmental combined). The 
analysis was adjusted for categories of age, time period, Charlson Comorbidity Index and 
stage. 
All analyses were performed using STATA Statistical Software.31 
Socio-economic status (SES) was defined using Socio-Economic Indexes for Areas (SEIFA) 
which provides a measure of SES for small geographically defined neighbourhoods based on 
information from the Australian Census.32  Accessibility/Remoteness Index of Australia Plus 
(ARIA+) measures were used to indicate remoteness of residence.  ARIA+ is based on the 
National Localities Index from the Australian Bureau of Statistics and determined from the 
residential address of the patient.   ARIA+ categorises individuals in the following categories; 
major cities, inner regional, outer regional, remote and very remote.33  For the purpose of this 
study, these categories were further collapsed into; major city, inner regional, outer 
regional/remote. 
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Ethical approval to conduct this study was provided by The Queensland Health Human 
Research Ethics Committee and The University of Queensland School of Population Health 
Ethics Committee. 
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Results 
The data set included 14,343 patients who had a segmental resection for cancer of the colon 
and 6,402 patients who had resection for rectal cancer between July 1st 1999 and June 30th 
2011.  Patients with rectal cancer were younger and more likely to be male than colon cancer 
patients (Tables 1 and 2).  Over the entire study period, about 47% of resections of the rectum 
and segmental resections of the colon were conducted in high-volume private hospitals 
(Tables 1 and 2).  Right hemicolectomies were the most common segmental resection of the 
colon (Table 1).  More than 80% of resections for rectal cancer were restorative 
proctectomies, the remaining rectal resections were abdomino-perineal resections and these 
decreased slightly over time.  For resections of both rectal and colon cancers, Charlson co-
morbidity index decreased over time along with decreases in the percentage of patients with 
co-morbid cardiac or pulmonary disease (Tables 1 and 2).  Otherwise, the baseline 
characteristics of patients did not change materially over time.  
The number of elective segmental resections for colon cancer increased from 1,055 in 
1999/2000 to 1,309 in 2010/2011; the corresponding increase for rectal cancer was from 403 
to 625.  The laparoscopic percentage increased from 7% to 59% over this time for all 
segmental resections of the colon; and from 7% to 65% for all rectal resections.  The 
laparoscopic percentage for rectal resections remained at a low level of 4% to 7% from 
1999/2000-2003/2004.  In 2003/2004 there was an abrupt and large increase to 15.7% (Figure 
1).  In contrast, the laparoscopic percentage for segmental resections of the colon increased 
steadily over the entire 12-year period, although, as with resections of the rectum, the 
increase was more marked from 2003/2004 (Figure 1).   
The laparoscopic percentage for sigmoid colectomy/high anterior resection increased from 
10.4% in 1999/2000-2002/2003 to 61.4% in 2009/2010-2010/2011.  Similarly, right- 
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hemicolectomy increased from 10.7% to 54.5% and left-hemicoloectomy from 4.0% to 
54.0%.  There were also large increases for more difficult procedures: transverse colectomy 
(4.1% to 47.6%); extended right hemicolectomy (5.8% to 40.3%); and restorative 
proctectomy (5.5% to 63.2%) (Figure 2). 
Increases in the percentage of laparoscopic resections were smallest for patients with distant 
disease for cancer of the colon or rectum; however, laparoscopic percentages approached 
50% in the latest time period.  Likewise, while patients with cardiac or pulmonary disease 
had smaller increases in laparoscopic resections between the first and last time periods, the 
laparoscopic percentages for this subgroup were: rectal resections 53%; segmental colon 
resections 44%.  Laparoscopic percentages were highest across all time periods for those 
living in the most advantaged areas and those treated in private hospitals.  Further details are 
available in Supplementary Tables 1 and 2.  
After adjusting for potential confounders, the length of hospital stay was significantly shorter 
following rectal resection (-1.7 days; 95% CI -2.3 days, -1.2 days) and segmental resections 
of the rectum (-1.7 days; 95%CI -2.0 days, -1.4 days).   
There were 271 deaths within 30 days of the procedure; 50/6402 (1%) following rectal 
resection, and 166/14343 (1.2%) following segmental resection of the colon.  For rectal 
cancer patients, the percentage who died within 30 days of discharge was less than 1% in the 
laparoscopic and open groups.  Percentages were similarly low for segmental resections of 
the colon; 1.2% in the open group and 1.0% in the laparoscopic group. These low percentages 
reflect the fact that this study only included patients booked for elective resection of their 
colorectal cancer; patients requiring non-booked (emergency) operations were excluded.  
    
Discussion 
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This population-based study, across all hospitals in a defined geographic area, found only 
marginally slower uptake of laparoscopic surgery for more difficult operations; and similarly 
for patients with metastases and cardio-pulmonary disease.  These results suggest that 
surgeons are judging that the results from RCTs can be validly generalised to nearly all 
patients with CRC.  These data also confirm a reduced length of hospital stay for 
laparoscopic resection.  
There are no other published studies which have considered the type of procedures performed 
laparoscopically over time.  A study based on data from non-profit academic medical centres 
of the United States, reports laparoscopic percentages for the time period 2007-2009 less than 
half those found in this study for the same period.34  While both studies found smallest 
laparoscopic percentages for abdomino-perineal resection and transverse colectomy, this 
current study identified substantial increases in the laparoscopic percentages of these 
procedures following this period, such that by 2009/2010 – 2010/2011, they were similar to 
the percentages for right-hemicolectomy and sigmoid colectomy. 
A strength of this study is that it is population-based and includes all patients treated for CRC 
across all hospitals in a geographically defined area.  This study does not take into account 
planned laparoscopic resections which were converted to open resection at the time of 
surgery, although this is likely to have occurred in less than 7% of the cohort.17 
The four years prior to 2003/04 represent the early period, before outcomes from most RCTs 
were reported12, 14, 35, 36 and prior to advances in available technical equipment.  This has 
allowed for comparison between the early phase of adoption and the time periods following, 
when uptake was more rapid.   
Improvements in surgical equipment, specifically high-quality videoendoscopic equipment 
around 2003, played a major role in increasing the laparoscopic percentage of resections of 
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the rectum.  Not only did this equipment allow for improved visualisation within the pelvis, it 
arguably allowed for better visualisation than obtainable in an open resection.  This, 
combined with the advancement of skills among the surgical teams, resulted in a steady and 
rapid uptake of laparoscopic resection of the rectum from the early 2000s.  This experience 
led to confidence in selecting other complicated procedures for laparoscopic resection, 
including the transverse colectomy and extended right hemicolectomy.   
High-risk patients are not well represented in the RCTs assessing the efficacy of laparoscopic 
surgery for CRC of these patients following laparoscopic resection for CRC.11, 12, 14, 37, 38  
While there were fewer laparoscopic resections for patients with co-morbid chronic cardiac 
or pulmonary disease, by the last time period, almost half had laparoscopic resection.  With 
the current constraints on the number of laparoscopic resections that can be performed, it is 
possible that patients with fewer co-morbidities are preferred for laparoscopic resection.  
Only recently, the European Association for Endoscopic Surgery stated that cardiopulmonary 
impairment is not a contraindication for laparoscopic resection of rectal cancer9 and with 
improvements in anaesthetic techniques and monitoring, including adjustment to  intra-
abdominal pressure, laparoscopic resection for CRC can have minimal adverse anaesthetic 
events with improved patient outcomes38.  With this in mind, these patients will be 
specifically selected for laparoscopic resection in coming years.  
Even in high-volume private hospitals where surgeons are the most experienced in 
laparoscopic resections for CRC and where (compared with public hospitals) there should be  
few capacity or systemic constraints, the percentage of patients selected for laparoscopic 
resection falls short of the previously suggested 90% of patients16.  This is probably a 
consequence of the technical difficulty of this intervention and the associated long learning 
curve.  It takes a number of years for a surgeon to become experienced in conducting 
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laparoscopic resections for cancers of the colon and rectum.  When a surgeon is willing to 
conduct laparoscopic resection for complicated cases depends on the individual surgeon and 
the operating teams and may not occur until both have gained ample experience.  There will 
always be surgeons in the earlier phase of the learning curve and the training regime requires 
that they also learn techniques in open resection.  The percentage increase of laparoscopic 
segmental resections of the colon among high-volume private hospitals has slowed; even in 
hospitals where surgeons are fully-trained and have adequate experience, surgeons are 
choosing to perform open resections on 38% of colon cancer patients.   
A group of specialist colorectal surgeons drove the uptake of laparoscopic resection in 
Queensland and from the early phase of adoption offered training courses in laparoscopic 
colorectal surgery.  In doing so, they developed clear referral pathways whereby more 
difficult procedures were referred to the most experienced surgeons.  The likelihood of 
patients requiring rectal resections, transcolectomies or extended right hemicolectomies 
having their procedure with laparoscopic access, was similar to patients requiring less 
complicated procedures. We postulate that clear referral pathways mean that patients are 
consulting with surgeons who have the experience appropriate for the complexity of their 
presenting clinical circumstances and condition. 
In experienced hands, perhaps the only patients not suitable for laparoscopic resection for 
colorectal cancer, will be those with threatened margins (detected on magnetic resonance 
imaging) or with a history of complicated previous surgery.16  Which patients receive 
laparoscopic surgery may depend not so much on characteristics of the cancer (e.g., site 
stage) or patient (e.g., age, co-morbidities), but on the experience of the surgical team and 
available resources.  This raises the problem of how to ensure equitable access to this 
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technology for all patients, because suitably experienced surgeons might not be available in 
the local area. 
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Table 1: Baseline characteristics of patients having segmental resection for cancer of the 
colon by four time periods. 
† High-volume hospitals conducted at least 40 colorectal cancer resections for a minimum of 8 years over the 
study period.  
‡  Statistical significance for variation over the four time periods determined using log-likelihood ratio.  
      
   
 
 
 1999/00 – 2002/03 (4) 
2003/04 – 
2005/06 (3) 
2006/07 – 
2008/09 (3) 
2009/10 – 
2010/11 (2) P-value‡ 
N 4362 3435 3911 2635  
Age group     0.808 
 ≤50 286 (6.6) 239 (7.0) 256 (6.6) 202 (7.7)  
 51-75 2724 (62.5) 2100 (61.1) 2354 (60.2) 1517 (57.6)  
 ≥76 1352 (31.0) 1096 (31.9) 1301 (33.3) 916 (34.8)  
Sex      0.660 
 Male 2237 (51.3) 1783 (51.9) 2026 (51.8) 1335 (50.7)  
 Female 2125 (48.7) 1652 (48.1) 1885 (48.2) 1300 (49.3)  
ARIA     <0.001 
 Major city 2169 (49.7) 1691 (49.2) 1934 (49.5) 1239 (47.0)  
 Inner regional 1355 (31.1) 1119 (32.6) 1230 (31.5) 863 (32.8)  
 Outer regional/remote 838 (19.2) 625 (18.2) 747 (19.1) 533 (20.2)  
SEIFA     0.023 
 3 (most adv.) 1448 (33.9) 1163 (34.8) 1260 (33.2) 764 (30.0)  
 2  1457 (34.1) 1090 (32.6) 1307 (34.4) 929 (36.5)  
 1 (least adv.) 1365 (32.0) 1088 (32.6) 1233 (32.5) 854 (33.5)  
Hospital type†     <0.001 
 High-volume private  1840 (42.2) 1643 (47.8) 1896 (48.5) 1254 (47.6)  
 Low-volume private 692 (15.9) 398 (11.6) 461 (11.8) 324 (12.3)  
 High-volume public 1340 (30.7) 1054 (30.7) 1105 (28.3) 748 (28.4)  
 Low-volume public 490 (11.2) 340 (9.9) 449 (11.5) 309 (11.7)  
Procedure     <0.001 
 Right hemicolectomy 2032 (46.6) 1523 (44.3) 1808 (46.2) 1239 (47.0)  
 Transverse colectomy 340 (7.8) 148 (4.3) 183 (4.7) 103 (3.9)  
 Extended right 
hemicolectomy 86 (2.0) 270 (7.9) 309 (7.9) 201 (7.6)  
 Left hemicolectomy 423 (9.7) 364 (10.6) 439 (11.2) 304 (11.5)  
 Sigmoid colectomy / high 
 anterior resection of 
 rectum 
1481 (34.0) 1130 (32.9) 1172 (30.0) 788 (29.9) 
 
Extent of disease     0.018 
 Local 2789 (63.9) 2198 (64.0) 2555 (65.3) 1783 (67.7)  
 Regional 1038 (23.8) 834 (24.3) 952 (24.3) 605 (23.0)  
 Distant 535 (12.3) 403 (11.7) 404 (10.3) 247 (9.4)  
Charlson score     0.011 
 0 2081 (47.7) 1665 (48.5) 1991 (50.9) 1503 (57.0)  
 1 499 (11.4) 373 (10.9) 382 (9.8) 185 (7.0)  
 2+ 1782 (40.9) 1397 (40.7) 1538 (39.3) 947 (35.9)  
Cardiac or pulmonary disease 474 (10.9) 283 (8.2) 309 (7.9) 170 (6.5) <0.001 
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Table 2: Baselines characteristics patients having resection for rectal cancer by four time 
periods. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
† High-volume hospitals conducted at least 40 colorectal cancer resections for a minimum of 8 years over the 
study period.  
‡  Statistical significance for variation over the four time periods determined using log-likelihood ratio.     
  
  
 1999/00 – 2002/03 (4) 
2003/04 – 
2005/06 (3) 
2006/07 – 
2008/09 (3) 
2009/10 – 
2010/11 (2) P-value‡ 
N 1852 1539 1806 1205  
Age group     0.771 
 ≤50 179 (9.7) 165 (10.7) 178 (9.9) 157 (13.0)  
 51-75 1257 (67.9) 1043 (67.8) 1291 (71.5) 822 (68.2)  
 ≥76 416 (22.5) 331 (21.5) 337 (18.7) 226 (18.8)  
Sex      0.681 
 Male 1197 (64.6) 971 (63.1) 1163 (64.4) 787 (65.3)  
 Female 655 (35.4) 568 (36.9) 643 (35.6) 418 (34.7)  
ARIA     0.348 
 Major city 888 (48.0) 731 (47.5) 843 (46.7) 542 (45.0)  
 Inner regional 535 (28.9) 441 (28.7) 565 (31.3) 361 (30.0)  
 Outer regional/remote 429 (23.2) 367 (23.9) 398 (22.0) 302 (25.1)  
SEIFA      0.030 
 3 (most adv.) 617 (34.7) 517 (34.9) 585 (33.5) 346 (29.8)  
 2  612 (34.4) 503 (34.0) 565 (32.3) 409 (35.3)  
 1 (least adv.) 549 (30.9) 461 (31.1) 598 (34.2) 405 (34.9)  
Hospital type†     <0.001 
 High-volume private  855 (46.2) 733 (47.6) 892 (49.4) 541 (44.9)  
 Low-volume private 198 (10.7) 106 (6.9) 123 (6.8) 119 (9.9)  
 High-volume public 636 (34.3) 587 (38.1) 691 (38.3) 485 (40.3)  
 Low-volume public 163 (8.8) 113 (7.3) 100 (5.5) 60 (5.0)  
Procedure     0.018 
 Restorative proctectomy 1485 (80.2) 1253 (81.4) 1514 (83.8) 1004 (83.3)  
 APR 367 (19.8) 286 (18.6) 292 (16.2) 201 (16.7)  
Extent of disease     0.031 
 Local 1223 (66.0) 978 (63.6) 1194 (66.0) 834 (69.2)  
 Regional 438 (23.7) 372 (24.2) 413 (22.9) 267 (22.2)  
 Distant 191 (10.3) 189 (12.3) 199 (11.0) 104 (8.6)  
Charlson score     <0.001 
0 914 (49.4) 790 (51.3) 993 (55.0) 723 (60.0)  
1 206 (11.1) 132 (8.6) 144 (8.0) 76 (6.3)  
2+ 732 (39.5) 617 (40.1) 669 (37.0) 406 (33.7)  
Cardiac or pulmonary 
disease 199 (10.8) 85 (5.5) 92 (5.1) 62 (5.2) 
<0.001 
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Figure 1: Laparoscopic resections as a percentage of all elective segmental resections of the 
colon and resection of the rectum for colorectal cancer, Queensland, 1999/2000 – 2010/2011 
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Figure 2: Percentage laparoscopic resections by procedure type over four time periods. 
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Table 6-1 and Table 6-2 were submitted for publication as online supplementary tables. 
Table 6-1 Characteristics of patients having laparoscopic segmental resection for cancer of the 
colon by four time periods.  
N.B. Footnotes for Table 6-1 are the same as for Table 6-2  
 
1999/00 – 
2002/03 (4) 
2003/04 – 
2005/06 (3) 
2006/07 – 
2008/09 (3) 
2009/10 – 
2010/11 (2) 
Percentage 
increase1 
(%) (95%CI) 
N 4362 3435 3911 2635  
Laparoscopic n (%) 407 (9.3) 755 (22.0) 1651 (42.2) 1453 (55.1) 45.8 (43.7, 47.9) 
Age (median) 70 (28-91) 70 (17-94) 70 (16-97) 70 (22-102)  
Age category      
 ≤50 29/286 (10.1) 57/239 (23.9) 107/256 (41.8) 118/202 (58.4) 48.3 (40.6, 55.9) 
 51-75 250/2724 (9.2) 466/2100 (22.2) 1022/2354 (43.4) 854/1517 (56.3) 47.1 (44.4, 49.8) 
 ≥76 128/1352 (9.5) 232/1096 (21.2) 522/1301 (40.1) 481/916 (52.5) 43.0 (39.5, 46.6) 
Sex       
 Male 207/2237 (9.3) 384/1783 (21.5) 856/2026 (42.3) 750/1335 (56.2) 46.9(44.0, 49.8) 
 Female 200/2125 (9.4) 371/1652 (22.5) 795/1885 (42.2) 703/1300 (54.1) 44.7 (41.7, 47.6) 
ARIA2      
 Major city 269/2169 (12.4) 450/1691 (26.6) 967/1934 (50) 792/1239 (63.9) 51.5 (48.5, 54.5) 
 Inner regional 58/1355(4.3) 177/1119 (15.8) 456/1230 (37.1) 433/863 (50.2) 45.9 (42.4, 49.4) 
 Outer regional/remote 83/838 (9.6) 128/625 (20.5) 228/747 (30.5) 228/533 (42.8) 39.0 (34.5, 43.5) 
SEIFA3      
 3 (most adv.) 188/1448 (13.0) 316/1163 (27.2) 611/1260 (48.5) 488/764 (63.9) 50.9 (47.1, 54.7) 
 2  116/1457 (8.0) 240/1090 (22.0) 575/1307 (44.0) 487/929 (52.4) 44.4 (41.0, 48.0) 
 1 (least adv.) 83/1365 (6.1) 154/1088 (14.2) 401/1233 (32.5) 415/439 (48.6) 42.5 (38.9, 46.1) 
Hospital type4      
 High-volume private 297/1840 (16.1) 532/1643 (32.4) 984/1896 (51.9) 776/1254 (61.9) 45.7 (42.6, 48.9) 
 Low-volume private 17/692 (2.5) 54/398 (13.6) 180/461 (39.1) 161/324 (49.7) 47.2 (41.7, 52.8) 
 High-volume public 82/1340 (6.1) 161/1054 (15.3) 373/1105 (33.8) 363/748 (48.5) 42.4 (38.6, 46.2) 
 Low-volume public 11/490 (2.2) 8/340 (2.4) 114/449 (25.4) 153/309 (49.5) 47.3 (41.5, 53.0) 
Procedure      
 Right hemicolectomy 217/2032 (10.7) 353/1523 (23.2) 802/1808 (44.4) 675/1239 (54.5) 43.8 (40.7, 46.9) 
 Transverse colectomy 14/340 (4.1) 25/148 (15.5) 49/183 (26.8) 49/103 (47.6) 43.5 (33.6, 53.3) 
 Extended right   
 hemicolectomy 5/86 (5.8) 40/270 (14.8) 76/309 (24.6) 81/201 (40.3) 34.5 (26.0, 42.9) 
 Left hemicolectomy 17/423 (4.0) 54/364 (14.8) 171/439 (39.0) 164/304 (54.0) 49.9 (44.0, 55.8) 
 Sigmoid colectomy / 
 high anterior resection 
 of rectum 
154/1481 (10.4) 285/1130 (25.2) 553/1172 (47.2) 484/788 (61.4) 51.0 (47.3, 54.8) 
Extent of disease      
 Local 252/2789 (9.0) 515/2198 (23.4) 1127/2555 (44.1) 989/1783 (55.5) 46.4 (43.9, 49.0) 
 Regional 99/1038 (9.5) 160/834 (19.2) 385/952 (40.4) 345/605 (57.0) 47.5 (43.2, 51.8) 
 Distant 56/535 (10.5) 80/403 (19.9) 139/404 (34.4) 119/247 (48.2) 37.7 (31.0, 44.5) 
Charlson score      
 0 196/2081 (9.4) 412/1665 (24.7) 916/1991 (46.0) 871/1503 (58.0) 48.5 (45.7, 51.3) 
 1 39//499 (7.8) 82/373 (22.0) 135/382 (35.3) 77/185 (41.6) 33.8 (26.3, 41.3) 
 2+ 172/1782 (9.7) 261/1397 (18.7) 600/1538 (39.0) 505/947 (53.3) 43.7 (40.2, 47.1) 
Cardiac or pulmonary 
disease      
 No 372/3516 (9.6) 706/3152 (22.4) 1543/3602 (42.8) 1379/2465 (55.9) 45.4 (43.2, 47.6) 
 Yes 35/474 (7.4) 49/283 (17.3) 108/309 (35.0) 74/170 (43.5) 36.1 (28.3, 44.0) 
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Table 6-2 Characteristics of patients having laparoscopic resection for cancer of the rectum by four 
time periods.  
1 Percentage increase is the difference between the first time period (1999/00 – 2002/03) and the 
last time period (2009/10 – 2010/11) 
2 Accessibility/Remoteness Index Australia(91) 
3 Socio-Economic Indexes for Areas(92) 
4 High-volume hospitals conducted at least 40 CRC resections for a minimum of 8 years over the 
study period. 
  
 
1999/00 – 
2002/03 (4) 
2003/04 – 
2005/06 (3) 
2006/07 – 
2008/09 (3) 
2009/10 – 
2010/11 (2) 
Percentage 
increase1  
(%) (95%CI) 
N 1852 1539 1806 1205  
Laparoscopic n (%) 104/1852 (5.6) 336/1539 (21.8) 745/1806 (41.3) 729/1205 (60.5) 54.9 (51.9, 57.8) 
Age (median) 69 (19-91) 64 (20-96) 65 (25-93) 65 (25-91)  
Age category      
 ≤50 8/179 (4.5) 43/165 (26.1) 73/178 (41.0) 94/157 (59.9) 55.4 (47.2, 63.6)
 51-75 71/1257 (5.7) 227/1043 (21.8) 546/1291 (42.3) 504/822 (61.3) 55.7 (52.1, 59.2)
 ≥76 25/416 (6.0) 66/331 (19.9) 126/337 (37.4) 131/226 (58.0) 52.0 (45.1, 58.8)
Sex       
 Male 56/1197 (4.7) 199/971 (20.5) 487/1163 (41.9) 471/787 (59.8) 55.2 (51.5, 58.8)
 Female 48/655 (7.3) 137/568 (24.1) 258/643 (40.1) 258/418 (61.7) 54.4 (49.3, 59.5)
ARIA2      
 Major city 60/888 (6.8) 149/731 (20.4) 393/843 (46.6) 342/542 (63.1) 56.3 (52.0, 60.7)
 Inner regional 17/535 (3.2) 79/441 (17.9) 199/565 (35.2) 211/361 (58.4) 55.3 (50.0, 60.6)
 Outer regional/remote 27/429 (6.3) 108/367 (29.4) 153/398 (38.4) 176/302 (58.3) 52.0 (46.0, 58.0)
SEIFA3       
 3 (most adv.) 39/617 (6.3) 133/517 (25.7) 276/585 (47.2) 228/346 (65.9) 59.6 (54.2, 64.9)
 2  35/612 (5.7) 99/503 (19.7) 214/565 (37.9) 235/409 (57.5) 51.7 (46.6, 56.9)
 1 (least adv.) 20/549 (3.6) 84/463 (18.1) 224/598 (37.5) 234/405 (57.8) 54.1 (49.1, 59.2)
Hospital type4      
 High-volume private  82/855 (9.6) 236/733 (32.2) 474/892 (53.1) 379/541 (70.1) 60.4 (56.1, 64.8)
 Low-volume private 3/198 (1.5) 13/106 (12.3) 32/123 (26.0) 63/119 (52.9) 51.4 (42.3, 60.6)
 High-volume public 18/636 (2.8) 86/587 (14.7) 221/691 (32.0) 265/485 (54.6) 51.8 (47.2, 56.4)
 Low-volume public 1/163 (0.6) 1/113 (0.9) 18/100 (18.0) 22/60 (36.7) 36.1 (23.8, 48.3)
Procedure      
 Restorative proctectomy 82/1485 (5.5) 298/1253 (23.8) 665/1514 (43.9) 635/1004 (63.2) 57.7 (54.5, 60.9)
 Abdomino-perineal 
 resection 22/367 (6.0) 38/286 (13.3) 80/292 (27.4) 94/201 (46.8) 40.8 (33.5, 48.1)
Extent of disease      
 Local 70/1223 (5.7) 218/978 (22.3) 494/1194 (41.4) 508/834 (60.9) 55.2 (51.6, 58.7)
 Regional 21/438 (4.8) 73/372 (19.6) 185/413 (44.8) 172/267 (64.4) 59.6 (53.5, 65.7)
 Distant 13/191 (6.8) 45/189 (23.8) 66/199 (33.2) 49/104 (47.1) 40.3 (30.1, 50.5)
Charlson score      
 0 48/914 (5.3) 182/790 (23.0) 421/993 (42.4) 450/723 (62.2) 57.0 (53.2, 60.8)
 1 14/206 (6.8) 26/132 (19.7) 52/144 (36.1) 39/76 (51.3) 44.5 (32.8, 56.3)
 2+ 42/732 (5.7) 128/617 (20.8) 272/669 (40.7) 240/406 (59.1) 53.4 (48.3, 58.4)
Cardiac or pulmonary 
disease      
 No 91/1653 (5.5) 317/1454 (21.8) 715/1714 (41.7) 696/1143 (60.9) 55.4 (52.4, 58.4)
 Yes 13/199 (6.5) 19/85 (22.4) 30/92 (32.6) 33/62 (53.2) 46.7 (33.8, 59.6)
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6.2 Discussion and implications of findings 
The findings from this study indicate that the ability to access surgeons with adequate skills and 
experience such as those in private hospitals and high-volume public hospitals, are stronger 
determinants of laparoscopic resection for CRC than characteristics of the cancer (site and stage) 
and patient characteristics (comorbidities and age). The total numbers of resections for rectal cancer 
in the low-volume public hospitals are small, indicating that these patients are probably referred to 
the more experienced surgeons in the high-volume public hospitals. These results suggest that in 
Queensland, the more complex cases are referred to surgeons with experience appropriate for the 
complexity of the presenting clinical circumstances and condition. 
Conclusion 
The objective of this study was to understand the types of patients and procedures performed in a 
large sample of patients who underwent surgery for CRC. This study is the first to describe which 
procedures and patients are being selected for laparoscopic resection for CRC. The results indicate 
that over time there has been equitable access to Queensland patients with CRC regardless of the 
complexity of the procedure and the clinical presentation of the patient. This is an important finding 
because it suggests that, since 1999/2000, there were strong referral pathways in Queensland 
whereby the more complex cases being treated by the most experienced surgeons; which, in turn, 
has ensured equitable access to laparoscopic resection. These findings are now extended in Chapter 
7, which the economic cost implication of laparoscopic resection for CRC in Queensland will be 
discussed.  
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Chapter 7 In-hospital costs of laparoscopic resection compared with open 
resection for colorectal cancer  
7.1 Introduction 
This chapter reports on the cost of the index admission for laparoscopic compared with open 
resection for CRC. Hospital costing data were sourced for all public hospital admissions in 
Queensland for which the primary procedure was a resection of the colon or rectum for CRC. Data 
were sourced for the period between June 2009 and June 2011 when more than half of resections 
for patients with CRC were laparoscopic. Differences in costs, length of stay, duration of surgery 
and duration of intensive care units (ICU) admission were determined using multivariable least-
squares regression to adjust for potential confounding. 
Each of the authors contributed to this study and the resulting manuscript as follows. Each author, 
including Michael Coory, John Lumley, Louisa Gordon and I were responsible for the conception 
and design of the study. I was responsible for the data acquisition, analysis and interpretation of the 
results. Michael Coory and Louisa Gordon provided guidance on the data analysis and 
interpretation of the results. Michael Coory, John Lumley and Louisa Gordon provided guidance 
and feedback on the first and subsequent drafts of the manuscript, while I was the primary author. 
This study was accepted for publication in the peer-reviewed journal Surgical Endoscopy on 19 
November 2013.  
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Abstract
Background Previous cost analyses of laparoscopic
resection for colorectal cancer (CRC) reported slightly
higher or similar costs to those of open resection. These
analyses were based on randomised controlled trials when
the laparoscopic approach was newly adopted. This study
compared costs for laparoscopic versus open resection in a
region of high uptake where adoption is mature.
Methods Hospital cost data were obtained for elective
resections for CRC that occurred between June 2009 and
June 2011 in public hospitals in Queensland, Australia. The
primary outcome was total cost and secondary outcomes
were length-of-stay, operating time, and ICU admission.
Multivariate least-squares regression was used to adjust for
potential confounders: age, sex, comorbidities, procedure,
and hospital volume.
Results The crude mean cost for laparoscopic resection
was €20,036 compared with that for open resection of
€22,780 (difference = €2,744). Patients who underwent
laparoscopic resection (744/1,397; 53 %) were slightly
younger and had fewer comorbidities (decreasing costs) but
more had rectal surgery (increasing costs). The adjusted
mean cost for laparoscopic resection was €20,396 com-
pared with €22,442 for open resection (differ-
ence = €2,054). Compared with open resection, when
adjusted for potential confounders, laparoscopic resection
resulted in similar operating time (216 vs. 214 min),
shorter length-of-stay (difference = -1.1 days, 95 % CI -
1.9, -0.3), and shorter admission to ICU (difference =
-7.3 h, 95 % CI -11.9, -2.7).
Conclusions This non-randomised study in a region of
high uptake found a similar operating time and lower cost
for laparoscopic resection for CRC compared with those of
open resection due to a shorter length-of-stay and shorter
time in ICU. Laparoscopic resection for CRC saves money
when the procedure is widely adopted and surgeons are
experienced in the technique.
Keywords Colorectal cancer  Laparoscopic resection 
Cost comparison  Population-based data
High-quality evidence from randomised controlled trials
(RCTs) shows that when compared with open resection,
laparoscopic resection for colorectal cancer (CRC) results in
less intraoperative blood loss, less postoperative pain, faster
return of bowel function, shorter length-of-stay [1, 2], and
lower risk of thromboembolism [2]. Clinical effectiveness is
essential for the adoption of new technology in healthcare;
however, healthcare administrators must consider the eco-
nomic value of new technologies. Published analyses have
reported that the cost of laparoscopic resection for CRC is
similar or slightly greater than the costs for open resection
[3–7]. While fewer complications and shorter length of
hospital stay result in reduced costs, previous studies have
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and Other Interventional Techniques 
reported increased costs associated with the specialised
equipment required for laparoscopic resection and increased
costs associated with longer operating times [8]. For exam-
ple, the Australasian Laparoscopic Colon Cancer Study
(ALCCaS) reported an increased cost of disposable equip-
ment in the operating theatre of $AUD274 [7]. Similar
additional costs have been reported in the US [9] and UK [4].
Franks et al. [4] reported longer operating times for laparo-
scopic resections of CRC leading to increased costs for
theatre staff of £114 per operation in the UK.
Cost analyses of laparoscopic resection for CRC, to date,
were based predominantly on RCTs performed when the
procedures were in the early stage of adoption of laparoscopic
resection for CRC. As the level of experience, patient selec-
tion, techniques, and equipment for surgical procedures
change over time, so too do the associated costs. For example,
patients excluded from the RCTs in the early 1990s are now
routinely considered for laparoscopic resection, specifically
for resection of rectal cancer which is known to be more
expensive than that for colon cancer [10]. Also, with experi-
ence, the operating time for laparoscopic resection can be
similar to that for open resection [11]. It is therefore possible
that as uptake of laparoscopic resection moves from the
innovators to the early adopters and on to an early/late majority
[12], the increased cost associated with the longer operating
time for laparoscopic resection of CRC will decrease and may
even result in cost savings compared with open resection.
Queensland is the third largest state of Australia with a
population of 4.6 million. Surgeons in Queensland adopted
laparoscopic resection for CRC early [13], and adoption has
been faster than in any other state in Australia [14] and faster
than in most other places around the world [15–17]. Training
courses in laparoscopic resection of the colon and rectum
were conducted by a group of colorectal surgeons in
Queensland during the early 2000s, providing experience in
this technique to surgeons in the early period of adoption.
Currently, more than 50 % of resections for CRC in public
hospitals in Queensland are laparoscopic. This study
includes all CRC patients admitted to public hospitals for an
elective resection of the colon or rectum and provides a ‘‘real
world’’ cost assessment done on unselected patients. The
specific research question is: What are the differences in total
and component (e.g., theatre, ICU) costs for laparoscopic
versus open resection for CRC in a region with high uptake?
Methods
Data
This study was based on data drawn from the statewide
Transition II Clinical Costing database with standardised
feeder systems and processing. The database’s main role is
to support activity-based funding and it is also regularly
used by researchers to undertake cost studies [18]. It is a
comprehensive collation of cost information associated
with the provision of services to individual patients treated
in public hospitals, including resource utilisation in the
operating theatre such as anaesthetics, pharmacy, pathol-
ogy, clinical imaging, and other allied health resources, as
well as general resources associated with hospital admis-
sion and stay on the hospital ward and associated with
hospital administration. It does not include costs associated
with surgical training outside of the operating theatre.
Transition II collects information for public hospitals,
where patients receive treatment without any out-of-pocket
costs. Resections performed in private hospitals, where the
cost of treatment is covered by a combination of govern-
ment subsidy, private health insurance, and patient pay-
ments, were excluded. About 60 % of CRC patients in
Queensland are treated in private hospitals; this paper
focuses on the 40 % treated in public hospitals.
Total cost of the index admission for resection was
obtained from Transition II for 1,273 of the 1,391 patients
treated for CRC in public hospitals (92 %). Component
costs of interest included theatre, anaesthetics, pharmacy,
clinical imaging, and pathology; these costs were obtained
for 1,315 of the 1,391 patients (95 %).
Patient level cost data in Transition II is a collation of costs
specific to the care of an individual patient, average cost of
resources associated with admission, and standard daily costs.
For instance, the cost of the staff in the operating theatre for an
individual patient is calculated as [cost allocated for each
clinician (surgeons and nurses) multiplied by the number of
minutes spent in the operating theatre]. The costs specific to
the care of a patient also includes the costs associated with
anaesthesia and disposable surgical equipment (single use
such as the harmonic scalpel). The cost of clinical consum-
ables is based on the average cost specific to the surgical
procedure. Costs associated with stays in the hospital ward are
set at a per diem or per shift rate and include the cost for items
such as laundry and meals. Admissions to the ICU are allo-
cated at a standard cost per minute per patient.
The de-identified, unit-record data from Transition II was
for the period from June 2009 to June 2011. Data extraction
was limited to patients with CRC who had an elective surgical
resection. Patients who had undergone an emergency resection
(e.g., for bowel obstruction, bleeding, or perforation secondary
to CRC) or a Hartmann procedure were excluded because these
are not routinely considered for the laparoscopic approach.
Statistical analysis
Costs are presented in €2012 after inflating Australian
dollars to 2012 using the Australian consumer price index
[19] and converting to euros [20] (AUD1 = €0.81354).
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Hospitals were categorised as high volume if they per-
formed at least 80 resections for CRC over the 2-year study
period. Procedures were grouped according to their relative
technical difficulty (see Tables 1 and 2). The intention-to-
treat principle was applied throughout the analyses.
The t test was used to compare the unadjusted mean cost
of laparoscopic resection with that of open resection, and
multivariate, ordinary-least-squares regression analysis was
used to compare the adjusted mean cost after accounting
for differences in age, sex, Dukes stage, Charlson comor-
bidity index (excluding diagnosis codes for CRC and
metastatic cancer), hospital volume (high/low), and type of
procedure (e.g., right hemicolectomy, anterior resection).
The robust variance method of Huber and White was used
to account for any heteroscedasticity [21].
Cost data are known to be right-skewed (i.e., a few
patients have very high costs) [22]. For a small sample size,
right-skewed data can invalidate statistical inferences
based on multivariate, ordinary-least-squares regression.
However, for the large sample available for this study,
simulation studies have shown that statistical inferences
based on multivariate ordinary-least-squares regression are
valid [22]. Also, mean costs are preferred by service
planners and budget holders [22]. Nevertheless, to confirm
the robustness of our conclusions, we also provide adjusted
median costs using absolute residuals regression [23].
Marginal analysis was used to determine the adjusted
means from the ordinary-least-squares regression model.
All analyses were performed using STATA ver. 11
(StataCorp, College Station, TX, USA).
Ethical approval for this study was granted by the
Queensland Health Human Research Ethics Committee
and the University of Queensland School of Population
Health Human Research Ethics Committee.
Results
Over the 2 years of the study, 1,391 patients had elective
resection for CRC in 18 public hospitals. Eight hospitals
were high volume ([80 major resections during the
2 years) and accounted for 1,031 (74 %) of the resections.
The mean age of the patients was 67 years, 800/1,397
(57 %) were men, and 670/1,391 (48 %) had rectal
surgery.
Slightly more than half of the patients (744/1,391;
53 %) had a laparoscopic resection, which was more
common in younger patients with no comorbidities and
those who were treated in high-volume hospitals (Table 1).
Laparoscopic resection was performed more often for
anterior (and high anterior) resections of the rectum
(Table 1), reflecting the centralisation of rectal surgery to
high-volume hospitals. Open surgery was more common
for resections of the sigmoid, transverse, and right colon
(Table 1).
Of the 1,391 patients, 17 (1.2 %) died while in hospital
for resection (open: 13 deaths; laparoscopic: 4 deaths).
Exclusion of the deaths did not affect the cost results; all
cost analyses include the costs for those who died.
The unadjusted mean cost was €20,036 for laparoscopic
resection and €22,780 for open resection (differ-
ence = €2,744). The unadjusted median cost was €17,008
for laparoscopic resection and €18,094 for open resection
(difference = €1,086).
Table 1 Patient characteristics (N = 1,391)
Open
(N = 647)
Laparoscopic
(N = 744)
Difference %
(95 % CI)
Age group
\65 236 (36.5) 282 (37.9) 1.4 (-3.7, 6.5)
65–74 205 (31.7) 261 (35.1) 3.4 (-1.6, 8.4)
75? 206 (31.8) 201 (27.0) -4.8 (-9.6, 0.1)
Hospital volume
High 455 (70.3) 576 (77.4) 7.1 (2.5, 11.7)
Sex
Male 370 (57.2) 425 (57.1) 0.1 (-5.3, 5.2)
Dukes stage
A/B 438 (67.7) 504 (67.7) 0.0 (-4.9, 5.0)
C 133 (20.6) 169 (22.7) 2.2 (-2.2, 6.5)
D 76 (11.8) 71 (9.5) -2.2 (-5.5, 1.0)
Charlson Index
0 516 (79.8) 645 (86.7) 6.9 (3.0, 10.9)
1 70 (10.8) 54 (7.3) -3.6 (-6.6, -0.5)
2? 61 (9.4) 45 (6.1) -3.2 (-6.1, -0.4)
Procedure group
Colon
Right
hemicolectomy
205 (31.7) 201 (27.0) -4.7 (-9.5, 0.1)
Transcolectomy 18 (2.8) 10 (1.3) -1.4 (-3.0, 0.1)
Extended right
hemicolectomy/
total colectomy
52 (8.0) 60 (8.1) 0.1 (-2.8, 2.9)
Left
hemicolectomy
59 (9.1) 56 (7.5) -1.6 (-4.5, 1.3)
Sigmoidectomy 52 (8.0) 30 (4.0) -4.0 (-6.5, -1.5)
High anterior
resection
42 (6.5) 101 (13.6) 7.1 (4.0, 10.2)
Rectal
Abdominoperineal
resection
56 (8.7) 47 (6.3) -2.3 (-5.1, 0.4)
Anterior resection
of the rectum
158 (24.4) 233 (31.3) 6.9 (2.2, 11.6)
Ultralow anterior
resection
5 (0.8) 6 (0.8) 0.0 (-0.9, 1.0)
Values are n (%)
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Factors influencing total cost, length of hospital stay,
surgery duration, and time spent in the ICU are listed in
Table 2. Older patients, those with comorbidities, those
with metastases, and those who had rectal surgery incurred
greater costs. Patients treated in high-volume hospitals
incurred lower costs. Increased costs for the rectal proce-
dures (abdominoperineal resection, anterior resection, and
ultralow anterior resection) coincide with increased length-
of-stay and operating time (Table 2).
After accounting for any differences in age, sex, comor-
bidities, stage, type of procedure, and hospital volume, the
adjusted mean cost for laparoscopic resection was €20,369
compared with €22,442 for open resection (differ-
ence = €2,053) (Table 3). The adjusted median cost was
€808 (95 % CI €33, €1,584) less for laparoscopic resection.
Most of the difference in cost (mean or median) was
accounted for by a shorter length-of-stay and fewer and
shorter ICU admissions. Including length-of-stay in the
adjusted model decreased the mean difference in cost to
€314 (95 % CI -€1,215, €587), while including admission
to ICU reduced the mean difference in cost to €841 (95 %
CI -€2,290, €608).
To further check the robustness of the finding that lapa-
roscopic surgery is associated with substantially lower costs
Table 2 In-hospital resource utilization surgery access/type, patient characteristics, and hospital volume
Total cost (€2,012) Length-of-stay
(days)
Operating
time (min)
Time in ICU (h)
(N = 1,273) (N = 1,391) (N = 1,040) (N = 1,391)
Surgical access P = 0.010 P = 0.008 P = 0.687 P = 0.002
Open Reference Reference Reference Reference
Laparoscopic -2,054 (-3,609, -498) -1.1 (-1.9, -0.3) 2.6 (-10.2, 15.5) -7.3 (-11.9, -2.7)
Age group P = 0.203 P \ 0.001 P = 0.375 P = 0.909
\65 Reference Reference Reference Reference
65-74 1,467 (-780, 3,715) 1.2 (0.4, 2.1) -1.1 (-14.2, 12.0) 3.1 (-3.2, 9.5)
75? 1,748 (-647, 4,143) 3.0 (2.0, 4.1) -0.6 (-16.4, 15.2) 0.6 (-6.0, 7.2)
Sex P = 0.066 P = 0.022 P = 0.008 P = 0.369
Female Reference Reference Reference Reference
Male 1,385 (-94, 2,863) 0.9 (0.1, 1.6) 17.4 (4.5, 30.2) 2.0 (-2.4, 6.5)
Dukes stage P = 0.180 P = 0.037 P = 0.509 P = 0.984
A/B Reference Reference Reference Reference
C -241 (-1,803, 1,321) 0.6 (-0.3, 1.6) -3.0 (-15.3, 9.4) -5.2 (-9.2, -1.2)
D 2,513 (-449, 5,475) 1.1 (-0.3, 2.5) 15.8 (-10.1, 41.8) 3.9 (-4.4, 12.3)
Charlson comorbidity index P \ 0.001 P \ 0.001 P = 0.070 P \ 0.001
0 Reference Reference Reference Reference
1 5,902 (2,629, 9,175) 2.6 (1.0, 4.2) 6.6 (-16.0, 29.3) 13.3 (1.3, 25.3)
2? 16,404 (9,576, 23,232) 7.4 (4.8, 10.0) 31.8 (-0.9, 64.6) 42.1 (21.6, 62.6)
Procedure type P \ 0.001 P \ 0.001 P \ 0.001 P = 0.315
Right hemicolectomy Reference Reference Reference Reference
Transcolectomy 3,788 (-854, 8,429) -0.2 (-1.8, 1.4) 84.0 (17.0, 151.1) 1.6 (-16.1, 19.3)
Sigmoidectomy 2,001 (-2,214, 6,216) 0.6 (-0.7, 1.8) 35.0 (5.2, 64.9) 2.3 (-11.3, 15.9)
Extended right hemicolectomy/total colectomy 1,914 (-337, 4,166) 1.5 (0.1, 2.8) 16.5 (-10.2, 43.2) -4.3 (-10.5, 1.9)
Left hemicolectomy 3,997 (-1,012, 9,007) 0.7 (-0.8, 2.3) 25.6 (7.5, 43.7) 6.3 (-7.6, 20.1)
High anterior resection 2,437 (181, 4,693) -0.2 (-1.2, 0.7) 44.0 (22.7, 65.2) 2.5 (-5.3, 10.2)
Abdominoperineal resection 10,543 (7,347, 13,740) 6.8 (5.0, 8.6) 69.9 (43.7, 96.0) 6.6 (-2.4, 15.6)
Anterior resection 6,908 (4,772, 9,043) 3.2 (2.0, 4.4) 76.1 (59.6, 92.6) 1.4 (-5.0, 7.7)
Ultralow anterior resection 5,908 (473, 11,343) 2.5 (-1.4, 6.5) 82.8 (29.5, 136.1) -9.2 (-20.5, 2.1)
Hospital volume P = 0.041 P = 0.014 P = 0.112 P \ 0.001
Low Reference Reference Reference Reference
High -2,124 (-4,158, -91) -1.1 (-1.9, -0.2) -15.3 (-34.1, 3.6) -14.0 (-20.6, -7.4)
The association between each variable and the outcome of interest was controlled for all other variables included in this table
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than open surgery, we conducted an analysis on a homoge-
neous subgroup, similar to patients recruited to RCTs for
laparoscopic surgery (\80 years of age, no metastasis, no
preplanned ICU admission, no chronic pulmonary disease,
and no pre-existing heart failure). After adjusting for age,
sex, stage, comorbidities, type of surgery, and hospital vol-
ume within this subgroup, the results were similar to those for
the entire study population. Specifically, the adjusted mean
cost was €18,917 for laparoscopic resection and €20,986 for
open resection (difference = €2 068; 95 % CI €379,
€3,758). Similarly, a separate analysis restricted to high-
volume hospitals found that the difference in adjusted mean
cost was €2,107 (95 % CI €458, €3,756).
ICU admission (224 patients) was more frequent for open
versus laparoscopic resection patients (22.6 % vs. 10.5 %,
P \ 0.001). Preplanned ICU admissions were more com-
mon among patients who had open resection (70/647;
10.8 %) than those who had laparoscopic resection (43/744;
5.8 %). Patients who had a prebooked ICU admission were
older and more likely to have had comorbidities; these fac-
tors, along with procedure type and hospital volume, were
included in the multivariate analysis, i.e., the analysis
adjusted for these differences. To further assess the possible
effect of prebooked ICU admissions, we conducted analyses
excluding these patients. The adjusted mean costs decreased
to €19,754 for laparoscopic resection and €21,350 for open
resection (difference = €1,595; 95 % CI €18, €3,173), and
the difference in time in ICU decreased to -5.4 h (from
-7.3 h; Table 2). In short, the results were robust to the
effect of preplanned ICU admissions.
Discussion
This study of a region where uptake of laparoscopic
resection for CRC is mature found that it is significantly
less expensive than open resection for CRC. This coincides
with laparoscopic patients having a shorter length of hos-
pital stay, fewer and shorter admissions to the ICU, and
equivalent operating time compared with open resection
patients.
In 2006, the National Institute of Health and Clinical
Excellence (NICE) in the UK found that laparoscopic
surgery for CRC was slightly more expensive (£265)
compared with open resection [24]. Franks et al. [4]
reported similar results based on patients recruited into the
MRC CLASICC trial (UK) between 1996 and 2002.
However, the mean cost (inflated to 2013 from 1999) [25]
reported by NICE was about half that found in our study;
€10,833 (£9,186) for the laparoscopic group compared with
€10,415 (£8,829) for the open group [24]. Similarly, Nor-
wood et al. [7], who compared costs using a cohort from
the ALCCaS RCT, reported total costs of admission that
were less than half that found in this study [7]. As their
results were based on patients recruited into RCTs, the cost
comparisons by NICE and Norwood et al. [7] exclude
patients who needed more complex care and thus have the
associated higher costs.
The ALCCaS RCT reports an operating time for lapa-
roscopic resection 60 min longer than that for open
resection, resulting in statistically significant increased
costs for the operating surgeon, anaesthetist, and operating
room staff [7]. In our study, there was no difference in the
operating times of the two approaches, indicating that the
difference in theatre costs was due to equipment use rather
than time-dependent resources such as staffing. The
ALCCaS RCT reported an increased cost in disposable
surgical equipment used in the operating theatre of €215
($AUD274) for the laparoscopic group [7], which is
slightly more than the unadjusted mean increase in theatre
cost of €120 found in the current study. This slightly lower
cost associated with disposable surgical equipment is due
probably in part to the more experienced surgeons who
Table 3 Adjusted cost components (€2,012), length-of-stay, duration of surgery and anaesthesia, and admission to ICU
Open [mean (95 % CI)] Laparoscopic [mean (95 % CI)] Difference (95 % CI) P value
Total cost (€2,012) 22,442 (21,125, 23,719) 2,368 (19,451, 21,286) -2,054 (-3,609, -498) 0.010
Anaesthesia cost (€2,012) 2,155 (2,028, 2,273) 2,424 (2,323, 2,525) 268 (112, 424) 0.001
Imaging cost (€2,012) 134 (108, 161) 168 (130, 208) 34 (-15, 83) 0.174
Pathology cost (€2,012) 818 (768, 867) 789 (748, 830) -29 (-94, 37) 0.389
Pharmacy cost (€2,012) 229 (164, 295) 154 (122, 187) -75 (-152, 2) 0.058
Theatre cost (€2,012) 5,584 (5,386, 5,783) 5,28 (5,445, 5,810) 43 (-231, 318) 0.757
Length-of-stay (days) 10.3 (9.7, 11.0) 9.2 (8.7, 9.7) -1.1 (-1.9, -0.3) 0.008
Operating time (min) 214 (204, 224) 216 (209, 224) 2.6 (-10.2, 15.5) 0.687
Anaesthesia duration (min) 261 (251, 272) 260 (252, 269) -0.6 (-14.4, 13.3) 0.937
ICU admission (h) 14.7 (10.8, 18.7) 7.4 (4.8, 10.0) -7.3 (-11.9, -2.7) 0.002
Adjusted for age, sex, stage, Charlson Comorbidity Index, type of procedure, and hospital volume
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have developed efficient techniques including a reduction
in the use of staples.
Like all observational (nonrandomised) studies, the
present study could be subject to confounding, i.e., the
lower cost for laparoscopic versus open surgery could be
due to differences in the types of patients rather than the
laparoscopic approach, per se. Laparoscopic patients were
slightly less likely to have some characteristics that tend to
increase costs, e.g., age [ 75 years, metastases, comor-
bidities, and treatment in a low-volume hospital. On the
other hand, they were more likely to have a rectal proce-
dure, which tends to increase cost. The results of our study
were adjusted for these potential confounders. This is also
the case for factors that may have contributed to pre-
planned admission to ICU (i.e., age and comorbidities). In
addition, we defined a more homogeneous subgroup
(\80 years of age, no metastasis, no preplanned ICU
admission, no chronic pulmonary disease, no pre-existing
heart failure) and still found a difference in cost of about
€2,000. Also, a separate analysis of just high-volume
hospitals similarly found that the adjusted mean total cost
was about €2,100 lower for laparoscopic resection than for
open resection.
In conclusion, the results of this study are different from
those of earlier studies, which have reported similar or
slightly higher costs for laparoscopic versus open resection
for CRC. Laparoscopic resection has a lower cost than
open resection probably because Queensland is further
along the adoption curve of laparoscopic resection and the
majority of surgeons are very experienced with the pro-
cedure. For instance, previous studies have reported longer
operating times for laparoscopic resection [8], while this
study found no difference in operating time, even after
adjusting for potential confounders such as procedure type
and comorbidities.
The findings of this study indicate that in regions where
the procedure is widely adopted and surgical teams are
experienced in the technique, there will be cost savings
associated with laparoscopic resection for colorectal cancer
because of fewer admissions to ICU and decreases in
operating time and length-of-stay. Specific inferences
regarding the degree of cost benefit in other settings will
depend on the relative cost of these determinants. For
instance, it may be inferred that healthcare systems where
hospital bed days are more expensive than in this study will
see a greater cost benefit.
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The findings below are included to provide further detail about tests performed for multivariable 
analysis. These were not included in the publication. 
No statistically significant 2-way interactions were found between hospital volume and the other 
explanatory or predictor variables, as outlined in Table 7-1. Because there were no statistically 
significant 2-way interactions, 3-way interactions were not considered. 
 
Table 7-1 Outcomes of testing for interaction terms in the final models 
Dependent variable Interaction term  P-value  
for interaction term 
Total cost  
 
Procedure*Hospital volume 0.186 
Charlson comorbidity score*Hospital volume 0.465 
Age group*Hospital volume 0.824 
Length of stay  
 
Procedure*Hospital volume 0.168 
Charlson comorbidity score*Hospital volume 0.984 
Age group*Hospital volume 0.777 
Duration of 
surgery 
Procedure*Hospital volume 0.200 
Charlson comorbidity score*Hospital volume 0.950 
Age group*Hospital volume 0.117 
Duration in ICU Procedure*Hospital volume 0.133 
Charlson comorbidity score*Hospital volume 0.179 
Age group*Hospital volume 0.901 
* All explanatory variables included in the models as follows: age group, sex, stage, Charlson 
comorbidity score, type of procedure and hospital volume.
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The tables of results in the published manuscript include reported costs converted to Euro (€). The tables below present the same results in Australian 
dollars (AU). 
 
Table 7-2 In-hospital resource utilisation surgery access/type, patient characteristics and hospitals volume  
 Total cost (AU$2012) Length of stay (days) Surgery duration (mins) ICU duration 
(hours) 
 N = 1 273 N = 1 391 N = 1 040 N = 1 391 
Surgical access P = 0.010 P = 0.008 P = 0.687 P = 0.002 
Open Reference Reference Reference Reference 
Laparoscopic -2 524 (-4 436, -613) -1.1 (-1.9, -0.3) 2.6 (-10.2, 15.5) -7.3 (-11.9, -2.7) 
Age group P = 0.203 P <0.001 P =0.375 P =0.909 
<65 Reference Reference Reference Reference 
65-74 1 804 (-959, 4 566) 1.2 (0.4, 2.1) -1.1 (-14.2, 12.0) 3.1 (-3.2, 9.5) 
75+ 2 148 (-795, 5 093) 3.0 (2.0, 4.1) -0.6 (-16.4, 15.2) 0.6 (-6.0, 7.2) 
Sex P = 0.041 P = 0.022 P = 0.008 P = 0.369 
Female Reference Reference Reference Reference 
Male 1 702 (-115, 3 519) 0.9 (0.1, 1.6) 17.4 (4.5, 30.2) 2.0 (-2.4, 6.5) 
Dukes Stage  P = 0.180 P =  0.037 P =  0.509 P =0.984 
A/B Reference Reference Reference Reference 
C -297 (-2 217, 1 623) 0.6 (-0.3, 1.6) -3.0 (-15.3, 9.4) -5.2 (-9.2, -1.2) 
D 3 089 (-552, 6 729) 1.1 (-0.3, 2.5) 15.8 (-10.1, 41.8) 3.9 (-4.4, 12.3) 
Charlson co-morbidity 
index 
P <0.001 P <0.001 P = 0.070 P <0.001 
0 Reference Reference Reference Reference 
1 7255 (3 232, 11 278) 2.6 (1.0, 4.2) 6.6 (-16.0, 29.3) 13.3 (1.3, 25.3) 
2+ 20 164 (11 771, 28 557) 7.4 (4.8, 10.0) 31.8 (-0.9, 64.6) 42.1 (21.6, 62.6) 
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 Total cost (AU$2012) Length of stay (days) Surgery duration (mins) ICU duration 
(hours) 
 N = 1 273 N = 1 391 N = 1 040 N = 1 391 
Procedure type  P <0.001 P <0.001 P <0.001 P = 0.315 
Right hemicolectomy  Reference Reference Reference Reference 
Transcolectomy 4 656 (-1 050, 10 361) -0.2 (-1.8, 1.4) 84.0 (17.0, 151.1) 1.6 (-16.1, 19.3) 
Sigmoidectomy    2 460 (-2 721, 7 641) 0.6 (-0.7, 1.8) 35.0 (5.2, 64.9) 2.3 (-11.3, 15.9) 
Extended right 
hemicolectomy/ total 
colectomy            
2 353 (-414, 5 120) 1.5 (0.1, 2.8) 16.5 (-10.2, 43.2) -4.3 (-10.5, 1.9) 
Left hemicolectomy     4 194 (-1 245, 11 072) 0.7 (-0.8, 2.3) 25.6 (7.5, 43.7) 6.3 (-7.6, 20.1) 
High anterior 
resection   2 995 (223, 5 768) -0.2 (-1.2, 0.7) 44.0 (22.7, 65.2) 2.5 (-5.3, 10.2) 
Abdomino-perineal 
resection 12 960 (9 031, 16 889) 6.8 (5.0, 8.6) 69.9 (43.7, 96.0) 6.6 (-2.4, 15.6) 
Anterior resection 8 491 (5 866, 11 116) 3.2 (2.0, 4.4) 76.1 (59.6, 92.6) 1.4 (-5.0, 7.7) 
Ultra low anterior 
resection 7 262 (581, 13 943) 2.5 (-1.4, 6.5) 82.8 (29.5, 136.1) -9.2 (-20.5, 2.1) 
Hospital volume P = 0.041 P = 0.014 P = 0.112 P <0.001 
Low Reference Reference Reference Reference 
High -2 611 (-5 110, -112) -1.1 (-1.9, -0.2) -15.3 (-34.1, 3.6) -14.0 (-20.6, -7.4) 
The association between each variable and the outcome of interest was controlled for all other variables included in this table. 
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Table 7-3 Adjusted* cost components (AU$2012), length of stay, duration of surgery and anaesthesia, and admission to intensive care units  
 Mean (95% CI) Difference (95%CI) P-value  Open Laparoscopic 
Total cost  27 561 (25 966, 29 156) 25 036 (23 909, 26 165) -2 524 (-4 436, -613) 0.010 
Anaesthesia cost  2 650 (2 505, 2 794) 2 980 (2 855, 3 104) 330 (138, 522) 0.001 
Imaging cost  165 (132, 198) 207 (159, 255) 42 (-19, 103) 0.174 
Pathology cost  1 005 (944, 1 066) 970 (919, 1 020) -35 (-115, 45) 0.389 
Pharmacy cost  282 (201, 362) 189 (149, 230) -92 (-187, 3) 0.058 
Theatre cost  6 864 (6 620, 7 108) 6 917 (6 693, 7 142) 53 (-284, 391) 0.757 
Length of stay (days) 10.3 (9.7, 11.0) 9.2 (8.7, 9.7) -1.1 (-1.9, -0.3) 0.008 
Surgery duration (mins) 214 (204, 224) 216 (209, 224) 2.6 (-10.2, 15.5) 0.687 
Anaesthesia duration (mins) 261 (251, 272) 260 (252, 269) -0.6 (-14.4, 13.3) 0.937 
ICU admission (hours) 14.7 (10.8, 18.7) 7.4 (4.8, 10.0) -7.3 (-11.9, -2.7) 0.002 
* Adjusted for age, sex, stage, Charlson Co-morbidity Index, type of procedure and hospital-volume 
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7.2 Discussion and implications of findings 
This is the first study to demonstrate cost savings for laparoscopic resection for CRC. Among the 
existing cost analysis literature, most studies have used RCT data, which means that the most 
complicated cases are excluded. Despite laparoscopic procedures being performed on patients with 
comorbid conditions and those requiring complex procedures (e.g., rectal resection), this study 
found cost savings to the Queensland Government associated with laparoscopic resection compared 
with open resection for CRC.(93)  
Conclusion 
The objective of this study was to determine whether laparoscopic resection was associated with 
cost savings in this jurisdiction, where surgical teams are experienced in the technique. Where 
surgeons are now experienced in performing laparoscopic resection for CRC, surgical duration is 
equivalent to open resection. This, combined with reduced length of hospital stay and shorter and 
fewer admissions to ICU, results in considerable cost savings for patients who have laparoscopic 
resection compared with open resection for CRC. It is important that jurisdictions where adoption is 
delayed realise that cost savings will be attained when surgical teams have gained adequate 
experience in the technique. Economic cost should no longer be a barrier for uptake of laparoscopic 
resection for CRC. Potential barriers are considered in Chapter 8, in a study that compares uptake of 
laparoscopic surgery for a range of other procedures.  
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Chapter 8 Differentials in the uptake of laparoscopic surgery by site and cancer 
and non-cancer related indications. 
8.1  Introduction  
In contrast to the other chapters in this thesis, this chapter is not in the format of a manuscript for 
publication but rather the format of a traditional thesis. This is a university requirement. 
Surgical innovation is the foundation for continued improvements to patient outcomes and quality-
of-life, and from which life-saving procedures are developed.(94) The uptake of healthcare 
innovations is one of the major pressures on health services.(95) To ensure effective uptake and 
planning of research and control of innovation in healthcare, healthcare administrators must 
consider factors that may affect uptake and be able to estimate the likely rate of uptake.(95) 
Furthermore, if these factors can be predicted, then healthcare providers can more accurately plan 
for increase in the use of innovative procedures.(95)   
Over the past two decades, common abdominal surgical procedures have increasingly been 
performed using minimal-access laparoscopic technology, and have demonstrated significant 
improvements to patient outcomes. Since the introduction of laparoscopic surgery in the late 1980s 
and early 1990s, they have been associated with short-term benefits to patients compared with open 
resection. These include shorter hospital length of stay,(19, 96-99) reduced post-operative 
morbidity,(21, 97) faster return to normal activities,(96, 99-101) as well as reduced blood loss,(21, 
98, 99), wound infection (59, 99) and post-operative pain (21, 99, 100, 102).  
There have been considerable improvements to laparoscopic surgical equipment. First, the video 
imaging via the laparoscope was two-dimensional until the visual image of the surgical area was 
vastly enhanced through the introduction of high-definition video cameras in the early 2000s. 
Coming into popular use around the same time, the Harmonic scalpel uses high-frequency 
mechanical energy to simultaneously cut and coagulate tissue.(103) There have also been 
improvements to the articulation of handheld instruments, and suturing and stapling devices.(104) 
The availability of better techniques in imaging, such as magnetic resonance imaging (MRI), 
provides better pre-operative information about the tumour location, size and the extent of invasion. 
When performed by a surgical team who are experienced in the techniques, there are few 
contraindications for laparoscopic procedures.(43, 105, 106) Compromised cardiopulmonary status 
is an important pre-surgery assessment due to potential complicating effects of the carbon dioxide 
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pneumoperitoneum required for laparoscopic surgery. However, as surgeons and anaesthetists have 
gained knowledge and experience, methods for managing pneumoperitoneum in patients with 
cardiopulmonary conditions have been developed.(107) When in the hands of an experienced 
minimal-access surgeon, laparoscopic cholecystectomy is considered an appropriate technique for 
use in all patients.(104) Severe obesity is stated as a contraindication for laparoscopic 
fundoplication due to obstruction from bulky structures.(104) For CRC, it has been suggested that 
90% of patients are suitable for laparoscopic resection of their primary tumour; the exceptions are 
patients with MRI-predicted threatened margins of rectal cancer, and those with a history of 
complicated previous surgery suggesting extensive abdominal adhesions.(43)   
The data presented in Chapter 5 show a delayed and slow uptake of laparoscopic resection for CRC 
in Australia. Uptake has not been slow for all laparoscopic procedures. In the US, there has been 
great variation in the speed of uptake between procedures. Within five years of being introduced, 
more than 70% of cholecystectomies were performed with laparoscopic access, while the 
laparoscopic percentage for nephrectomies and hysterectomies remained below 20% for over 10 
years.(108) Similarly in Australia, laparoscopic cholecystectomy quickly became the standard of 
care. The laparoscopic percentage for cholecystectomies increased from 11% in the financial year 
1990/91 to 73% in 1991/92.(109) This is far quicker than the nationwide adoption of laparoscopic 
segmental colon resection for cancer, which increased from 2.4% in 2000/01 to 27.5% in 
2007/08.(90)   
This chapter was formulated with the guidance and assistance of each of my PhD supervisors. 
Additional assistance was provided by Jim Nicklin, a Gynaecologist specialising in gynaecological 
oncology, and Sue Walker, Director of the National Centre for Health Information Research and 
Training. Michael Coory, John Lumley and I were each responsible for the conception and design 
of the study. I was responsible for the data acquisition and performed the data analysis. Sue Walker 
was integral in determining the Australian Classification of Health Intervention codes for each of 
the procedures and in clarifying the rules around coding for laparoscopic procedures. Under the 
guidance of Michael Coory, John Lumley, and Louisa Gordon, and with the assistance of Jim 
Nicklin, I interpreted the results. I was responsible for the first and subsequent drafts of the chapter 
under the guidance of, and with feedback from, Michael Coory, John Lumley and Louisa Gordon. 
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8.2 Aims  
The aim of the analyses presented and discussed in this chapter is to: 
1. Calculate the annual percentage of all procedures in Australia which have been conducted 
with laparoscopic access between financial years 1993/94 to 2009/10, individually for each 
of the procedures outlined in Table 8-3, for the purpose of: 
a. Comparing the timing of introduction of laparoscopy between procedures 
b. Comparing the rate of uptake of laparoscopic access between procedures by 
calculating the annual percentage increase 
c. Comparing the uptake of laparoscopic access between  cancer and non-cancer related 
indications for surgery 
d. Discussing the procedure specific factors likely to influence the timing and rapidity 
of uptake of laparoscopic access 
8.3 Background literature 
Table 8-1 includes a summary of recommendations from health technology assessments, clinical 
practice guidelines (CPG) and consensus from specialist committees for laparoscopic hysterectomy, 
laparoscopic colorectal resection, laparoscopic nephrectomy, laparoscopic cholecystectomy and 
laparoscopic fundoplasty. Table 8-2 summarises results from the meta-analyses, reviews and 
individual studies. These tables provide a comprehensive but not an exhaustive list of the available 
recommendations or evidence for these procedures.  
Hysterectomy, nephrectomy, colorectal resection, cholecystectomy and fundoplasty were 
specifically chosen because there are large numbers of these procedures performed and clear rules 
for identifying laparoscopic procedures using Australian Classification of Health Interventions 
classification system(ACHI) procedure codes in hospital morbidity data. Other procedures were 
considered unsuitable for the study; for example, laparoscopic prostatectomy was not included 
because robotic prostatectomy is the emerging method of interest, which is outside of the scope of 
this study.  
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Table 8-1 Recommendations for laparoscopic hysterectomy, laparoscopic colorectal resection, laparoscopic fundoplasty, laparoscopic nephrectomy 
and laparoscopic cholecystectomy.  
Procedure Indication Guideline Not Recommended Recommended 
Laparoscopic 
Hysterectomy 
  
Epithelial 
ovarian cancer 
Australian Cancer Network and the National 
Breast Cancer Centre Clinical practice 
guidelines for the management of women with 
epithelial ovarian cancer(110) 2004 
 X 
Cancer and non-
cancer 
National Institute for Health and Clinical 
Excellence (United Kingdom) – Guidance(111) 
2007 
X  
Colorectal 
resection 
 
Colon cancer  Consensus of the European Association of 
Endoscopic Surgery(112) 2004  X 
Colon cancer The American Society of Colon and Rectal 
Surgeons – Approved Statement(44) 2004  X 
Colon cancer The Cancer Council Australia/Australian 
Cancer Network Clinical Practice 
Guidelines(8) 2005 
 
X 
 
Rectal cancer The Cancer Council Australia/Australian 
Cancer Network Clinical Practice 
Guidelines(8) 2005 
X  
Colorectal 
cancer 
National Institute for Health and Clinical 
Excellence (United Kingdom) – technology 
appraisal(18) 2006 
 X 
Colectomy 
(cancer and non-
cancer) 
French Authority for Health 
Health technology assessment(113) 2008  X 
 Rectal cancer  Clinical Practice Guidelines of the European 
Association of Endoscopic Surgery(46) 2011  X 
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Procedure Indication Guideline Not Recommended Recommended 
Laparoscopic 
fundoplasty 
Non-cancer Society of American Gastrointestinal and 
Endoscopic Surgeons - Guidelines for the 
clinical application of laparoscopic biliary tract 
surgery(114) 
2010 (previous 2001) 
X  
Laparoscopic 
nephrectomy 
 
Cancer and non-
cancer 
National Institute for Health and Clinical 
Excellence (United Kingdom) – Guidance 
(115) 
Five non-randomised comparative studies 2005 
 X 
Laparoscopic 
radical 
nephrectomy T1-
T2 tumours  
Doublet J. et al.(116) 
Guidelines on Laparoscopy. European 
Association of Urology. 2006 
 
X 
 
Laparoscopic 
nephro-urectomy 
for low-stage 
cell carcinomas  
Doublet J. et al.(116) 
Guidelines on Laparoscopy. European 
Association of urology. 2006 
X  
Laparoscopic 
cholecystectomy 
Non-cancer NIH consensus statement(117) 1992  X 
Non-cancer UpToDate Review(118) 2013  X 
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Table 8-2 Summary of findings from meta-analyses, reviews and individual studies for laparoscopic hysterectomy, nephrectomy, colorectal resection, 
cholecystectomy and fundoplication 
Procedure Indication 
(cancer/non-cancer) 
Year What (CPG/review) Outcome/recommendation 
Laparoscopic 
hysterectomy 
Not stated 2005 The NIHR Evaluation, Trials and 
Studies Coordinating Centre (United 
Kingdom)(119) 
- Health technology appraisal 
Compared with abdominal hysterectomy: 
Higher rate of complications (11.1% vs 6.2%) 
Shorter hospital stay (1 day) 
Longer operating time (84 vs 50 minutes) 
Sexual frequency and body image better in short-
term  
 Non-cancer 
gynaecological 
disease 
2006 Johnson, N.(98) 
Cochrane review 
27 RCTs 
Less blood loss (WMD 45.3 mls, 95%CI 17.9 to 
72.7 mls) 
Short hospital stay (2 days; 95%CI 1.9, 2.2) 
Faster return to normal activities (WMD 13.6 days, 
95%CI 11.8 to 15.4 days) 
Fewer wound or abdominal wall infections (OR 
0.32, 95%CI 0.12 to 0.85) 
Longer operating time (WMD 10.6 minutes, 95%CI 
7.4 to 13.8 minutes)  
Increased urinary tract (bladder or ureter) injuries 
(OR 2.61, 95%CI 1.22 to 5.60) 
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Procedure Indication 
(cancer/non-cancer) 
Year What (CPG/review) Outcome/recommendation 
Laparoscopic 
hysterectomy 
Non-cancer 
gynaecological 
disease 
2009 Nieboer, T. et al.(99) 
Cochrane review 
34 RCTs 
4 495 patients 
Laparoscopic hysterectomy recommended 
Fewer febrile episodes or unspecified infection (OR 
3.77)  
Longer operation time (MD 20.3 minutes; 95%CI 
4.0, 36.6) 
Faster return normal activities (MD -13.6 days; -
15.4, -11.8) 
Less blood loss (MD -45.3; 95%CI -72.7, -17.9)  
Shorter length of stay (MD -3.8; 95%CI -4.3, -3.3) 
 Early endometrial 
cancer 
2012 Galaal, K. et al.(97) 
Cochrane review  
8 RCTs 
3 644 patients 
Laparoscopic hysterectomy recommended 
Overall survival HR = 1.14, 95% confidence 
interval (CI): 0.62 to 2.10)  
Recurrence free survival HR = 1.13, 95% CI: 0.90 
to 1.42) 
Less blood loss (MD = -106.82 mL, 95% CI: -
141.59 to -72.06) 
Severe post-operative adverse events (RR = 0.58, 
95% CI: 0.37 to 0.91) 
Shorter length of stay 
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Procedure Indication 
(cancer/non-cancer) 
Year What (CPG/review) Outcome/recommendation 
Laparoscopic 
colorectal 
resection 
Colorectal cancer 2007 The NIHR Evaluation, Trials and 
Studies Coordinating Centre (United 
Kingdom) 
- Health technology appraisal(120) 
Laparoscopic resection associated with additional cost 
- 40% chance that laparoscopic resection is the more 
cost effective at a willingness to pay threshold of    
£30 000 per QALY. A judgment is required as to 
whether the benefits of earlier recovery are worth the 
extra cost. 
Laparoscopic 
fundoplasty 
Cancer 1999 Ono, Y. et al.(121) 
Retrospective comparative study 
Japan 
100 patients 
Equivalent DFS (95.5% vs 97.5%) 
Longer operating time (5.2 vs 3.3 hours; P<0.001) 
Less analgesia (31 vs 68mg; P<0.001) 
Faster return normal activities (23 versus 57 
days, P <0.001). 
Equivalent complications 
Reduced blood loss (255 versus 512 mL, P< 0.001). 
1.7% conversions 
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Procedure Indictation 
(cancer/non-cancer) 
Year What (CPG/review) Outcome/recommendation 
Laparoscopic 
nephrectomy 
 
Cancer 2000 Dunn, M. et al(122) 
Non-randomised comparative study  
US 
93 patients 
Longer operating time (5.9 vs 2.8 hrs; P<0.001) 
Reduced blood loss (172 versus 451 ml., P<0.001) 
Reduced analgesia (28.0 versus 78.3 mg., P<0.001)   
Shorter length stay (3.4 versus 5.2 days, P<0.001) 
Faster return normal activities(3.6 versus 8.1 weeks, 
P<0.001) 
Faster return normal activities (5.1 vs 7.6 weeks; P = 
0.11) 
Fewer complications  
 Non-cancer 2001 Fornara, P. et al.(96) 
Retrospective comparative study  
Germany 
249 patients 
Equivalent operating time (90 mins; P = 0.361) 
Reduced blood loss (200 vs 250 mls; P <0.001) 
Reduced blood transfusion (9.9% vs 18.6%; P <0.001) 
Reduced analgesia (median 32 vs 48; P <0.001) 
Shorter length stay (median 4 vs 10 days; P <0.001) 
Faster return normal activities (median 24 vs 36 days; 
P < 0.001) 
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Procedure Indication 
(cancer/non-cancer) 
Year What (CPG/review) Outcome/recommendation 
Laparoscopic 
cholecystectomy 
Non-cancer 1997 Eldar, S. et al.(102) 
RCT 
271 patients 
(Data unavailable) 
Shorter operating time and hospital stay 
Less frequent use of nasogastric tube 
Reduced analgesia 
Equivalent post-operative complications 
 Non-cancer 1998 Kiviluoto, T. et al.(123) 
RCT  
63 patients 
Equivalent operating time (mean 108 vs 100 mins; P = 
0.49) 
Shorter length stay (median 4 [IQR 2–5] 
vs 6 [5–8] days; P=0·0063) 
Faster return to normal activities (mean 13.9 vs 30.1 
days; 95%CI 10.9-21.7) 
Fewer post-operative complications (3% vs 19%; P = 
0.05) 
 Non-cancer 2005 Johansson, M. et al.(124)  
RCT 
70 patients 
Equivalent post-operative pain (Visual Analogue 
Score) (11 vs 14; P = 0.771) 
Longer operating time (median 90 vs 80; P = 0.04) 
Equivalent hospital stay (2 days; P = 0.011) 
Equivalent post-operative complications 2 vs 3; P = 
0.652) 
Faster return to normal activities (median 11 vs 14; P 
= 0.771) 
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Procedure Indictation 
(cancer/non-cancer) 
Year What (CPG/review) Outcome/recommendation 
Laparoscopic 
nephrectomy 
 
Cancer 2004 Hsueh, T. et al.(100)  
Retrospective comparative study 
Taiwan 
145 patients 
 
 
Longer operating time (mean 259 vs 230 mins; P = 
0.006) 
Reduced analgesia (mean 26 vs 35 mg; P = 0.03) 
Reduced blood loss (mean 409 vs 747 mls; P < 0.001) 
Shorter length of staylength of stay (mean 9.3 vs 12.6 
days; P < 0.001) 
Faster return normal activities (mean 19 vs 25 days; 
P<0.001) 
Equivalent local recurrence (9% vs 9%; P= 0.23) 
Equivalent metastasis (10% vs 8%; P = 0.20) 
 Cancer 2004 Bariol, S. et al.(125) 
Non-randomised comparative study  
United Kingdom 
64 patients 
Equivalent recurrence (8% vs 15%; P = 0.3) 
Equivalent DFS (87% vs 82%; P = 0.26) 
 
 
DFS = Disease free survival; OS = overall survival; MD = mean difference; SMD = standardised mean differences; QALY = Quality Adjusted Life 
Years WMD = Weighted Mean Difference, HR= Hazard Ratio
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8.4 Methods 
We obtained unit-record data for 17 financial years, 1993/1994-2009/2010, from the National 
Hospital Morbidity Data (NHMD), which collates administrative inpatient data from all of the 
Australian states and territories.(126) The extraction was restricted to elective surgical admissions 
for resections of the colon or rectum, nephrectomy, hysterectomy, fundoplication and 
cholecystectomy and included all procedure and diagnosis codes. Patients who had emergency 
resections (e.g., for bowel obstruction, trauma) were excluded because emergency procedures are 
less likely to be performed laparoscopically. No data were provided that could identify (or re-
identify) an individual patient or the Australian state where the patients were treated.  
Included in the analysis are additional aggregated laparoscopic cholecystectomy data for 1989/90 to 
1992/93 sourced from a report from the Australian Institute of Health and Welfare.(127) The 
number of cholecystectomies was estimated using state level hospital morbidity data, national state 
level population ratios and known variations in surgical rates between states. The number of 
laparoscopic cholecystectomies was extrapolated from the Medicare database.(127)   
NHMD uses ACHI codes which are derived from the Medicare Benefits Schedule to indicate the 
procedure performed. The 10 edition releases of the ACHI codes throughout the study period were 
reviewed to identify relevant procedure codes. To distinguish between cancer and non-cancer 
related conditions, all relevant editions of the International Classification of Diseases (ICD) were 
reviewed. The ACHI and ICD codes to classify the procedure groups and to identify laparoscopic 
procedures are included in 8.7 Appendix 1. 
The laparoscopic percentage was calculated separately for 10 groups (Table 8-3), including six 
procedures; four of these were sub-grouped into cancer and non-cancer related conditions. The 
laparoscopic percentage was calculated as the number of laparoscopic resections divided by the 
total number of procedures (open + laparoscopic). These were calculated for each year of the study 
to give an annual percentage. The data analyses were generated using SAS software (Version 9.2; 
SAS Institute, Cary, NC).Graphs were produced using STATA Version 11.0 statistical software 
package.(128)  
Ethical approval was granted by The University of Queensland’s School of Population Health 
Human Research Ethics Committee. 
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Table 8-3 List of procedures and stratified sub-groups included in the analyses 
Procedure Conditions 
Cholecystectomy Non-cancer 
Fundoplication Gastro-oesphageal Reflux Disease 
Resection of the colon or rectum Cancer 
Non-cancer 
Partial nephrectomy Cancer 
Non-cancer 
Total nephrectomy Cancer 
Non-cancer 
Hysterectomy Cancer 
Non-cancer 
8.5 Results 
The total number of cases differed greatly between procedures. Cholecystectomy was the most 
common procedure throughout the study; 37 572 procedures were performed in 1993/94, which 
increased to 49 892 in 2009/10. The total annual numbers of cholecystectomy, and number and 
percentage performed as laparoscopic cholecystectomy are presented in Table 8-4. Abdominal 
hysterectomy for non-cancer related disease was also common, however, since the early 2000s the 
numbers of abdominal hysterectomies have decreased slightly. There were 19 932 hysterectomies 
for non-cancer related disease in 1993/94, which increased to almost 32 000 by 2001/02 and 
decreased to 26 397 by 2009/10 (Table 8-5). The total annual number of cases was less than 10 000 
for colorectal resection (Table 8-7), fundoplasty (Table 8-4) and hysterectomy for cancer-related 
disease (Table 8-5). Nephrectomy was the least common procedure, particularly partial 
nephrectomy for which there were 500 in the most recent year, 2009/10 for cancer related disease, 
and 222 for non-cancer related disease (Table 8-8).  
8.5.1 Laparoscopic procedures 
Cholecystectomy 
Cholecystectomy was the earliest and most rapidly adopted laparoscopic surgery (Figure 8-1). In 
1990/01, the laparoscopic percentage for cholecystectomy was just short of 10%; by 1991/92 this 
increased by 55% to 63% (Table 8-4). Annual percentage increases decreased considerably 
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thereafter; however, the prevalence of this procedure did continue to increase until around 2000 
where it has remained at just over 90% (Table 8-4 and Figure 8-1).  
Figure 8-1 Annual percentage laparoscopic cholecystectomy and fundoplication, 1993/94 to 
2009/10 
 
Fundoplasty 
Uptake of laparoscopic fundoplasty was less rapid than cholecystectomy. The early data available 
indicates that the laparoscopic percentage for fundoplasty was 37% in 1993/94; annual percentage 
increases ranged from 5%-11% until 2000 when the laparoscopic percentage was greater than 80% 
and annual percentage increases decreased to around 2%. Laparoscopic fundoplasty reached its 
maximum just short of 90% in the early 2000s where it has since remained (Table 8-4 and Figure 
8-1).  
Hysterectomy 
Increases in laparoscopic hysterectomy have been slow for cancer and non-cancer related conditions 
(Figure 8-2 and Table 8-5). Towards the late 1990s, the laparoscopic percentage increased to greater 
than 5% for non-cancer related conditions and the annual percentage increase has continued to be 
small at less than 5%. Annual percentage increases for cancer related conditions commenced around 
the same time as for non-cancer related conditions; however, the increases were smaller. For the 
financial year 2008/09, the annual percentage increase rose to above 5% for both cancer and non-
cancer related conditions; this increase did not continue in the following year (Table 8-5). By 
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2009/10, the laparoscopic percentage for hysterectomy was around 20% for cancer and non-cancer 
related conditions (Figure 8-2 and Table 8-5). The data included in Table 8-6 includes vaginal 
hysterectomies for cancer and non-cancer indications. This table shows a decrease in open 
hysterectomies for cancer conditions, with correlating slow increases in laparoscopic hysterectomy 
and vaginal hysterectomy. However, the percentage of vaginal hysterectomies for non-cancer 
related conditions has decreased from 39% in 1993/94 to 27.1% in 2009/10, and there has been little 
change in the percentage of open hysterectomies over the study period.  
Figure 8-2 Annual percentage laparoscopic hysterectomy for cancer and non-cancer 
indications, 1993/94 to 2009/10 
 
0
10
20
30
40
50
60
70
80
90
100
19
93
/9
4
19
94
/9
5
19
95
/9
5
19
96
/9
7
19
97
/9
8
19
98
/9
9
19
99
/0
0
20
00
/0
1
20
01
/0
2
20
02
/0
3
20
03
/0
4
20
04
/0
5
20
05
/0
6
20
06
/0
7
20
07
/0
8
20
08
/0
9
20
09
/1
0
Hysterectomy non-cancer
Hysterectomy cancer
  
100 
 
Colorectal resection 
By the early 1990s, the laparoscopic percentage for colorectal resection for non-cancer related 
conditions was around 3%; from which point there were moderate annual percentage increases of 
less than 5% throughout the study period (Table 8-7). Increases in laparoscopic colorectal resection 
for cancer related conditions commenced five years later in 1998/99. Annual percentage increases 
were greatest for cancer related conditions from 2004/05; by 2009/10 the laparoscopic percentage 
was greater than for non-cancer related conditions (33% versus 31%) (Figure 8-3). 
Figure 8-3 Annual laparoscopic colorectal resection, by cancer and non-cancer indication, 
1993/94 to 2009/10 
 
Nephrectomy 
There were irregular trends in the laparoscopic percentages of radical and partial nephrectomies 
throughout the study period due to the small numbers of these procedures. For example, the small 
peak in the graph 1998/99 for partial nephrectomies for non-cancer related conditions is the result 
of 13 laparoscopic procedures out of 154 (Table 8-8). Following 2001/02 the percentage of 
laparoscopic partial nephrectomies increased at a moderate rate of 3%-7%; reaching 32% in 
2009/10 (Table 8-8). Throughout the period, laparoscopic percentages were similar for cancer and 
non-cancer related conditions (Figure 8-4). Increases in laparoscopic radical nephrectomy began in 
the early 1990s for non-cancer related conditions and in the late 1990s for cancer related conditions 
(Figure 8-4). Annual percentage increases were larger and more consistent throughout the study 
0
10
20
30
40
50
60
70
80
90
100
19
93
/9
4
19
94
/9
5
19
95
/9
5
19
96
/9
7
19
97
/9
8
19
98
/9
9
19
99
/0
0
20
00
/0
1
20
01
/0
2
20
02
/0
3
20
03
/0
4
20
04
/0
5
20
05
/0
6
20
06
/0
7
20
07
/0
8
20
08
/0
9
20
09
/1
0
Colorectal cancer
Colorectal non-cancer
  
101 
 
period for cancer related conditions resulting in a laparoscopic percentage of 62% in 2009/10, 
compared with 54% for non-cancer related conditions (Table 8-9). 
Figure 8-4 Annual percentage laparoscopic partial and radical nephrectomy, by cancer and 
non-cancer indication, 1993/94 to 2009/10 
 
Comparing uptake of laparoscopic percentage between procedures 
Figure 8-5 includes the individual graphs for cholecystectomy, hysterectomy, colorectal resection 
and nephrectomy to allow for comparison in the uptake of laparoscopic resection across these 
procedure types. 
Increases in the laparoscopic percentage of innovative surgical techniques differ greatly between the 
procedures. Cholecystectomy was the most common laparoscopic procedure throughout the study 
period, with very rapid uptake over a couple of years at introduction. The laparoscopic percentage 
for fundoplasty was also high; however, uptake was more gradual throughout the 17 years of the 
study. Although abdominal hysterectomy was a very common procedure, the laparoscopic 
percentage was smallest and uptake slowest of all procedures, particularly for cancer related 
conditions. There was similarly slow uptake of laparoscopic colorectal resection. Although 
laparoscopic resections for cancer-related conditions were delayed, uptake was rapid from the early 
2000s. Uptake of laparoscopic radical nephrectomy was earlier and more rapid than for 
hysterectomy or colorectal resection. For cancer related conditions, uptake of laparoscopic radical 
nephrectomy did not start until the late 1990’s, when uptake was quite rapid. The uptake of 
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laparoscopic partial nephrectomy was delayed (early 2000s) from which time there was moderately 
rapid uptake.  
Figure 8-5 Annual percentage laparoscopic procedures for cholecystectomy, hysterectomy, 
colorectal resection and nephrectomy, 1993/94 to 2009/10  
 
8.6 Discussion 
There were considerable differences in the uptake of laparoscopic surgery between each of the 
procedures presented in this chapter. Laparoscopic cholecystectomy and fundoplasty were more 
rapidly adopted than the other laparoscopic procedures. For colorectal resection, hysterectomy and 
nephrectomy, laparoscopic procedures for cancer related conditions were generally delayed by three 
to five years compared with non-cancer related conditions however, following the delay, uptake 
followed similar trends compared with the other procedures.  
Laparoscopic cholecystectomy was the first laparoscopic procedure popularised around the 
world.(19) It was first introduced to the US in 1988 and was rapidly adopted by surgeons.(19) 
Similar to the uptake shown in this chapter, data from the Nationwide Inpatient Sample (NIS) in the 
US shows an increase in the laparoscopic percentage for cholecystectomy of about 65% in the first 
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few years of introduction.(108) By 2003, almost 80% of cholecystectomies in the NIS were 
laparoscopic,(108) which is comparable with the 90% found in this study at the same time.  
Uptake of laparoscopic fundoplasty in the NIS was also similar to this current study, however, the 
laparoscopic percentage levelled to about 60%,(108) while increases in Australia continued up to 
around 90%. Studies have reported uptake of laparoscopic radical nephrectomy in the US(108, 129) 
and France(130) comparable to those experienced in Australia. Likewise, similar percentages for 
laparoscopic hysterectomies were reported in the NIS in the US,(108) while studies in the US using 
different data sources have found percentages of laparoscopic hysterectomy considerably higher 
than that found in this current study.(131, 132) Also from the NIS database in the US, 50% of 
colorectal resections for cancer were performed with laparoscopic access in 2008 and 2009, which 
is considerably greater than the laparoscopic percentage found in Australia.(70) For non-cancer 
related conditions, laparoscopic percentages for colon resections were also higher than in this 
current study; 38% in 2008 and 44% in 2011.(133) 
The short-term benefits of laparoscopic access for various procedures were quickly realised in the 
1990’s; however, there remained limited information on the risks. For example, the slower uptake 
of laparoscopic fundoplasty compared with laparoscopic cholecystectomy is probably because of 
the relative risk of unsuccessful fundoplasty. While cholecystectomy is an ablative surgery resulting 
in the removal of the gall bladder, there is greater risk that fundoplasty will not be successful in 
achieving its functional purpose of reinforcing the lower oesophageal sphincter. It is probable that 
uptake was more gradual as surgeons sought assurance that outcomes were equivalent to open 
fundoplasty. Similarly, following colorectal resection, the bowel must be functional, as should the 
kidney following a partial nephrectomy.  
The risks associated with adopting a new surgical technique for cancer related disease exceed the 
risks for non-cancer related disease. The risks are increased because the surgical requirements for 
achieving oncologic principles are more demanding; including removal of the primary tumour with 
adequate surgical margins and the assessment of any regional spread of cancer.(13) For example, 
there were concerns about a reduced yield of regional lymph nodes in laparoscopic colon 
resection.(134) In the early period of adoption, there were also concerns about port-site metastasis 
following laparoscopic surgery for cancer-related conditions.(134) However, experience with the 
technique rapidly improved adherence to oncological principles in laparoscopic surgery, largely 
alleviating these concerns by the early 2000s.(134) 
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The evidence and corresponding recommendations and CPG, and how these influence uptake of 
laparoscopic techniques, varies greatly between the procedures. For instance, laparoscopic resection 
for colon cancer is one of the few surgical procedures for which there is high-quality evidence from 
large multi-centre RCTs. These studies provide the evidence to assure surgeons, healthcare 
providers and patients that the short and long-term oncological outcomes for laparoscopic resection 
are equivalent to open resection for colorectal cancer.(54) The uptake of laparoscopic resection for 
CRC in Australia was delayed until 2003/04, partly because it was around this time that the long-
term outcomes for laparoscopic resection for colon cancer became available. It is probable then, that 
the rate of uptake will probably increase further when long-term outcomes for laparoscopic 
resection for rectal cancer become available. 
In contrast, there is no RCT evidence for laparoscopic nephrectomy and there are currently no CPG 
for the management of renal disease or cancer in Australia. In 2006, the European Association of 
Urology recommended laparoscopic nephrectomy and nephro-urectomy for non-cancer conditions. 
The guidelines stated laparoscopic radical nephrectomy was feasible in early stage (T1-T2) tumours 
while laparoscopic nephro-urectomy for low stage cell carconomas, was not recommended.(116)  
Despite the lack of formal recommendation in Australia, uptake in laparoscopic radical 
nephrectomy for cancer and non-cancer related conditions, has been greater than for laparoscopic 
colorectal resection since 1998/99.  
Sub-specialised surgeons, such as urologists and colorectal surgeons, will have better knowledge of 
current practice of the latest technological developments in their sub-specialities. Although 
nephrectomies are usually always performed by a specialist urologist, it is not uncommon for 
colorectal resections to be performed by general surgeons. Sub-specialist surgeons are also exposed 
to a greater number of cases and may therefore progress through the learning curve more quickly 
than general surgeons who perform a wider range of procedures. Resections for CRC are likely to 
be referred to specialist colorectal surgeons, which may account for the more rapid uptake in 
laparoscopic colorectal resection for cancer than for non-cancer conditions in the later period. 
Laparoscopic hysterectomy is also supported by RCT evidence for non-cancer related 
conditions(99) and for early endometrial cancer(97). It appears that this evidence and 
recommendations for laparoscopic hysterectomy from the National Institute for Health and Clinical 
Excellence(111) and resulting from two Cochrane reviews,(97, 99) has not influenced the uptake of 
laparoscopic hysterectomy in any material way. There are other factors which are likely influencing 
uptake of laparoscopic hysterectomy. First, the need for hysterectomy is decreasing as 
gynaecologists experience growing success with conservative therapeutic management. Also, 
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vaginal hysterectomies are the preferred minimally invasive approach.(99) Similar to the US(131), 
the current study found a decrease in the percentage of vaginal hysterectomies for non-cancer 
conditions and slow uptake in vaginal hysterectomies for cancer related conditions. Pelvic organ 
prolapse/incontinence is the most common indication for vaginal hysterectomy; this is decreasingly 
being treated with hysterectomy in favour of more conservative treatment, thus explaining a 
decrease on vaginal hysterectomy for non-cancer related conditions. 
The National Health and Medical Research Council along with the Australian Cancer Network and 
The Cancer Council, release CPGs to provide healthcare professionals with evidence-based 
recommendations to assist with clinical decision-making and improve healthcare for patients.(135)  
There are currently no Australian CPGs that address laparoscopic cholecystectomy, fundoplication 
or nephrectomy. The CPG for epithelial ovarian cancer does not recommend laparoscopic 
hysterectomy.(110) For colorectal cancer, laparoscopic resection is recommended for colon cancer 
but not for rectal cancer.(8) The CPG for epithelial ovarian cancer and colorectal cancer were 
published in 2004 and 2005, respectively,(8, 110) and therefore do not incorporate recent evidence 
to reach the recommendation. In some cases, there are contrary recommendations in other 
jurisdictions; for example, in 2007 the National Institute for Health and Clinical Excellence 
recommended laparoscopic hysterectomy for cancer and non-cancer related conditions.(111) If 
these recommendations existed in Australia, there may be higher expectations for minimal-access 
surgery from patients, which would result in more pressure on healthcare providers to increase 
access to laparoscopic procedures. 
The learning curve is directly associated with the complexity of the procedure; that is, the more 
complex the procedure, the longer it takes and the more cases are required for a surgeon to gain 
adequate skills and experience. Laparoscopic cholecystectomy is a very common procedure for 
which the risks are relatively small. General surgeons are trained to perform cholecystectomy with 
laparoscopic access relatively quickly. This is reflected in the very rapid uptake of this procedure 
from its introduction. Laparoscopic colorectal resection, laparoscopic hysterectomy and 
laparoscopic nephrectomy are complex procedures with long learning curves. Despite large 
numbers of hysterectomies offering ample opportunity for observation and trial, the uptake of 
laparoscopic hysterectomy has remained slow and far less than the uptake of laparoscopic 
nephrectomy. Difference in the opportunity for formalised training is a potential reason for this 
slow uptake; for example urologists probably have more training opportunities to gain skills and 
experience in laparoscopic nephrectomy in their surgical training, while opportunities for 
laparoscopic specific training for gynaecologist may be limited.  
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Robotics is an emerging field of surgery, particularly for hysterectomy and colorectal resection. 
Robotic hysterectomy results in the short-term benefits normally associated with minimal-access 
surgery, such as reductions in length of hospital stay, blood loss and complications.(136) There are 
also increased costs for robotic hysterectomy because of a longer operating time and the 
requirement for very expensive equipment. However, as surgical teams gain adequate experience in 
the technique (it has been suggested 90 cases is the necessary number of procedures before a 
surgeon is proficient), the increased cost of equipment is counteracted by reduced operating time 
and shorter length of stay.(137) In the US, over the three years since its introduction, there have 
been decreases in the percentage of laparoscopic, open and vaginal hysterectomies, while the 
percentage of robotic hysterectomy has increased to over 20%.(132) In Australia, robotic 
hysterectomy and colorectal resection are still in the very early days of introduction; however, in 
future years as surgeons focus on gaining skills in robotic surgery, laparoscopic surgery will 
become less common.  
It is a common belief that laparoscopic surgery is more appealing treatment option for patients.(21) 
However, there may be a small sub-group of patients who request traditional methods of surgery 
and opt for open procedure, possibly because of concerns about the experience of the surgeon in the 
technique and the associated potential risks. Patient preference for open procedure along with 
medical contraindications for laparoscopic procedure means that the laparoscopic percentage for 
any procedure will reach maximum potential short of 100%. For cholecystectomy, the maximum 
potential has been reached at 94%, for fundoplasty this is 90%. It is probable that in future years, 
similar percentages will be reached for other laparoscopic procedures as more surgeons acquire the 
necessary skills and experience. 
This study is based on routinely collected population-based data (NHMD) and therefore provides 
complete measures of laparoscopic surgery in public and private hospitals across Australia from 
very early in the introduction of laparoscopic procedures (2003/04) until the most recent data 
available (2009/10). Each of the procedures included in the analysis for this chapter is a major 
procedure resulting in considerable reimbursement in both the private and the public sectors; data is 
therefore likely to be accurate and complete. On the other hand, it has been suggested that clinical 
information, such as cancer diagnosis, is not subject to government reimbursement, and therefore 
may not be coded with the same attention given to procedure codes.(138, 139) The coding for 
cancer related conditions in this study is validated by the lag in uptake of laparoscopic procedures 
for cancer compared with non-cancer related conditions; a result which is consistent with a 
previously published study(108). 
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Conclusion 
This study has identified vast differences in the rate of uptake of laparoscopic surgical procedures. 
The procedures with relatively reduced risk, particularly laparoscopic cholecystectomy and 
laparoscopic fundoplasty, were adopted very rapidly. Procedures for cancer related conditions were 
delayed in their uptake compared with the same procedure for non-cancer conditions, mainly due to 
the increased risk but also because the learning curve for surgeons is long and experience in the 
technique for non-cancer conditions must be obtained prior to performing the procedure for cancer 
conditions. It is important that the uptake of innovative techniques is monitored, to inform 
healthcare administrators of past and current practices, and to predict future practice. Healthcare 
administrators can use this knowledge to plan for impending increases in the utilisation of 
innovative technologies and to improve patient access to the best available treatments. This may be 
achieved through ensuring that there are up-to-date recommendations for innovative techniques and 
that appropriate training opportunities exist for healthcare providers.  
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8.7 Appendix 1: Procedure codes 
Procedure ICD9 ICD10 
Open Laparoscopic Open  Laparoscopic 
Colorectal 457, 486, 
485 
Concurrent 
with code for 
open 
resection: 
542, 545 
3200000, 3200001, 
3200300, 3200301, 
3200400, 3200401, 
3200500, 3202600, 
3202800, 3202801, 
3203900, 3203600, 
3202800, 3204700, 
3206000, 3209900, 
3211200, 4399301, 
9034100, 9220800, 
3202400, 3203000 
Concurrent with code 
for open resection: 
3039000, 3039300 
Fundoplasty 446 Concurrent 
with code for 
open 
resection: 
542, 545 
3052700, 3052701, 
3053304, 3053305,  
3052702, 3052703, 
3052704, 3052705, 
3052900, 3052901, 
3053000, 3053300, 
3053301, 3053302, 
3053303, 4395100, 
4395400 
Concurrent with code 
for open resection: 
3039000, 3039300 
Cholecystectomy 512 Concurrent 
with code for 
open 
resection: 
542, 545 
3044300, 3045401, 
3045500 
3044500, 3044600, 
3044800, 3044900 
Concurrent with code 
for open resection: 
3039000, 3039300 
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 ICD9 ICD10 
TAH* TLH* Vaginal 
hysterectomy
TAH* TLH* Vaginal hysterectomy 
Hysterectomy 683, 684, 
686 
Concurrent 
with code for 
open 
resection: 
542, 545 
685, 687 3566100, 
3566700, 
3567000,  
9044801, 9044802, 9044800, 
3575000, 3575300, 3575301, 
3575302, 3575600, 3575601, 
3575602, 3575603, 3575000 
Concurrent with code for open 
resection: 3039000, 3039300 
3565700, 3566701, 
3567300, 3567301, 
3567302 
*TAH = Total abdominal hysterectomy; TLH = Total laparoscopic hysterectomy 
 ICD9 ICD10 
Radical Partial Laparoscopic Radical Partial Laparoscopic 
Nephrectomy 555 5539, 
554 
Concurrent 
with code for 
open resection: 
542, 545 
3651601, 3651603, 
3652800, 3652801, 
3652900, 3653100, 
3653101, 3653300, 
3651902, 3651903 
3652200, 3652201, 3652500, 
3652501 
3651600, 3651602, 
3651902, 3652200, 
3652500, 3652800, 
3653100, 3655800 
 
  
110 
 
8.8 Appendix 2: Results tables 
Table 8-4 Laparoscopic resections for cholecystectomy and fundoplasty 
 Cholecystectomy Fundoplasty 
Year Total 
N 
Laparoscopic 
n (%) 
Annual 
increase 
(%) 
Total 
N 
Laparoscopic 
n (%) 
Annual 
increase 
(%) 
1989-90* 25 422 0 (0) -    
1990-91* 25 002 2 205 (8.8) 8.8 - - - 
1991-92* 33 877 21 295 (62.9) 54.1 - - - 
1992-93 30 428 22 030 (72.4) 9.5 - - - 
1993-94 37 572 29 828 (79.4) 7.0 1 731 644 (37.2) - 
1994-95 38 876 31 447 (81.0) 1.6 1 875 782 (41.7) 4.5 
1995-96 40 131 32 111 (80.0) -1.0 2 025 975 (48.2) 6.5 
1996-97 41 680 33 657 (80.8) 0.8 2 182 1 226 (56.2) 8.0 
1997-98 43 034 35 163 (81.7) 0.9 2 380 1 542 (64.8) 8.6 
1998-99 43 914 37 935 (86.4) 5.6 2 822 2 112 (75.8) 11.0 
1999-00 44 467 39 807 (89.5) 3.1 2 838 2 175 (76.6) 0.8 
2000-01 46 204 41 703 (90.3) 0.8 2 995 2 476 (82.7) 6.1 
2001-02 45 919 41 693 (90.8) 0.5 2 942 2 464 (83.8) 1.1 
2002-03 45 884 41 693 (90.8) 0 2 854 2 475 (86.7) 2.9 
2003-04 46 318 42 657 (92.1) 1.3 2 833 2 510 (88.6) 1.9 
2004-05 46 689 43 205 (92.5) 0.4 2 824 2 474 (87.6) 1.0 
2005-06 46 746 43 333 (92.7) 0.2 2 865 2 548 (88.9) 1.3 
2006-07 47 407 44 127 (93.1) 0.4 2 866 2 536 (88.5) -0.4 
2007-08 47 376 44 511 (94.0) 0.9 3 027 2 677 (88.4) -0.1 
2008-09 47 763 44 893 (94.0) 0 3 223 2 876 (89.2) 0.8 
2009-10 49 892 46 975 (94.2) 0.2 3 377 3 012 (89.2) 0 
* Data sourced from: Marshall, D. AIHW(127) 
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Table 8-5 Laparoscopic abdominal hysterectomy; cancer versus non-cancer 
 Non-cancer 
Year Total 
N 
Laparoscopic 
n (%) 
Annual 
increase 
(%) 
Total 
N 
Laparoscopic 
n (%) 
Annual 
increase 
(%) 
1993-94 2 042 27 (1.3) - 19 932 289 (1.5) - 
1994-95 2 148 15 (0.7) -0.6 20 017 345 (1.7) 0.2 
1995-96 1 964 26 (1.3) 0.6 18 453 354 (1.9) 0.2 
1996-97 2 039 21 (1.0) 0.7 18 035 343 (1.9) 0 
1997-98 2 043 34 (1.7) 0.7 17 003 384 (2.3) 0.4 
1998-99 2 153 84 (3.9) 2.2 25 004 1 824 (7.3) 5.0 
1999-00 2 388 105 (4.4) 0.5 31 251 3 255 (10.4) 3.1 
2000-01 2 429 102 (4.2) -0.2 31 766 3 678 (11.6) 1.2 
2001-02 2 409 104 (4.3) 0.1 31 966 4 192 (13.1) 1.5 
2002-03 2 397 110 (4.6) 0.3 30 173 3 760 (12.5) -0.6 
2003-04 2 412 107 (4.4) -0.2 29 576 3 852 (13.0) 0.5 
2004-05 2 484 128 (5.2) 0.8 28 844 4 061 (14.1) 0.6 
2005-06 2 482 157 (6.3) 1.1 27 856 4 144 (14.9) 0.8 
2006-07 2 598 170 (6.5) 0.2 27 239 3 988 (14.6) -0.3 
2007-08 2 614 209 (8.0) 1.5 27 240 4 081 (15.0) 0.4 
2008-09 2 767 459 (16.6) 8.6 26 166 5 332 (20.4) 5.4 
2009-10 2 875 529 (18.4) 1.8 26 397 5 752 (21.8) 1.4 
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Table 8-6 Laparoscopic hysterectomy; cancer versus non-cancer 
 Cancer Non-cancer 
Year Total 
N 
Laparoscopic 
n (%) 
Vaginal 
Hysterectomy 
Open 
abdominal 
Total 
N 
Laparoscopic 
n (%) 
Vaginal 
Hysterectomy 
Open abdominal 
1993-94 2 153 27 (1.3%) 111 (5.2%) 2 015 (93.6%) 32 649 289 (1.4%) 12 717 (39.0%) 19 643 (60.2%)
1994-95 2 297 15 (1.7%) 149 (6.5%) 2 133 (92.9%) 34 121 345 (1.7%) 14 104 (41.3%) 19 672 (57.7%)
1995-96 2 109 26 (1.2%) 145 (6.9%) 1 938 (91.9%) 32 907 354 (1.9%) 14 454 (43.9%) 18 099 (55.0%)
1996-97 2 192 21 (1.0%) 153 (7.0%) 2 018 (92.1%) 33 523 343 (1.9%) 15 488 (46.2%) 17 692 (52.8%)
1997-98 2 231 34 (1.5%) 188 (8.4%) 2 009 (90.0%) 32 106 384 (2.3%) 15 103 (47.0%) 16 619 (51.8%)
1998-99 2 403 84 (3.5%) 250 (10.4%) 2 069 (86.1%) 38 397 1824 (7.3%) 13 393 (34.9%) 23 180 (60.4%)
1999-00 2 736 105 (3.8%) 348 (12.7%) 2 283 (83.4%) 43 364 3 255 (10.4%) 12 113 (27.9%) 27 996 (64.6%)
2000-01 2 755 102 (3.7%) 326 (11.8%) 2 327 (84.5%) 43 695 3 678 (11.6%) 11 929 (27.3%) 28 088 (64.3%)
2001-02 2 790 104 (3.7%) 381 (13.7%) 2 305 (82.6%) 43 924 4 192 (13.1%) 11 958 (27.2%) 27 774 (63.2%)
2002-03 2 776 110 (4.0%) 379 (13.7%) 2 287 (82.4%) 41 911 3 760 (12.5%) 11 738 (28.0%) 26 413 (63.0%)
2003-04 2 810 107 (3.8%) 398 (14.2%) 2 305 (82.0%) 41 204 3 852 (13.0%) 11 628 (28.2%) 25 724 (62.4%)
2004-05 2 908 128 (4.4%) 424 (14.6%) 2 356 (81.0%) 40 092 4 061 (14.1%) 11 248 (28.1%) 24 783 (61.8%)
2005-06 2 915 157 (5.4%) 433 (14.9%) 2 325 (79.8%) 38 478 4 144 (14.9%) 10 622 (27.6%) 23 712 (61.6%)
2006-07 3 061 170 (5.6%) 463 (15.1%) 2 428 (79.3%) 37 399 3 988 (14.6%) 10 160 (27.2%) 23 251 (62.2%)
2007-08 3 107 209 (6.7%) 493 (15.9%) 2 405 (77.4%) 37 410 4 081 (15.0%) 10 170 (27.2%) 23 159 (61.9%)
2008-09 3 323 459 (13.8%) 556 (16.7%) 2 308 (69.5%) 36 075 5 332 (20.4%) 9 909 (27.5%) 20 834 (57.8%)
2009-10 3 452 529 (15.3%) 557 (16.7%) 2 346 (68.0%) 36 212 5 752 (21.8%) 9 815 (27.1%) 20 645 (57.0%)
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Table 8-7 Colorectal resection; cancer versus non-cancer 
 Cancer Non-cancer 
Year Total 
N 
Laparoscopic 
n (%) 
Annual 
increase 
(%) 
Total 
N 
Laparoscopic 
n (%) 
Annual 
increase 
(%) 
1993-94 7 398 161 (2.2) - 7 438 184 (2.5) - 
1994-95 8 131 129 (1.6) -0.6 8 079 233 (2.9) 0.4 
1995-96 8 279 143 (1.7) 0.1 8 152 256 (3.1) 0.3 
1996-97 8 647 125 (1.5) -0.2 8 510 340 (4.0) 0.9 
1997-98 8 875 137 (1.5) 0 8 902 373 (1.2) -2.8 
1998-99 9 116 160 (7.8) 6.3 7 664 447 (5.8) 4.6 
1999-00 9 380 187 (2.0) 5.8 6 829 442 (6.5) 0.7 
2000-01 9 843  200 (2.0) 0 6 956 550 (7.9) 1.4 
2001-02 9 972 279 (2.8) 0.8 6 921 584 (8.4) 0.5 
2002-03 10 078 360 (3.6) 0.8 7 207 737 (10.3) 1.9 
2003-04 9 973 510 (5.1) 1.5 7 269 938 (12.9) 2.6 
2004-05 10 081 953 (9.5) 4.4 7 463 1 358 (18.2) 5.3 
2005-06 10 326 1 539 (14.9) 5.4 7 615 1 521 (20.0) 1.8 
2006-07 10 907 2 109 (19.3) 4.4 7 753 1 849 (23.9) 3.9 
2007-08 11 303 2 596 (23.0) 3.7 7 616 1 952 (25.6) 1.7 
2008-09 11 056 3 179 (28.8) 5.8 7 735 2 200 (28.4) 2.8 
2009-10 10 953 3 639 (33.2) 4.4 7 891  2 459 (31.2) 2.8 
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Table 8-8 Laparoscopic partial nephrectomy; cancer versus non-cancer 
 Cancer Non-cancer 
Year Total 
N 
Laparoscopic 
n (%) 
Annual 
increase 
(%) 
Total 
N 
Laparoscopic 
n (%) 
Annual 
increase 
(%) 
1993-94 40 0 (0) - 130 5 (3.9) - 
1994-95 68 0 (0) - 126 0 (0) -3.9 
1995-96 50 0 (0) - 139 3 (2.2) 2.2 
1996-97 80 0 (0) - 142 5 (3.5) 1.3 
1997-98 82 0 (0) - 143 7 (4.9) 1.4 
1998-99 92 0 (0) - 158 13 (8.2) 3.3 
1999-00 125 5 (4.0) 4.0 154 9 (5.8) -2.4 
2000-01 117 0 (0) -4.0 102 0 (0) -5.8 
2001-02 154 0 (0) 0 138 1 (0.7) 0.7 
2002-03 180 12 (6.7) 6.7 135 16 (11.9) 11.2 
2003-04 195 19 (9.7) 3.0 149 20 (13.4) 1.5 
2004-05 252 34 (13.5) 3.8 159 27 (17.0) 3.6 
2005-06 302 56 (18.5) 5.0 162 39 (24.1) 7.1 
2006-07 324 76 (23.5) 5.0 182 44 (24.2) 0.1 
2007-08 345 86 (24.9) 1.4 157 44 (28.0) 3.8 
2008-09 401 123 (30.7) 5.8 197 63 (32.0) 4.0 
2009-10 500 162 (32.4) 1.7 222 75 (33.8) 1.8 
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Table 8-9 Laparoscopic radical nephrectomy; cancer versus non-cancer 
 Cancer Non-cancer 
Year Total 
N 
Laparoscopic 
n (%) 
Annual 
increase 
(%) 
Total 
N 
Laparoscopic 
n (%) 
Annual 
increase 
(%) 
1993-94 1 296 3 (0.2) - 992 16 (1.6) - 
1994-95 1 391 2 (0.1) -0.1 1 024 20 (2.0) 0.4 
1995-96 1 426 1 (0.1) 0 1 056 33 (3.1) 1.1 
1996-97 1 461 0 (0.0) -0.1 1 125 25 (2.2) -0.9 
1997-98 1 613 3 (0.2) 0.2 1 130 46 (4.1) 1.9 
1998-99 1 686 12 (0.7) 0.5 1 019 46 (4.5) 0.4 
1999-00 1 699 67 (3.9) 3.2 893 101 (11.3) 6.8 
2000-01 1 700 177 (10.4) 6.5 849 128 (15.1) 3.8 
2001-02 1 668 234 (14.0) 3.6 844 188 (22.3) 7.2 
2002-03 1 692 387 (22.9) 8.9 873 216 (24.7) 2.4 
2003-04 1 714 546 (31.9) 9.0 784 232 (29.6) 4.9 
2004-05 1 786 713 (39.9) 8.0 1 077 269 (25.0) -4.6 
2005-06 1 831 793 (43.3) 3.4 943 418 (44.3) 19.3 
2006-07 1 933 941 (46.7) 3.4 961 425 (44.2) -0.1 
2007-08 1 994 1 079 (54.9) 8.2 908 473 (52.1) 7.9 
2008-09 1 974 1 181 (59.8) 4.9 1 000 510 (51.0) -1.1 
2009-10 1 972 1 230 (62.4) 2.6 904 487 (53.9) 2.9 
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Chapter 9 Discussion 
Laparoscopic resection is a safe, effective and accepted treatment for patients with CRC. Patients 
having laparoscopic resection have a better overall experience than those having open resection 
because they encounter less intraoperative blood loss, reduced pain, reduced postoperative ileus and 
shorter hospital stay, and improved pulmonary function and quality of life.(21) Almost all patients 
with CRC are suitable for laparoscopic resection provided that they are treated by appropriately 
trained and experienced surgeons.  
The population is aging and because CRC primarily affects the older population, the number of 
elective colorectal resections is likely to increase. Also, increased population screening for CRC 
will result in the detection of tumours which might not have otherwise come to light during the 
patient’s life time, further increasing demand for laparoscopic resection. Further, population 
screening will mean that fewer cases present as emergencies; requiring emergency as opposed to 
elective resection will result in larger number of patients who are eligible for laparoscopic resection. 
An increasing proportion of patients moving from emergency to elective resection will also increase 
demand for laparoscopic resection. 
By analysing the uptake and diffusion of laparoscopic resection, the findings reported in this thesis 
can be used by policy-makers to ensure equitable, evidence-based access for all CRC patients.  This 
final chapter summarises the contribution of the studies that form this thesis to the current state of 
knowledge in the uptake of laparoscopic resection.  
9.1 Overview of findings  
9.1.1 Uptake and diffusion of laparoscopic procedures 
Chapter 5 describes a moderate uptake of laparoscopic resection for CRC across Australia. The 
annual percentages found in Australia are slightly higher than those reported in the United Kingdom 
by NICE.(65, 66) However, it is possible that the Australian percentages are inflated by the high 
annual percentages experienced in Queensland and that some Australian states and territories have 
annual percentages which are similar to those in the UK. Comparison was not made between the 
Australian states and territories because these data were not provided by AIHW. 
Although laparoscopic resection is performed in all types of hospitals (public and private, low-
volume and high-volume), patients treated in private hospitals were more likely to have 
laparoscopic resection. Disparity in the laparoscopic percentage between private and public 
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hospitals and between low- and high-volume hospitals reduced after 2003/2004 when there was a 
large increase in the percentage across all types of hospitals.  
In Queensland, there has been less disparity in uptake between hospital types. Referring to the 
findings in Chapter 6, although patients treated in high-volume private hospitals have been the most 
likely to have laparoscopic resection, the uptake of laparoscopic resection has also been rapid for 
the other hospital types. The exception is rectal resections in low-volume public hospitals, where 
very few rectal resections for cancer were performed. Rectal resections are more technically 
difficult to perform than segmental resections of the colon, and surgeons performing these will be 
among the most skilled and experienced.   
Reported laparoscopic percentages for CRC also vary greatly within the US. Based on data from the 
University Health System Consortium, the laparoscopic percentage for CRC from 2007 to 2009 was 
15%,(140) which is far less than reports of 50% from the National Inpatient Sample(70). 
In Queensland, where surgeons were early and rapid adopters of the technique, there was little 
disparity in the uptake of laparoscopic resection by procedure type and patient characteristics. That 
is, even the most complex procedures involving resection of the rectum or transverse colon were 
performed with laparoscopic access throughout the adoption of the technique. Similarly, patients 
presenting with complicating clinical comorbidities or advanced cancer were also selected for 
laparoscopic resection. The data used in Chapter 6 provides the opportunity to perform logistic 
regression analysis to determine predictors of laparoscopic resection over time. However, this is a 
different research question and outside of the scope of this thesis and may be addressed at a later 
date.  
No literature exists describing which patients are being selected for laparoscopic resection for CRC 
and whether disparities exist in the uptake between procedure and patient characteristics. A single-
hospital study reported an increase in the percentage of all colorectal resections for cancer which 
were considered suitable for laparoscopic resection from 38% in 1994-1997 to 94% in 2002-2005 of 
adoption.(43) The conclusion was that among experienced surgeons, the only elective procedures 
not suitable for laparoscopic resection for CRC are those with a history of complicated abdominal 
surgery and those with threatened margins in rectal cancer predicted using MRI.(43) Patients 
requiring emergency resection are not suitable for laparoscopic resection and are excluded from the 
studies presented in this thesis. 
Australian trends in the uptake of laparoscopic resection for CRC are compared with other 
laparoscopic procedures in Chapter 8. An association was found between the rate of uptake and the 
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complexity and risk associated with the procedure. Laparoscopic cholecystectomy was adopted very 
rapidly and almost all cholecystectomies were performed with laparoscopic access within four years 
of introduction. Laparoscopic hysterectomy, nephrectomy and colorectal resection are more 
technically complex and adoption of these procedures was much slower. Also, there were 
substantial variations in uptake of these procedures. Relative to laparoscopic colorectal resection, 
the uptake of laparoscopic hysterectomy has been very slow, while uptake of laparoscopic 
nephrectomy has been rapid. In fact, the uptake of laparoscopic radical nephrectomy for cancer has 
been more rapid than laparoscopic resection for CRC in Queensland. For colorectal resection, 
hysterectomy, and partial and total nephrectomy, adoption of laparoscopic approach was delayed 
for treatment of cancer compared with non-cancer indications. However, following the initial period 
of adoption, annual increases were similar for cancer and non-cancer indications. 
9.1.2 Hospital resource implications for laparoscopic resection for colorectal cancer 
In the 12 years between 1999/2000 and 2010/2011, more than 6000 Queenslanders received 
laparoscopic resection for CRC. Surgical teams in Queensland have performed large numbers of 
these procedures and are experienced in the technique. Chapter 7 describes the first study to report 
on the resource implications of laparoscopic resection for CRC in a location where adoption of the 
procedure is mature.  
When adoption is mature and surgeons are experienced in the technique, laparoscopic resection for 
CRC is associated with equivalent surgical duration to open resection. Previous studies and meta-
analyses have found laparoscopic resection is associated with longer surgical duration.(18, 35, 43, 
56, 59) Patients having laparoscopic resection utilise fewer hospital resources compared with 
patients having open resection. After adjusting for differences between the groups (age group of 
patient, sex, summary stage, Charlson comorbidity index, procedure type and hospital volume), 
patients having laparoscopic resection had a length of stay which was one day shorter, were 
admitted to intensive care less frequently and for shorter duration, had equivalent surgical duration 
and had a total cost of hospital stay which was $2 524 less. This is the first study to examine the 
impact that laparoscopic resection for CRC has on healthcare facilities using data from a location 
where the procedure is mature; and the likely reason why this is the first study to find cost savings 
for laparoscopic resection compared with open resection for CRC. 
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9.2 Synthesis of findings 
Increases in uptake of laparoscopic resection for CRC occurred around 2003/04, which coincided 
with several advancements in the field of laparoscopic resection for CRC. First, there were major 
improvements to the available equipment, namely the ultrasonic tissue dissector, high-definition 
videoendoscopy and better endoscopic stapling devices. Second, in Queensland particularly, 
surgeons were selecting more patients with CRC for laparoscopic resection because they had 
acquired adequate levels of experience. Finally, in 2004, long-term outcome data became available 
from one of the large RCTs, providing assurance in the long-term oncological safety of the 
procedure.(77)  
The findings in Chapter 6 indicate that whether a patient receives laparoscopic resection for CRC is 
determined by access to surgical teams who have the appropriate training, skills and experience, 
rather than the characteristics of the patient or procedure type. Laparoscopic resection for CRC is a 
complex procedure requiring advanced and specialised training. Training for laparoscopic resection 
is hierarchical because colorectal resection includes a range of procedures of varying complexity. 
For instance, surgeons must acquire adequate skills and experience in performing laparoscopic 
segmental resection of the left or right colon before progressing to the more technically difficult 
resections of the rectosigmoid colon, transverse colon or extraperitoneal rectum.  
It is important to ensure that surgeons have the opportunity to acquire the appropriate training and 
adequate experience to offer patients with CRC laparoscopic resection. Although uptake across 
Australia has been slow, especially in low-volume public hospitals, increases in the percentage of 
laparoscopic resection have been seen across all types of hospitals. This finding suggests that there 
is successful post-fellowship education and training of surgeons. That is, surgeons in low-volume 
public hospitals are gaining skills in this technique. 
However, the learning curve is long and there will always be surgeons in the earlier phase of 
training of laparoscopic resection for CRC, meaning that unless the more complex cases are 
referred to the more experienced surgeons, the percentage of patients selected for laparoscopic 
resection will continue to fall short of the previously suggested 90% of patients who are 
eligible.(43) Queensland has experienced high uptake in laparoscopic resection for all procedure 
types and all patients, regardless of complexity. We postulate that referral pathways were 
established early in the adoption of this technology, ensuring that most patients had the best 
opportunity to receive laparoscopic resection. Although this was not a result of policy, clinicians, 
healthcare policy-makers, planners and budget-holders from locations that are in the earlier phase of 
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adoption, may consider developing service capability frameworks, such as, restricting complex 
procedures to major hospitals with experienced surgeons.   
Health technology assessments evaluate the benefits, harms and cost-effectiveness of a new 
technology.(141) The evidence available for health technology assessments is usually based on 
experiences early in the adoption or uptake of an innovative technique. For example, the health 
technology assessment for laparoscopic resection for CRC conducted by the National Institute for 
Health and Clinical Excellence (UK) in 2006, estimated a higher cost for laparoscopic resection 
based on two studies from the early period of adoption.(18) The cost comparison presented in 
Chapter 7, shows that when the procedure is widely adopted and surgical teams are experienced in 
the technique, laparoscopic resection for CRC is associated with cost saving compared with open 
resection. It is therefore important that health technology assessments are systematically updated to 
include the latest available evidence.  
In Australia, there is no health technology assessment for laparoscopic resection for CRC and the 
clinical practice guidelines have not been updated since 2005.(8) Similarly for the other 
laparoscopic procedures; laparoscopic hysterectomy is only addressed in the clinical practice 
guidelines for ovarian cancer (2004). I also did not find recommendations in the form of clinical 
practice guidelines or health technology assessments for laparoscopic nephrectomy, laparoscopic 
cholecystectomy or laparoscopic fundoplasty. While laparoscopic cholecystectomy and fundoplasty 
are generally considered the “gold standard” in care, the uptake of laparoscopic hysterectomy 
continues to be very slow. It would be appropriate to update the Australian assessment of 
laparoscopic hysterectomy to bring recommendation in line with recent evidence.(97) For CRC, it is 
important that a contemporary recommendation is available, similar to those available in the 
UK,(18) Europe(46) and America(43, 44).  
According to Roger’ theories on the dynamics of diffusion, adoption acquires its own momentum at 
around 15-20% of adoption of an innovation, provided that there is contact between the innovators 
and early adopters with the early majority and late majority (Figure 2-6).(71) Marketing techniques 
to implement change in medical intervention include an informal setting in which an influential 
person imparts their local experiences to opinion leaders.(142) Within the medical community, 
social influence is a major driver for individual change.(72, 143) To ensure continued uptake of 
innovative techniques within their jurisdictions, it is important that clinicians and members of 
surgical teams have opportunities to attend conferences, forums and training programs.   
Evidence suggests that technological advances are generally associated with increased costs.(129) 
Even when technical advancement decreases the cost of providing a procedure to an individual 
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patient, there is more capital investment in the equipment, labour and expenses associated with the 
spread of knowledge.(129) In addition, greater availability is associated with greater per capita use 
and higher spending on those services.(129) For instance, there were rapid increases in the total 
number of cholecystectomies following the introduction of laparoscopic cholecystectomy. In 1998 
it was reported that, in New South Wales, the unit cost for laparoscopic cholecystectomy was lower 
because of a shorter length of stay; however, increases in the number of procedures meant that there 
were no net savings for the health system.(130)  
In Australia, the public healthcare system is able to contain costs in surgical innovation. For 
example, healthcare providers may limit the availability of specialised equipment necessary to 
perform the procedure, therefore limiting its uptake. Costs associated with surgical innovation are 
less of a problem among private hospitals where additional costs are passed on to patients and 
private health insurers. Consequently, the percentage of cholecystectomies that were laparoscopic in 
1995 was 96% among private hospitals compared with 71% among public hospitals in New South 
Wales.(130) However, if patients who are able to afford private healthcare are able to access the 
latest technology, then there is a moral obligation to ensure equal opportunities to public patients. 
The adoption of laparoscopic resection for CRC is unlikely to ever reach 100% of all eligible 
patients. Aside from patient preference and contra-indications for laparoscopic surgery, there will 
always be newer surgeons who are required to learn open surgical techniques as well as 
laparoscopic techniques. There will also be those who choose to perform a procedure with open 
access because they consider themselves not to have adequate skills and experience to perform 
certain procedures with laparoscopic access. For example, patients in rural settings may elect not 
travel to metropolitan centres for their treatment, where they are more likely to have laparoscopic 
resection, and the local surgeon/surgical team may choose to perform an open resection because 
they lack adequate experience to perform laparoscopic resection. 
9.3 Strengths and limitations 
The studies included in this thesis have several strengths.  
The main strength is that these studies utilise very large government databases which are likely to 
show the most representative and accurate account of service use in Queensland and National 
populations. These datasets are not usually available to researchers to conduct extensive analysis 
because of concerns about the privacy of individuals.   
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Chapter 5, Chapter 6 and Chapter 8 are observational studies based on routinely collected 
population-based hospital morbidity data sources. They include information for every patient 
admitted for the procedures of interest to public and private hospitals. Similar to hospital morbidity 
data, the costing data utilised in Chapter 7 is comprised of routinely collected population-based data 
for all public hospital patients in Queensland. Observational studies have the ability to include a 
broader range of patients than those selected for inclusion in RCTs.(144) Observational studies 
therefore usually have a larger sample size, are not subject to the same degree of selection bias and 
allow for assessment of clinical practice and outcomes in the “real world”.(89)  
However, these databases were designed for purposes other than research which pose potential 
methodological issues. For example, administrative databases such as hospital morbidity data were 
designed for billing purposes.(89) These databases usually contain primary and secondary 
diagnosis, information about procedures performed and demographic information.(139)  However, 
it has been suggested that data which directly results in reimbursement are likely to be better coded 
than comorbidities and complications.(138) Because they lack relevance for financial 
reimbursement, results for laboratory tests, pathology or radiology reports, and clinical measures 
such as blood pressure or height and weight are not usually recorded in population-based 
administrative data.(138, 139) Hospital morbidity data are routinely audited by each of the 
Australian states and territories to ensure complete and accurate coding of procedure and diagnosis 
codes. Procedure codes were the most important variable throughout this thesis; these are the main 
source of financial reimbursement to hospitals and are the most reliably documented codes.  
In the absence of some measures of potential confounders, the inclusion of surrogate measures in 
risk adjustment models is better than complete omission of a construct. For example, Chapter 4 
identified that summary stage for colorectal cancer determined from other diagnosis codes is a 
suitable surrogate measure for stage. This method was employed to adjust for potential confounders 
in the multivariate analyses in Chapter 7. 
This research program is largely based on Queensland data, a region with advanced adoption of 
laparoscopic resection for CRC in Queensland. Chapter 6 and Chapter 7 present the first studies to 
examine clinical practice and outcomes for laparoscopic resection for CRC in a location where the 
adoption is mature and surgeons are experienced in the technique.  
The studies included in this thesis demonstrate that routinely collected hospital data sources can 
provide current information on practices in surgery and patient management. Hospital morbidity 
data from each of Australia’s states and territories are collated annually to give the National 
Hospital Morbidity Dataset, and information on national trends and patterns of care is available for 
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admission prior to the past year. State level hospital morbidity datasets, such as the Queensland data 
used in this research program, are more current than the national data and can provide information 
to within one year. Data were usually attained within six months of the initial request and 
retrospective data dating back to 1993 could be sourced.  
For CRC, there is currently no procedure code to identify planned laparoscopic colorectal resection 
converted to open resection. A planned laparoscopic resection converted to an open resection due to 
complications at the time of surgery, are coded in the hospital morbidity data as laparoscopic. This 
thesis therefore presents intention-to-treat analyses. Importantly, the conversion rate for patients 
with CRC in Queensland was identified as 7% in the early period of adoption,(64) and has probably 
decreased further with increasing surgical experience.  
9.4 Further research 
Lomas wrote;  
“Even with research information that, after diffusion, has been synthesized and then 
disseminated by a credible body, its impact is likely to go no further than the awareness, 
attitude, and knowledge of the physician without active and coordinated implementation 
efforts.”(145), p.230  
This study does not address methods of effective implementation of innovative surgery, ways to 
improve uptake, barriers to uptake, or who the key stakeholders are in improving uptake and 
increasing access to laparoscopic resection for CRC. However, this would be a valuable area of 
research that would probably require qualitative methods. For instance, it would be beneficial to 
discover from health service delivery providers, including clinicians and healthcare planners, 
policy-makers and budget-holders, their degree of understanding around laparoscopic resection for 
CRC, the need to improve access and to identify what is required to implement change. This 
process would benefit from close collaboration with clinicians through the Colorectal Surgical 
Society of Australia and New Zealand, and relevant state-level health policy departments.  
Regular monitoring of the implementation and diffusion of innovative techniques is important for 
resource management, planning of resource allocation and to ensure patients have equitable access 
to effective innovative techniques. This thesis has demonstrated that population-based routine data 
are suitable data sources to perform this function. As the custodians of these data, Queensland 
Health and other state and territory departments of health could investigate means to maximise the 
potential of these data sources; not only in terms of resources to perform data analytics, but also to 
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include information such as stage at diagnosis, required to conduct outcomes analysis. These data 
sources hold the potential to be used by Departments of Health to guide policy, perform health 
services research, measure the safety and effectiveness of patient care, and to understand the 
diffusion of innovative techniques in healthcare. While laparoscopic surgery was the innovative 
surgical technology in the early 1990s, robotic surgery is the current innovating technique in 
surgery, and, in the future, other innovative technologies will emerge. The methods used throughout 
this thesis as well as the potential lessons learnt from conducting studies into effective 
implementation techniques and enhancing the utility of government managed, routinely collected, 
population-based data sources may be applied to emerging technologies in the future. 
9.5 Conclusion 
Laparoscopic resection for CRC is supported by evidence from large multi-centre RCTs which have 
shown benefits to patients in the short-term, and equivalent oncological outcomes in the long-term. 
Despite this, Australia has experienced a relatively slow uptake of this procedure among public 
hospitals in particular. In Queensland, where there was rapid uptake of laparoscopic resection for 
CRC, all patients received laparoscopic resection regardless of complexity of the procedure, the 
extent of the disease (summary stage) and comorbidities of the patient. This suggests that the more 
technically difficult procedures or clinically complex cases were appropriately referred to the more 
experienced surgical teams. Importantly, in terms of benefits to the healthcare system, this thesis 
has demonstrated that laparoscopic resection for colorectal CRC is less expensive than open 
resection.  
The research questions included in this thesis are based on routinely collected population-based data 
sources which are government owned and managed. These studies have been effective in 
demonstrating the utility of these data sources for describing uptake and differentials in patient care, 
as well as for measuring hospital resource utilisation.  
The findings from this thesis can be used by healthcare providers including clinicians, policy-
makers, budget-holders and healthcare planners, to plan and manage the uptake of laparoscopic 
resection for CRC.  
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Appendix 1 Data obtained for this thesis 
 
Research 
Chapter 
Data source Variables/fields accessed Years extracted Date data obtained Comments 
Chapter 4 QHAPDC Variables used for linkage: 
Facility identifier 
Date of Birth 
Dates of admission and discharge 
Date of procedure 
Sex 
Procedure codes 
Variables used for analysis: 
Secondary diagnosis codes 
1st June 2001 to 
30th June 2008 
3rd June 2009 The years extracted from QHAPDC 
was determined by the data available 
from the clinical cancer registry. 
De-identified patient level data. 
 
 
 
Chapter 5 NHMD Aggregated data with counts for the 
numerator (laparoscopic) and 
denominator (all resections for CRC). 
The counts were stratified by the 
following: 
- Public hospital/private hospital 
- Low volume/high volume (40+ 
resection CRC/year) 
- Segmental resections of the colon / 
rectal resections 
- Year (e.g. 1999/00, 2000/01) 
1st July 1999 to 
30th June 2008 
22nd February 2010 This date range was determined by 
implementation of the ICD-10 (as 
opposed to ICD-9), until the most 
recent available data at the time of 
extraction. 
Cohort: 
All hospital admissions with a 
diagnosis code for CRC and a 
concurrent procedure code for 
resection of the colon or rectum. 
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Research 
Chapter 
Data source Variables/fields accessed Years extracted Date data obtained Comments 
Chapter 6 QHAPDC - Public hospital/private hospital 
- High volume (Yes/No) (40+ 
resection CRC/year) 
- Sex 
- Age (years) 
- ARIA+  
- SEIFA 
- Year (e.g. 1999/00, 2000/01) 
- Length of stay (days) 
- ICU admission (Yes/No) 
- Elective/Emergency admission 
- Death within 30 days of discharge 
(Yes/No) 
- Death within 30 days of procedure 
(Yes/No)  
- Principle Diagnosis 
- Other diagnoses (1 to 47) 
- Procedure (1 to 64) 
1st July 1999 to 
30th June 2011 
24th February 2012 This date range was determined by 
implementation of the ICD-10 (as 
opposed to ICD-9), until the most 
recent available data at the time of 
extraction. 
De-identified patient level data. 
Cohort: 
All hospital admissions with a 
diagnosis code for CRC and a 
concurrent procedure code for 
resection of the colon or rectum. 
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Research 
Chapter 
Data source Variables/fields accessed Years extracted Date data obtained Comments 
Chapter 7 Transition II - Sex 
- Age (years) 
- Procedure code (1 to 3) (resection of 
the colon or rectum only) 
- Principle diagnosis (CRC only) 
- Laparoscopic procedure code 
(Yes/No) 
- LOS (days) 
- Date of admission 
- Date of discharge 
- Days admitted to ICU 
- Total cost of admission 
- Total cost of theatre 
- Total cost of anaesthesia 
- Total cost of imaging 
- Total cost of pharmacy 
- Total cost of pathology 
- Duration of anaesthesia (mins) 
- Duration of surgery (mins) 
1st July 2009 to 
30th June 2011 
15th August 2011 Two years of the most recently 
available data were considered 
appropriate as it would provide 
adequate sample size.  
Cohort: 
All public hospital admissions with a 
diagnosis code for CRC and a 
concurrent procedure code for 
resection of the colon or rectum. 
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Note: QHAPDC = Queensland Hospital Admitted Patients Data Collection, NHMD = National Hospital Morbidity data 
Research 
Chapter 
Data source Variables/fields accessed Years extracted Date data obtained Comments 
Chapter 8 NHMD - Year  
- Procedures (1 to 5) 
- Diagnosis (1 to 3) 
1st July 1993 to 
30th June 2010 
25th January 2012 Procedure and diagnoses were 
provided for a specified list only. For 
most procedure types. the 2nd to 4th 
procedure codes identified a 
concurrent laparoscopic code, while 
procedure code 1 determined the 
major procedure type (e.g. liver 
resection).  
